<!DOCTYPE html>
<!-- saved from url=(0076)https://pubmed.ncbi.nlm.nih.gov/?term=chatGPT&page=15&format=pubmed&size=200 -->
<html lang="en"><head itemscope="" itemtype="http://schema.org/WebPage" prefix="og: http://ogp.me/ns#"><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
  <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov/">
  <link rel="preconnect" href="https://www.ncbi.nlm.nih.gov/">
  <link rel="preconnect" href="https://www.google-analytics.com/">

  
  
    <link rel="stylesheet" href="./page15_PubMed_files/output.5ecf62baa0fa.css" type="text/css">
  

  <link rel="stylesheet" href="./page15_PubMed_files/output.452c70ce66f7.css" type="text/css">

  
    
  

  
    <link rel="stylesheet" href="./page15_PubMed_files/output.97c300a159d1.css" type="text/css">
  

  


    <title>chatGPT - Search Results - PubMed</title>

  
  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico">
  <link rel="icon" type="image/png" href="https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png">

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png">

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">


  <!-- For Pinger + Google Optimize integration (NS-820) -->
  <meta name="ncbi_sg_optimize_id" content="">

  <!-- Mobile browser address bar color -->
  <meta name="theme-color" content="#20558a">

  <!-- Preserve the Referrer when going from HTTPS to HTTP -->
  <meta name="referrer" content="origin-when-cross-origin">

  <meta name="ncbi_pinger_gtm_track" content="true">
<!-- Logging params: Pinger defaults -->

  
    <meta name="ncbi_app" content="pubmed">
  

  
    <meta name="ncbi_db" content="pubmed">
  

  
    <meta name="ncbi_phid" content="658B00010FEE1FF500003A9584A35DC9.1.m_7">
  

  
    <meta name="ncbi_pinger_stat_url" content="https://www.ncbi.nlm.nih.gov/stat">
  

  
    <meta name="log_category" content="literature">
  

  
    <meta name="ncbi_cost_center" content="pubmed">
  



  <!-- Logging params: Pinger custom -->
  
    <meta name="log_op" content="search">
  
    <meta name="log_query" content="chatGPT">
  
    <meta name="ncbi_pdid" content="searchresult">
  
    <meta name="ncbi_pageno" content="15">
  
    <meta name="log_resultcount" content="2844">
  
    <meta name="log_userterm" content="chatGPT">
  
    <meta name="log_processedquery" content="&quot;chatGPT&quot;[All Fields]">
  
    <meta name="log_filtersactive" content="False">
  
    <meta name="log_filters" content="">
  
    <meta name="ncbi_log_query" content="chatGPT">
  
    <meta name="log_proximity_search_active" content="False">
  
    <meta name="log_format" content="pubmed">
  
    <meta name="log_sortorder" content="relevance">
  
    <meta name="log_pagesize" content="200">
  
    <meta name="log_displayeduids" content="37620423,37815442,36865161,37809482,38460841,38459362,38206661,38297371,37394024,38276872,38261580,37973919,38564079,37998082,38343631,37812419,37794316,38402209,37948788,38251407,38228575,38329526,38397498,38246117,38521241,38399078,38473838,38408584,37103054,37956558,37558532,38560589,38282327,38076325,37611418,37298303,38549836,38313196,38521362,38000386,37900350,37782499,38547639,38379510">
  
    <meta name="ncbi_search_id" content="R3Cs2GC7H0x0KE8U7UASSA:deef7cbfe7e81e7152f8e0e261e5ab1a">
  
    <meta name="ncbi_adj_nav_search_id" content="3WnQ-z7nmvUyGdL6DPMXMg:fbd847f89c96214ac23b7c62d7cb721a">
  



  <!-- Social meta tags for unfurling urls -->
  
<meta name="description" content="chatGPT - Search Results - PubMed"><meta name="robots" content="noindex,follow,noarchive"><meta property="og:title" content="chatGPT - Search Results - PubMed"><meta property="og:url" content="https://pubmed.ncbi.nlm.nih.gov/?term=chatGPT&amp;page=15&amp;format=pubmed&amp;size=200"><meta property="og:description" content="chatGPT - Search Results - PubMed"><meta property="og:image" content="https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image-v2.jpg"><meta property="og:image:secure_url" content="https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image-v2.jpg"><meta property="og:type" content="website"><meta property="og:site_name" content="PubMed"><meta name="twitter:domain" content="pubmed.ncbi.nlm.nih.gov"><meta name="twitter:card" content="summary_large_image"><meta name="twitter:title" content="chatGPT - Search Results - PubMed"><meta name="twitter:url" content="https://pubmed.ncbi.nlm.nih.gov/?term=chatGPT&amp;page=15&amp;format=pubmed&amp;size=200"><meta name="twitter:description" content="chatGPT - Search Results - PubMed"><meta name="twitter:image" content="https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image-v2.jpg">


  <!-- OpenSearch XML -->
  <link rel="search" type="application/opensearchdescription+xml" href="https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/opensearch.xml" title="PubMed search">

  <!-- Disables severely broken elements when no JS -->
  <noscript>
    <link rel="stylesheet" type="text/css" href="https://cdn.ncbi.nlm.nih.gov/pubmed/09ad9aad-98d9-47ec-b2ea-fb4dba3d550d/core/no-script.css">
  </noscript>

  
    <link rel="canonical" href="https://pubmed.ncbi.nlm.nih.gov/?term=chatGPT&amp;page=15&amp;format=pubmed&amp;size=200">
  


</head>
<body>

  
  <main class="search-page" id="search-page">
    <div class="search-results" id="search-results">
      
        <pre class="search-results-chunk">PMID- 37620423
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240402
IS  - 2398-6352 (Electronic)
IS  - 2398-6352 (Linking)
VI  - 6
IP  - 1
DP  - 2023 Aug 24
TI  - Evaluating large language models on medical evidence summarization.
PG  - 158
LID - 10.1038/s41746-023-00896-7 [doi]
LID - 158
AB  - Recent advances in large language models (LLMs) have demonstrated remarkable 
      successes in zero- and few-shot performance on various downstream tasks, paving 
      the way for applications in high-stakes domains. In this study, we systematically 
      examine the capabilities and limitations of LLMs, specifically GPT-3.5 and 
      ChatGPT, in performing zero-shot medical evidence summarization across six 
      clinical domains. We conduct both automatic and human evaluations, covering 
      several dimensions of summary quality. Our study demonstrates that automatic 
      metrics often do not strongly correlate with the quality of summaries. 
      Furthermore, informed by our human evaluations, we define a terminology of error 
      types for medical evidence summarization. Our findings reveal that LLMs could be 
      susceptible to generating factually inconsistent summaries and making overly 
      convincing or uncertain statements, leading to potential harm due to 
      misinformation. Moreover, we find that models struggle to identify the salient 
      information and are more error-prone when summarizing over longer textual 
      contexts.
CI  - © 2023. Springer Nature Limited.
FAU - Tang, Liyan
AU  - Tang L
AD  - School of Information, The University of Texas at Austin, Austin, TX, USA.
FAU - Sun, Zhaoyi
AU  - Sun Z
AUID- ORCID: 0009-0003-8197-1465
AD  - Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, 
      USA.
FAU - Idnay, Betina
AU  - Idnay B
AUID- ORCID: 0000-0002-4318-5987
AD  - Department of Biomedical Informatics, Columbia University, New York, NY, USA.
FAU - Nestor, Jordan G
AU  - Nestor JG
AUID- ORCID: 0000-0003-1418-3103
AD  - Department of Medicine, Columbia University, New York, NY, USA.
FAU - Soroush, Ali
AU  - Soroush A
AUID- ORCID: 0000-0001-6900-5596
AD  - Department of Medicine, Columbia University, New York, NY, USA.
FAU - Elias, Pierre A
AU  - Elias PA
AUID- ORCID: 0000-0002-9643-3024
AD  - Department of Biomedical Informatics, Columbia University, New York, NY, USA.
FAU - Xu, Ziyang
AU  - Xu Z
AD  - Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
FAU - Ding, Ying
AU  - Ding Y
AD  - School of Information, The University of Texas at Austin, Austin, TX, USA.
FAU - Durrett, Greg
AU  - Durrett G
AD  - Department of Computer Science, The University of Texas at Austin, Austin, TX, 
      USA.
FAU - Rousseau, Justin F
AU  - Rousseau JF
AUID- ORCID: 0000-0002-2817-9124
AD  - Departments of Population Health and Neurology, Dell Medical School, The 
      University of Texas at Austin, Austin, TX, USA. 
      justin.rousseau@utsouthwestern.edu.
AD  - Department of Neurology, University of Texas Southwestern Medical Center, Dallas, 
      TX, USA. justin.rousseau@utsouthwestern.edu.
FAU - Weng, Chunhua
AU  - Weng C
AUID- ORCID: 0000-0002-9624-0214
AD  - Department of Biomedical Informatics, Columbia University, New York, NY, USA. 
      cw2384@cumc.columbia.edu.
FAU - Peng, Yifan
AU  - Peng Y
AUID- ORCID: 0000-0001-9309-8331
AD  - Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, 
      USA. yip4002@med.cornell.edu.
LA  - eng
GR  - R01 LM014306/LM/NLM NIH HHS/United States
GR  - T15 LM007079/LM/NLM NIH HHS/United States
GR  - R00 LM013001/LM/NLM NIH HHS/United States
GR  - R01 LM009886/LM/NLM NIH HHS/United States
GR  - P30 AG066462/AG/NIA NIH HHS/United States
GR  - P30 CA013696/CA/NCI NIH HHS/United States
GR  - KL2 TR001874/TR/NCATS NIH HHS/United States
GR  - R01 LM014344/LM/NLM NIH HHS/United States
PT  - Journal Article
DEP - 20230824
PL  - England
TA  - NPJ Digit Med
JT  - NPJ digital medicine
JID - 101731738
UOF - medRxiv. 2023 Apr 24;:. PMID: 37162998
PMC - PMC10449915
COIS- The authors declare no competing interests.
EDAT- 2023/08/25 00:42
MHDA- 2023/08/25 00:43
PMCR- 2023/08/24
CRDT- 2023/08/24 23:27
PHST- 2023/05/25 00:00 [received]
PHST- 2023/08/03 00:00 [accepted]
PHST- 2023/08/25 00:43 [medline]
PHST- 2023/08/25 00:42 [pubmed]
PHST- 2023/08/24 23:27 [entrez]
PHST- 2023/08/24 00:00 [pmc-release]
AID - 10.1038/s41746-023-00896-7 [pii]
AID - 896 [pii]
AID - 10.1038/s41746-023-00896-7 [doi]
PST - epublish
SO  - NPJ Digit Med. 2023 Aug 24;6(1):158. doi: 10.1038/s41746-023-00896-7.

PMID- 37815442
OWN - NLM
STAT- MEDLINE
DCOM- 20231011
LR  - 20231105
IS  - 1527-1315 (Electronic)
IS  - 0033-8419 (Print)
IS  - 0033-8419 (Linking)
VI  - 309
IP  - 1
DP  - 2023 Oct
TI  - Feasibility of Using the Privacy-preserving Large Language Model Vicuna for 
      Labeling Radiology Reports.
PG  - e231147
LID - 10.1148/radiol.231147 [doi]
LID - e231147
AB  - Background Large language models (LLMs) such as ChatGPT, though proficient in 
      many text-based tasks, are not suitable for use with radiology reports due to 
      patient privacy constraints. Purpose To test the feasibility of using an 
      alternative LLM (Vicuna-13B) that can be run locally for labeling radiography 
      reports. Materials and Methods Chest radiography reports from the MIMIC-CXR and 
      National Institutes of Health (NIH) data sets were included in this retrospective 
      study. Reports were examined for 13 findings. Outputs reporting the presence or 
      absence of the 13 findings were generated by Vicuna by using a single-step or 
      multistep prompting strategy (prompts 1 and 2, respectively). Agreements between 
      Vicuna outputs and CheXpert and CheXbert labelers were assessed using Fleiss κ. 
      Agreement between Vicuna outputs from three runs under a hyperparameter setting 
      that introduced some randomness (temperature, 0.7) was also assessed. The 
      performance of Vicuna and the labelers was assessed in a subset of 100 NIH 
      reports annotated by a radiologist with use of area under the receiver operating 
      characteristic curve (AUC). Results A total of 3269 reports from the MIMIC-CXR 
      data set (median patient age, 68 years [IQR, 59-79 years]; 161 male patients) and 
      25 596 reports from the NIH data set (median patient age, 47 years [IQR, 32-58 
      years]; 1557 male patients) were included. Vicuna outputs with prompt 2 showed, 
      on average, moderate to substantial agreement with the labelers on the MIMIC-CXR 
      (κ median, 0.57 [IQR, 0.45-0.66] with CheXpert and 0.64 [IQR, 0.45-0.68] with 
      CheXbert) and NIH (κ median, 0.52 [IQR, 0.41-0.65] with CheXpert and 0.55 [IQR, 
      0.41-0.74] with CheXbert) data sets, respectively. Vicuna with prompt 2 performed 
      at par (median AUC, 0.84 [IQR, 0.74-0.93]) with both labelers on nine of 11 
      findings. Conclusion In this proof-of-concept study, outputs of the LLM Vicuna 
      reporting the presence or absence of 13 findings on chest radiography reports 
      showed moderate to substantial agreement with existing labelers. © RSNA, 2023 
      Supplemental material is available for this article. See also the editorial by 
      Cai in this issue.
FAU - Mukherjee, Pritam
AU  - Mukherjee P
AUID- ORCID: 0000-0002-9975-9994
AD  - From the Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Department 
      of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, 
      Bldg 10, Room 1C224D, 10 Center Dr, Bethesda, MD 20892-1182.
FAU - Hou, Benjamin
AU  - Hou B
AD  - From the Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Department 
      of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, 
      Bldg 10, Room 1C224D, 10 Center Dr, Bethesda, MD 20892-1182.
FAU - Lanfredi, Ricardo B
AU  - Lanfredi RB
AUID- ORCID: 0000-0001-8740-5796
AD  - From the Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Department 
      of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, 
      Bldg 10, Room 1C224D, 10 Center Dr, Bethesda, MD 20892-1182.
FAU - Summers, Ronald M
AU  - Summers RM
AUID- ORCID: 0000-0001-8081-7376
AD  - From the Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Department 
      of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, 
      Bldg 10, Room 1C224D, 10 Center Dr, Bethesda, MD 20892-1182.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Intramural
PL  - United States
TA  - Radiology
JT  - Radiology
JID - 0401260
SB  - IM
CIN - Radiology. 2023 Oct;309(1):e232335. PMID: 37815443
MH  - United States
MH  - Humans
MH  - Male
MH  - Animals
MH  - Aged
MH  - Middle Aged
MH  - *Camelids, New World
MH  - Privacy
MH  - Feasibility Studies
MH  - Retrospective Studies
MH  - Language
MH  - *Radiology
PMC - PMC10623189
COIS- Disclosures of conflicts of interest: P.M. No relevant relationships. B.H. No 
      relevant relationships. R.B.L. No relevant relationships. R.M.S. Cooperative 
      research and development agreement with PingAn; patent royalties or software 
      licenses from iCAD, Philips, PingAn, ScanMed, Translation Holdings, and MBG; 
      advisory board member for Duke University.
EDAT- 2023/10/10 12:43
MHDA- 2023/10/11 06:45
PMCR- 2024/10/01
CRDT- 2023/10/10 09:52
PHST- 2024/10/01 00:00 [pmc-release]
PHST- 2023/10/11 06:45 [medline]
PHST- 2023/10/10 12:43 [pubmed]
PHST- 2023/10/10 09:52 [entrez]
AID - 10.1148/radiol.231147 [doi]
PST - ppublish
SO  - Radiology. 2023 Oct;309(1):e231147. doi: 10.1148/radiol.231147.

PMID- 36865161
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231108
DP  - 2023 Feb 22
TI  - Arf6 Regulates Endocytosis and Angiogenesis by Promoting Filamentous Actin 
      Assembly.
LID - 2023.02.22.529543 [pii]
LID - 10.1101/2023.02.22.529543 [doi]
AB  - Clathrin-mediated endocytosis (CME) is a process vital to angiogenesis as well as 
      general vascular homeostasis. In pathologies where supraphysiological growth 
      factor signaling underlies disease etiology, such as in diabetic retinopathy and 
      solid tumors, strategies to limit chronic growth factor signaling by way of CME 
      have been shown to have tremendous clinical value. ADP ribosylation factor 6 
      (Arf6) is a small GTPase that promotes the assembly of actin necessary for CME. 
      In its absence, growth factor signaling is greatly diminished, which has been 
      shown to ameliorate pathological signaling input in diseased vasculature. 
      However, it is less clear if there are bystander effects related to loss of Arf6 
      on angiogenic behaviors. Our goal was to provide a analysis of Arf6â€™s function 
      in angiogenic endothelium, focusing on its role in lumenogenesis as well as its 
      relation to actin and CME. We found that Arf6 localized to both filamentous actin 
      and sites of CME in 2-dimensional culture. Loss of Arf6 distorted both apicobasal 
      polarity and reduced the total cellular filamentous actin content, and this may 
      be the primary driver underlying gross dysmorphogenesis during angiogenic 
      sprouting in its absence. Our findings highlight that endothelial Arf6 is a 
      potent mediator of both actin regulation and CME.
FAU - Francis, Caitlin R
AU  - Francis CR
AD  - Department of Biological Sciences, University of Denver, Denver, CO.
FAU - Bell, Makenzie L
AU  - Bell ML
AD  - Department of Biological Sciences, University of Denver, Denver, CO.
FAU - Skripnichuk, Marina M
AU  - Skripnichuk MM
AD  - Department of Biological Sciences, University of Denver, Denver, CO.
FAU - Kushner, Erich J
AU  - Kushner EJ
AD  - Department of Biological Sciences, University of Denver, Denver, CO.
LA  - eng
GR  - R01 HL155921/HL/NHLBI NIH HHS/United States
GR  - R15 HL156106/HL/NHLBI NIH HHS/United States
PT  - Preprint
DEP - 20230222
PL  - United States
TA  - bioRxiv
JT  - bioRxiv : the preprint server for biology
JID - 101680187
UIN - Microcirculation. 2023 Sep 26;:e12831. PMID: 37750425
PMC - PMC9980066
COIS- DISCLOSURES Authors declare no competing interests. No part of this manuscript 
      was created by AI or ChatGPT
EDAT- 2023/03/04 06:00
MHDA- 2023/03/04 06:01
PMCR- 2023/03/02
CRDT- 2023/03/03 02:28
PHST- 2023/03/03 02:28 [entrez]
PHST- 2023/03/04 06:00 [pubmed]
PHST- 2023/03/04 06:01 [medline]
PHST- 2023/03/02 00:00 [pmc-release]
AID - 2023.02.22.529543 [pii]
AID - 10.1101/2023.02.22.529543 [doi]
PST - epublish
SO  - bioRxiv [Preprint]. 2023 Feb 22:2023.02.22.529543. doi: 
      10.1101/2023.02.22.529543.

PMID- 37809482
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231031
IS  - 2405-8440 (Print)
IS  - 2405-8440 (Electronic)
IS  - 2405-8440 (Linking)
VI  - 9
IP  - 9
DP  - 2023 Sep
TI  - Are paid tools worth the cost? A prospective cross-over study to find the right 
      tool for plagiarism detection.
PG  - e19194
LID - 10.1016/j.heliyon.2023.e19194 [doi]
LID - e19194
AB  - BACKGROUND: The increasing pressure to publish research has led to a rise in 
      plagiarism incidents, creating a need for effective plagiarism detection 
      software. The importance of this study lies in the high cost variation amongst 
      the available options for plagiarism detection. By uncovering the advantages of 
      these low-cost or free alternatives, researchers could access the appropriate 
      tools for plagiarism detection. This is the first study to compare four 
      plagiarism detection tools and assess factors impacting their effectiveness in 
      identifying plagiarism in AI-generated articles. METHODOLOGY: A prospective 
      cross-over study was conducted with the primary objective to compare Overall 
      Similarity Index(OSI) of four plagiarism detection software(iThenticate, 
      Grammarly, Small SEO Tools, and DupliChecker) on AI-generated articles. ChatGPT 
      was used to generate 100 articles, ten from each of ten general domains affecting 
      various aspects of life. These were run through four software, recording the OSI. 
      Flesch Reading Ease Score(FRES), Gunning Fog Index(GFI), and Flesch-Kincaid Grade 
      Level(FKGL) were used to assess how factors, such as article length and language 
      complexity, impact plagiarism detection. RESULTS: The study found significant 
      variation in OSI(p&nbsp;&lt;&nbsp;0.001) among the four software, with Grammarly having the 
      highest mean rank(3.56) and Small SEO Tools having the lowest(1.67). Pairwise 
      analyses revealed significant differences(p&nbsp;&lt;&nbsp;0.001) between all pairs except for 
      Small SEO Tools-DupliChecker. Number of words showed a significant correlation 
      with OSI for iThenticate(p&nbsp;&lt;&nbsp;0.05) but not for the other three. FRES had a 
      positive correlation, and GFI had a negative correlation with OSI by 
      DupliChecker. FKGL negatively correlated with OSI by Small SEO Tools and 
      DupliChecker. CONCLUSION: Grammarly is unexpectedly most effective in detecting 
      plagiarism in AI-generated articles compared to the other tools. This could be 
      due to different softwares using diverse data sources. This highlights the 
      potential for lower-cost plagiarism detection tools to be utilized by 
      researchers.
CI  - © 2023 The Authors.
FAU - Anil, Abhishek
AU  - Anil A
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Saravanan, Aswini
AU  - Saravanan A
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Singh, Surjit
AU  - Singh S
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Shamim, Muhammad Aaqib
AU  - Shamim MA
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Tiwari, Krishna
AU  - Tiwari K
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Lal, Hina
AU  - Lal H
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Seshatri, Shanmugapriya
AU  - Seshatri S
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Gomaz, Simi Bridjit
AU  - Gomaz SB
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Karat, Thoyyib P
AU  - Karat TP
AD  - Department of Dermatology, Venereology and Leprosy, All India Institute of 
      Medical Sciences, Jodhpur, Rajasthan-342005, India.
FAU - Dwivedi, Pradeep
AU  - Dwivedi P
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Varthya, Shoban Babu
AU  - Varthya SB
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Kaur, Rimple Jeet
AU  - Kaur RJ
AD  - Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, 
      Rajasthan-342005, India.
FAU - Satapathy, Prakasini
AU  - Satapathy P
AD  - Global Center for Evidence Synthesis, Chandigarh-160036, India.
FAU - Padhi, Bijaya Kumar
AU  - Padhi BK
AD  - Department of Community Medicine and School of Public Health, Postgraduate 
      Institute of Medical Education and Research, Chandigarh - 160012, India.
FAU - Gaidhane, Shilpa
AU  - Gaidhane S
AD  - One Health Centre (COHERD), Jawaharlal Nehru Medical College, Datta Meghe 
      Institute of Higher Education, Wardha - 442001, India.
FAU - Patil, Manoj
AU  - Patil M
AD  - Division of Evidence Synthesis, School of Epidemiology and Public Health and 
      Research, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher 
      Education, Wardha - 442001, India.
FAU - Khatib, Mahalaqua Nazli
AU  - Khatib MN
AD  - Division of Evidence Synthesis, Global Consortium of Public Health and Research, 
      Datta Meghe Institute of Higher Education and Research, Wardha - 442001, India.
FAU - Barboza, Joshuan J
AU  - Barboza JJ
AD  - Escuela de Medicina, Universidad Cesar Vallejo, Trujillo, 13007, Peru.
FAU - Sah, Ranjit
AU  - Sah R
AD  - Tribhuvan University Teaching Hospital, Kathmandu - 46000, Nepal.
AD  - Department of Clinical Microbiology, DY Patil Medical College, Hospital and 
      Research Centre, DY Patil Vidyapeeth, Pune - 411000, Maharashtra, India.
AD  - Department of Public Health Dentistry, Dr. D.Y. Patil Dental College and 
      Hospital, Dr. D.Y. Patil Vidyapeeth, Pune - 411018, Maharashtra, India.
LA  - eng
PT  - Journal Article
DEP - 20230824
PL  - England
TA  - Heliyon
JT  - Heliyon
JID - 101672560
PMC - PMC10558310
OTO - NOTNLM
OT  - DupliChecker
OT  - Grammarly
OT  - Overall similarity index
OT  - Plagiarism
OT  - Small SEO tools
OT  - iThenticate
COIS- The authors declare that they have no known competing financial interests or 
      personal relationships that could have appeared to influence the work reported in 
      this paper.
EDAT- 2023/10/09 06:42
MHDA- 2023/10/09 06:43
PMCR- 2023/08/24
CRDT- 2023/10/09 05:55
PHST- 2023/06/01 00:00 [received]
PHST- 2023/08/14 00:00 [revised]
PHST- 2023/08/15 00:00 [accepted]
PHST- 2023/10/09 06:43 [medline]
PHST- 2023/10/09 06:42 [pubmed]
PHST- 2023/10/09 05:55 [entrez]
PHST- 2023/08/24 00:00 [pmc-release]
AID - S2405-8440(23)06402-2 [pii]
AID - e19194 [pii]
AID - 10.1016/j.heliyon.2023.e19194 [doi]
PST - epublish
SO  - Heliyon. 2023 Aug 24;9(9):e19194. doi: 10.1016/j.heliyon.2023.e19194. eCollection 
      2023 Sep.

PMID- 38460841
OWN - NLM
STAT- Publisher
LR  - 20240401
IS  - 1532-429X (Electronic)
IS  - 1097-6647 (Print)
IS  - 1097-6647 (Linking)
VI  - 26
IP  - 1
DP  - 2024 Mar 7
TI  - Generative Pre-trained Transformer 4 makes cardiovascular magnetic resonance 
      reports easy to understand.
PG  - 101035
LID - S1097-6647(24)01026-3 [pii]
LID - 10.1016/j.jocmr.2024.101035 [doi]
LID - 101035
AB  - BACKGROUND: Patients are increasingly using Generative Pre-trained Transformer 4 
      (GPT-4) to better understand their own radiology findings. PURPOSE: To evaluate 
      the performance of GPT-4 in transforming cardiovascular magnetic resonance (CMR) 
      reports into text that is comprehensible to medical laypersons. METHODS: ChatGPT 
      with GPT-4 architecture was used to generate three different explained versions 
      of 20 various CMR reports (n = 60) using the same prompt: "Explain the radiology 
      report in a language understandable to a medical layperson". Two cardiovascular 
      radiologists evaluated understandability, factual correctness, completeness of 
      relevant findings, and lack of potential harm, while 13 medical laypersons 
      evaluated the understandability of the original and the GPT-4 reports on a Likert 
      scale (1 "strongly disagree", 5 "strongly agree"). Readability was measured using 
      the Automated Readability Index (ARI). Linear mixed-effects models (values given 
      as median [interquartile range]) and intraclass correlation coefficient (ICC) 
      were used for statistical analysis. RESULTS: GPT-4 reports were generated on 
      average in 52&nbsp;s&nbsp;±&nbsp;13. GPT-4 reports achieved a lower ARI score (10 [9-12] vs 5 
      [4-6]; p&nbsp;&lt;&nbsp;0.001) and were subjectively easier to understand for laypersons than 
      original reports (1 [1] vs 4 [4,5]; p&nbsp;&lt;&nbsp;0.001). Eighteen out of 20 (90%) standard 
      CMR reports and 2/60 (3%) GPT-generated reports had an ARI score corresponding to 
      the 8th grade level or higher. Radiologists' ratings of the GPT-4 reports reached 
      high levels for correctness (5 [4, 5]), completeness (5 [5]), and lack of 
      potential harm (5 [5]); with "strong agreement" for factual correctness in 94% 
      (113/120) and completeness of relevant findings in 81% (97/120) of reports. 
      Test-retest agreement for layperson understandability ratings between the three 
      simplified reports generated from the same original report was substantial (ICC: 
      0.62; p&nbsp;&lt;&nbsp;0.001). Interrater agreement between radiologists was almost perfect 
      for lack of potential harm (ICC: 0.93, p&nbsp;&lt;&nbsp;0.001) and moderate to substantial for 
      completeness (ICC: 0.76, p&nbsp;&lt;&nbsp;0.001) and factual correctness (ICC: 0.55, 
      p&nbsp;&lt;&nbsp;0.001). CONCLUSION: GPT-4 can reliably transform complex CMR reports into 
      more understandable, layperson-friendly language while largely maintaining 
      factual correctness and completeness, and can thus help convey patient-relevant 
      radiology information in an easy-to-understand manner.
CI  - Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
FAU - Salam, Babak
AU  - Salam B
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Lab Bonn (QILaB), 
      University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Kravchenko, Dmitrij
AU  - Kravchenko D
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Lab Bonn (QILaB), 
      University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Nowak, Sebastian
AU  - Nowak S
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Lab Bonn (QILaB), 
      University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Sprinkart, Alois M
AU  - Sprinkart AM
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Lab Bonn (QILaB), 
      University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Weinhold, Leonie
AU  - Weinhold L
AD  - University Hospital Bonn, Department of Medical Biometry, Informatics, and 
      Epidemiology, Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Odenthal, Anna
AU  - Odenthal A
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Mesropyan, Narine
AU  - Mesropyan N
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Lab Bonn (QILaB), 
      University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Bischoff, Leon M
AU  - Bischoff LM
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Lab Bonn (QILaB), 
      University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Attenberger, Ulrike
AU  - Attenberger U
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Kuetting, Daniel L
AU  - Kuetting DL
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Lab Bonn (QILaB), 
      University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Luetkens, Julian A
AU  - Luetkens JA
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Lab Bonn (QILaB), 
      University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
FAU - Isaak, Alexander
AU  - Isaak A
AD  - Department of Diagnostic and Interventional Radiology, University Hospital Bonn, 
      Venusberg-Campus 1, 53127 Bonn, Germany; Quantitative Imaging Lab Bonn (QILaB), 
      University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany. Electronic 
      address: alexander.isaak@ukbonn.de.
LA  - eng
PT  - Journal Article
DEP - 20240307
PL  - England
TA  - J Cardiovasc Magn Reson
JT  - Journal of cardiovascular magnetic resonance : official journal of the Society 
      for Cardiovascular Magnetic Resonance
JID - 9815616
SB  - IM
PMC - PMC10981113
OTO - NOTNLM
OT  - Artificial intelligence
OT  - Cardiovascular magnetic resonance
OT  - Generative Pre-trained Transformers
OT  - Large language models
OT  - Text simplification
COIS- Declaration of competing interests The authors declare the following financial 
      interests/personal relationships which may be considered as potential competing 
      interests: Alexander Isaak reports financial support was provided by BONFOR 
      Research Commission of the Medical Faculty Bonn. The other authors declare that 
      they have no known competing financial interests or personal relationships that 
      could have appeared to influence the work reported in this paper.
EDAT- 2024/03/10 00:42
MHDA- 2024/03/10 00:42
PMCR- 2024/03/07
CRDT- 2024/03/09 19:19
PHST- 2023/11/24 00:00 [received]
PHST- 2024/02/19 00:00 [revised]
PHST- 2024/03/05 00:00 [accepted]
PHST- 2024/03/10 00:42 [pubmed]
PHST- 2024/03/10 00:42 [medline]
PHST- 2024/03/09 19:19 [entrez]
PHST- 2024/03/07 00:00 [pmc-release]
AID - S1097-6647(24)01026-3 [pii]
AID - 101035 [pii]
AID - 10.1016/j.jocmr.2024.101035 [doi]
PST - aheadofprint
SO  - J Cardiovasc Magn Reson. 2024 Mar 7;26(1):101035. doi: 
      10.1016/j.jocmr.2024.101035.

PMID- 38459362
OWN - NLM
STAT- MEDLINE
DCOM- 20240311
LR  - 20240322
IS  - 1436-3771 (Electronic)
IS  - 1432-6981 (Print)
IS  - 1432-6981 (Linking)
VI  - 28
IP  - 3
DP  - 2024 Mar 9
TI  - Performance of a commercially available Generative Pre-trained Transformer (GPT) 
      in describing radiolucent lesions in panoramic radiographs and establishing 
      differential diagnoses.
PG  - 204
LID - 10.1007/s00784-024-05587-5 [doi]
LID - 204
AB  - OBJECTIVES: To evaluate the performance of a commercially available Generative 
      Pre-trained Transformer (GPT) in describing and establishing differential 
      diagnoses for radiolucent lesions in panoramic radiographs. MATERIALS AND 
      METHODS: Twenty-eight panoramic radiographs, each containing a single radiolucent 
      lesion, were evaluated in consensus by three examiners and a commercially 
      available ChatGPT-3.5 model. They provided descriptions regarding internal 
      structure (radiodensity, loculation), periphery (margin type, cortication), 
      shape, location (bone, side, region, teeth/structures), and effects on adjacent 
      structures (effect, adjacent structure). Diagnostic impressions related to 
      origin, behavior, and nature were also provided. The GPT program was additionally 
      prompted to provide differential diagnoses. Keywords used by the GPT program were 
      compared to those used by the examiners and scored as 0 (incorrect), 0.5 
      (partially correct), or 1 (correct). Mean score values and standard deviation 
      were calculated for each description. Performance in establishing differential 
      diagnoses was assessed using Rank-1, -2, and - 3. RESULTS: Descriptions of 
      margination, affected bone, and origin received the highest scores: 0.93, 0.93, 
      and 0.87, respectively. Shape, region, teeth/structures, effect, affected region, 
      and nature received considerably lower scores ranging from 0.22 to 0.50. Rank-1, 
      -2, and - 3 demonstrated accuracy in 25%, 57.14%, and 67.85% of cases, 
      respectively. CONCLUSION: The performance of the GPT program in describing and 
      providing differential diagnoses for radiolucent lesions in panoramic radiographs 
      is variable and at this stage limited in its use for clinical application. 
      CLINICAL RELEVANCE: Understanding the potential role of GPT systems as an 
      auxiliary tool in image interpretation is imperative to validate their clinical 
      applicability.
CI  - © 2024. The Author(s).
FAU - Silva, Thaísa Pinheiro
AU  - Silva TP
AUID- ORCID: 0000-0002-7485-0206
AD  - Department of Oral Diagnosis, Division of Oral Radiology, Piracicaba Dental 
      School, University of Campinas, Piracicaba, Sao Paulo, 13414-903, Brazil.
FAU - Andrade-Bortoletto, Maria Fernanda Silva
AU  - Andrade-Bortoletto MFS
AUID- ORCID: 0000-0003-2300-3143
AD  - Department of Oral Diagnosis, Division of Oral Radiology, Piracicaba Dental 
      School, University of Campinas, Piracicaba, Sao Paulo, 13414-903, Brazil.
FAU - Ocampo, Thaís Santos Cerqueira
AU  - Ocampo TSC
AUID- ORCID: 0000-0002-6913-4416
AD  - Department of Oral Diagnosis, Division of Oral Radiology, Piracicaba Dental 
      School, University of Campinas, Piracicaba, Sao Paulo, 13414-903, Brazil.
FAU - Alencar-Palha, Caio
AU  - Alencar-Palha C
AUID- ORCID: 0000-0003-1856-793X
AD  - Department of Oral Diagnosis, Division of Oral Radiology, Piracicaba Dental 
      School, University of Campinas, Piracicaba, Sao Paulo, 13414-903, Brazil.
FAU - Bornstein, Michael M
AU  - Bornstein MM
AUID- ORCID: 0000-0002-7773-8957
AD  - Department of Oral Health &amp; Medicine, University Center for Dental Medicine Basel 
      UZB, University of Basel, Basel, 4058, Switzerland.
FAU - Oliveira-Santos, Christiano
AU  - Oliveira-Santos C
AUID- ORCID: 0000-0001-9936-7547
AD  - Department of Diagnosis and Oral Health, University of Louisville School of 
      Dentistry, Louisville, KY, 40202, USA.
FAU - Oliveira, Matheus L
AU  - Oliveira ML
AUID- ORCID: 0000-0002-8054-8759
AD  - Department of Oral Diagnosis, Division of Oral Radiology, Piracicaba Dental 
      School, University of Campinas, Piracicaba, Sao Paulo, 13414-903, Brazil. 
      matheus.limadeoliveira@unibas.ch.
AD  - Department of Oral Health &amp; Medicine, University Center for Dental Medicine Basel 
      UZB, University of Basel, Basel, 4058, Switzerland. 
      matheus.limadeoliveira@unibas.ch.
LA  - eng
PT  - Journal Article
DEP - 20240309
PL  - Germany
TA  - Clin Oral Investig
JT  - Clinical oral investigations
JID - 9707115
MH  - *Diagnosis, Differential
MH  - Radiography, Panoramic
MH  - Consensus
PMC - PMC10924032
OTO - NOTNLM
OT  - Artificial intelligence
OT  - Differential diagnosis
OT  - Generative pre-trained transformer
OT  - Panoramic radiography
COIS- The authors declare that they have no conflict of interest. The authors declare 
      no competing interests.
EDAT- 2024/03/09 10:43
MHDA- 2024/03/11 06:42
PMCR- 2024/03/09
CRDT- 2024/03/08 23:41
PHST- 2024/01/11 00:00 [received]
PHST- 2024/02/25 00:00 [accepted]
PHST- 2024/03/11 06:42 [medline]
PHST- 2024/03/09 10:43 [pubmed]
PHST- 2024/03/08 23:41 [entrez]
PHST- 2024/03/09 00:00 [pmc-release]
AID - 10.1007/s00784-024-05587-5 [pii]
AID - 5587 [pii]
AID - 10.1007/s00784-024-05587-5 [doi]
PST - epublish
SO  - Clin Oral Investig. 2024 Mar 9;28(3):204. doi: 10.1007/s00784-024-05587-5.

PMID- 38206661
OWN - NLM
STAT- MEDLINE
DCOM- 20240112
LR  - 20240128
IS  - 2369-3762 (Electronic)
IS  - 2369-3762 (Linking)
VI  - 10
DP  - 2024 Jan 11
TI  - Comprehensiveness, Accuracy, and Readability of Exercise Recommendations Provided 
      by an AI-Based Chatbot: Mixed Methods Study.
PG  - e51308
LID - 10.2196/51308 [doi]
LID - e51308
AB  - BACKGROUND: Regular physical activity is critical for health and disease 
      prevention. Yet, health care providers and patients face barriers to implement 
      evidence-based lifestyle recommendations. The potential to augment care with the 
      increased availability of artificial intelligence (AI) technologies is limitless; 
      however, the suitability of AI-generated exercise recommendations has yet to be 
      explored. OBJECTIVE: The purpose of this study was to assess the 
      comprehensiveness, accuracy, and readability of individualized exercise 
      recommendations generated by a novel AI chatbot. METHODS: A coding scheme was 
      developed to score AI-generated exercise recommendations across ten categories 
      informed by gold-standard exercise recommendations, including (1) health 
      condition-specific benefits of exercise, (2) exercise preparticipation health 
      screening, (3) frequency, (4) intensity, (5) time, (6) type, (7) volume, (8) 
      progression, (9) special considerations, and (10) references to the primary 
      literature. The AI chatbot was prompted to provide individualized exercise 
      recommendations for 26 clinical populations using an open-source application 
      programming interface. Two independent reviewers coded AI-generated content for 
      each category and calculated comprehensiveness (%) and factual accuracy (%) on a 
      scale of 0%-100%. Readability was assessed using the Flesch-Kincaid formula. 
      Qualitative analysis identified and categorized themes from AI-generated output. 
      RESULTS: AI-generated exercise recommendations were 41.2% (107/260) comprehensive 
      and 90.7% (146/161) accurate, with the majority (8/15, 53%) of inaccuracy related 
      to the need for exercise preparticipation medical clearance. Average readability 
      level of AI-generated exercise recommendations was at the college level (mean 
      13.7, SD 1.7), with an average Flesch reading ease score of 31.1 (SD 7.7). 
      Several recurring themes and observations of AI-generated output included concern 
      for liability and safety, preference for aerobic exercise, and potential bias and 
      direct discrimination against certain age-based populations and individuals with 
      disabilities. CONCLUSIONS: There were notable gaps in the comprehensiveness, 
      accuracy, and readability of AI-generated exercise recommendations. Exercise and 
      health care professionals should be aware of these limitations when using and 
      endorsing AI-based technologies as a tool to support lifestyle change involving 
      exercise.
CI  - ©Amanda L Zaleski, Rachel Berkowsky, Kelly Jean Thomas Craig, Linda S Pescatello. 
      Originally published in JMIR Medical Education (https://mededu.jmir.org), 
      11.01.2024.
FAU - Zaleski, Amanda L
AU  - Zaleski AL
AUID- ORCID: 0000-0002-0362-819X
AD  - Clinical Evidence Development, Aetna Medical Affairs, CVS Health Corporation, 
      Hartford, CT, United States.
AD  - Department of Preventive Cardiology, Hartford Hospital, Hartford, CT, United 
      States.
FAU - Berkowsky, Rachel
AU  - Berkowsky R
AUID- ORCID: 0000-0003-1150-1284
AD  - Department of Kinesiology, University of Connecticut, Storrs, CT, United States.
FAU - Craig, Kelly Jean Thomas
AU  - Craig KJT
AUID- ORCID: 0000-0002-9954-2795
AD  - Clinical Evidence Development, Aetna Medical Affairs, CVS Health Corporation, 
      Hartford, CT, United States.
FAU - Pescatello, Linda S
AU  - Pescatello LS
AUID- ORCID: 0000-0002-5841-798X
AD  - Department of Kinesiology, University of Connecticut, Storrs, CT, United States.
LA  - eng
PT  - Journal Article
DEP - 20240111
PL  - Canada
TA  - JMIR Med Educ
JT  - JMIR medical education
JID - 101684518
SB  - IM
MH  - Humans
MH  - *Artificial Intelligence
MH  - *Comprehension
MH  - Software
MH  - Awareness
MH  - Exercise
PMC - PMC10811574
OTO - NOTNLM
OT  - AI
OT  - artificial intelligence
OT  - chatbot
OT  - exercise prescription
OT  - health literacy
OT  - large language model
OT  - patient education
COIS- Conflicts of Interest: ALZ and KJTC are both employed and hold stock with CVS 
      Health Corporation. This study is an objective evaluation to better understand 
      ChatGPT and its outputs. To the best of our knowledge, CVS Health does not 
      currently use or endorse the use of ChatGPT for lifestyle recommendations. LSP is 
      the sole proprietor and founder of P3-EX, LLC, which could potentially benefit 
      from the tool used in this research. The results of this study do not constitute 
      endorsement by the American College of Sports Medicine.
EDAT- 2024/01/11 12:41
MHDA- 2024/01/12 06:43
PMCR- 2024/01/11
CRDT- 2024/01/11 11:53
PHST- 2023/07/27 00:00 [received]
PHST- 2023/12/11 00:00 [accepted]
PHST- 2023/10/05 00:00 [revised]
PHST- 2024/01/12 06:43 [medline]
PHST- 2024/01/11 12:41 [pubmed]
PHST- 2024/01/11 11:53 [entrez]
PHST- 2024/01/11 00:00 [pmc-release]
AID - v10i1e51308 [pii]
AID - 10.2196/51308 [doi]
PST - epublish
SO  - JMIR Med Educ. 2024 Jan 11;10:e51308. doi: 10.2196/51308.

PMID- 38297371
OWN - NLM
STAT- MEDLINE
DCOM- 20240202
LR  - 20240210
IS  - 1472-6947 (Electronic)
IS  - 1472-6947 (Linking)
VI  - 24
IP  - 1
DP  - 2024 Jan 31
TI  - An evaluation of GPT models for phenotype concept recognition.
PG  - 30
LID - 10.1186/s12911-024-02439-w [doi]
LID - 30
AB  - OBJECTIVE: Clinical deep phenotyping and phenotype annotation play a critical 
      role in both the diagnosis of patients with rare disorders as well as in building 
      computationally-tractable knowledge in the rare disorders field. These processes 
      rely on using ontology concepts, often from the Human Phenotype Ontology, in 
      conjunction with a phenotype concept recognition task (supported usually by 
      machine learning methods) to curate patient profiles or existing scientific 
      literature. With the significant shift in the use of large language models (LLMs) 
      for most NLP tasks, we examine the performance of the latest Generative 
      Pre-trained Transformer (GPT) models underpinning ChatGPT as a foundation for the 
      tasks of clinical phenotyping and phenotype annotation. MATERIALS AND METHODS: 
      The experimental setup of the study included seven prompts of various levels of 
      specificity, two GPT models (gpt-3.5-turbo and gpt-4.0) and two established gold 
      standard corpora for phenotype recognition, one consisting of publication 
      abstracts and the other clinical observations. RESULTS: The best run, using 
      in-context learning, achieved 0.58 document-level F1 score on publication 
      abstracts and 0.75 document-level F1 score on clinical observations, as well as a 
      mention-level F1 score of 0.7, which surpasses the current best in class tool. 
      Without in-context learning, however, performance is significantly below the 
      existing approaches. CONCLUSION: Our experiments show that gpt-4.0 surpasses the 
      state of the art performance if the task is constrained to a subset of the target 
      ontology where there is prior knowledge of the terms that are expected to be 
      matched. While the results are promising, the non-deterministic nature of the 
      outcomes, the high cost and the lack of concordance between different runs using 
      the same prompt and input make the use of these LLMs challenging for this 
      particular task.
CI  - © 2024. Crown.
FAU - Groza, Tudor
AU  - Groza T
AD  - Rare Care Centre, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, 
      6009, Australia. tudor.groza@health.wa.gov.au.
AD  - Telethon Kids Institute, 15 Hospital Avenue, Nedlands, WA, 6009, Australia. 
      tudor.groza@health.wa.gov.au.
AD  - School of Electrical Engineering, Computing and Mathematical Sciences, Curtin 
      University, Kent St, Bentley, WA, 6102, Australia. tudor.groza@health.wa.gov.au.
AD  - SingHealth Duke-NUS Institute of Precision Medicine, 5 Hospital Drive Level 9, 
      Singapore, 169609, Singapore. tudor.groza@health.wa.gov.au.
FAU - Caufield, Harry
AU  - Caufield H
AD  - Division of Environmental Genomics and Systems Biology, Lawrence Berkeley 
      National Laboratory, Berkeley, CA, 94720, USA.
FAU - Gration, Dylan
AU  - Gration D
AD  - Western Australian Register of Developmental Anomalies, King Edward Memorial 
      Hospital, 374 Bagot Road, Subiaco, WA, 6008, Australia.
FAU - Baynam, Gareth
AU  - Baynam G
AD  - Rare Care Centre, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, 
      6009, Australia.
AD  - Telethon Kids Institute, 15 Hospital Avenue, Nedlands, WA, 6009, Australia.
AD  - Western Australian Register of Developmental Anomalies, King Edward Memorial 
      Hospital, 374 Bagot Road, Subiaco, WA, 6008, Australia.
AD  - Faculty of Health and Medical Sciences, University of Western Australia, 35 
      Stirling Hwy, Crawley, WA, 6009, Australia.
FAU - Haendel, Melissa A
AU  - Haendel MA
AD  - University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
FAU - Robinson, Peter N
AU  - Robinson PN
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.
AD  - Institute for Systems Genomics, University of Connecticut, Farmington, CT, 06032, 
      USA.
FAU - Mungall, Christopher J
AU  - Mungall CJ
AD  - Division of Environmental Genomics and Systems Biology, Lawrence Berkeley 
      National Laboratory, Berkeley, CA, 94720, USA.
FAU - Reese, Justin T
AU  - Reese JT
AD  - Division of Environmental Genomics and Systems Biology, Lawrence Berkeley 
      National Laboratory, Berkeley, CA, 94720, USA.
LA  - eng
GR  - RM1HG010860, U24HG011449/HG/NHGRI NIH HHS/United States
GR  - R24 OD011883/OD/NIH HHS/United States
GR  - HG010860, OD011883/NH/NIH HHS/United States
GR  - U24 HG011449/HG/NHGRI NIH HHS/United States
GR  - RM1 HG010860/HG/NHGRI NIH HHS/United States
PT  - Journal Article
DEP - 20240131
PL  - England
TA  - BMC Med Inform Decis Mak
JT  - BMC medical informatics and decision making
JID - 101088682
SB  - IM
MH  - Humans
MH  - *Knowledge
MH  - *Language
MH  - Machine Learning
MH  - Phenotype
MH  - Rare Diseases
PMC - PMC10829255
OTO - NOTNLM
OT  - Artificial intelligence
OT  - Generative pretrained transformer
OT  - Human Phenotype Ontology
OT  - Large language models
OT  - Phenotype concept recognition
COIS- The authors declare no competing interests.
EDAT- 2024/02/01 00:42
MHDA- 2024/02/02 06:42
PMCR- 2024/01/31
CRDT- 2024/01/31 23:48
PHST- 2023/11/23 00:00 [received]
PHST- 2024/01/24 00:00 [accepted]
PHST- 2024/02/02 06:42 [medline]
PHST- 2024/02/01 00:42 [pubmed]
PHST- 2024/01/31 23:48 [entrez]
PHST- 2024/01/31 00:00 [pmc-release]
AID - 10.1186/s12911-024-02439-w [pii]
AID - 2439 [pii]
AID - 10.1186/s12911-024-02439-w [doi]
PST - epublish
SO  - BMC Med Inform Decis Mak. 2024 Jan 31;24(1):30. doi: 10.1186/s12911-024-02439-w.

PMID- 37394024
OWN - NLM
STAT- MEDLINE
DCOM- 20230811
LR  - 20230815
IS  - 1532-0480 (Electronic)
IS  - 1532-0464 (Linking)
VI  - 144
DP  - 2023 Aug
TI  - Increasing physical activity using an just-in-time adaptive digital assistant 
      supported by machine learning: A novel approach for hyper-personalised mHealth 
      interventions.
PG  - 104435
LID - S1532-0464(23)00156-9 [pii]
LID - 10.1016/j.jbi.2023.104435 [doi]
AB  - OBJECTIVE: Physical inactivity is a leading modifiable cause of death and disease 
      worldwide. Population-based interventions to increase physical activity are 
      needed. Existing automated expert systems (e.g., computer-tailored interventions) 
      have significant limitations that result in low long-term effectiveness. 
      Therefore, innovative approaches are needed. This special communication aims to 
      describe and discuss a novel mHealth intervention approach that proactively 
      offers participants with hyper-personalised intervention content adjusted in 
      real-time. METHODS: Using machine learning approaches, we propose a novel 
      physical activity intervention approach that can learn and adapt in real-time to 
      achieve high levels of personalisation and user engagement, underpinned by a 
      likeable digital assistant. It will consist of three major components: (1) 
      conversations: to increase user's knowledge on a wide range of activity-related 
      topics underpinned by Natural Language Processing; (2) nudge engine: to provide 
      users with hyper-personalised cues to action underpinned by reinforcement 
      learning (i.e., contextual bandit) and integrating real-time data from activity 
      tracking, GPS, GIS, weather, and user provided data; (3) Q&amp;A: to facilitate users 
      asking any physical activity related questions underpinned by generative AI 
      (e.g., ChatGPT, Bard) for content generation. RESULTS: The detailed concept of 
      the proposed physical activity intervention platform demonstrates the practical 
      application of a just-in-time adaptive intervention applying various machine 
      learning techniques to deliver a hyper-personalised physical activity 
      intervention in an engaging way. Compared to traditional interventions, the novel 
      platform is expected to show potential for increased user engagement and 
      long-term effectiveness due to: (1) using new variables to personalise content 
      (e.g., GPS, weather), (2) providing behavioural support at the right time in 
      real-time, (3) implementing an engaging digital assistant and (4) improving the 
      relevance of content through applying machine learning algorithms. CONCLUSION: 
      The use of machine learning is on the rise in every aspect of today's society, 
      however few attempts have been undertaken to harness its potential to achieve 
      health behaviour change. By sharing our intervention concept, we contribute to 
      the ongoing dialogue on creating effective methods for promoting health and 
      well-being in the informatics research community. Future research should focus on 
      refining these techniques and evaluating their effectiveness in controlled and 
      real-world circumstances.
CI  - Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
FAU - Vandelanotte, Corneel
AU  - Vandelanotte C
AD  - Appleton Institute, Central Queensland University, Bruce Highway, Rockhampton, 
      Queensland 4702, Australia. Electronic address: c.vandelanotte@cqu.edu.au.
FAU - Trost, Stewart
AU  - Trost S
AD  - School of Human Movement and Nutrition Science, The University of Queensland, St 
      Lucia, Queensland 4072, Australia. Electronic address: s.trost@uq.edu.au.
FAU - Hodgetts, Danya
AU  - Hodgetts D
AD  - Appleton Institute, Central Queensland University, Bruce Highway, Rockhampton, 
      Queensland 4702, Australia. Electronic address: d.hodgetts@cqu.edu.au.
FAU - Imam, Tasadduq
AU  - Imam T
AD  - School of Business and Law, Central Queensland University, 120 Spencer Street, 
      Melbourne, Victoria 3000, Australia. Electronic address: t.imam@cqu.edu.au.
FAU - Rashid, Mamunur
AU  - Rashid M
AD  - School of Engineering and Technology, Central Queensland University, 120 Spencer 
      Street, Melbourne, Victoria 3000, Australia. Electronic address: 
      m.rashid@cqu.edu.au.
FAU - To, Quyen G
AU  - To QG
AD  - Appleton Institute, Central Queensland University, Bruce Highway, Rockhampton, 
      Queensland 4702, Australia. Electronic address: q.to@cqu.edu.au.
FAU - Maher, Carol
AU  - Maher C
AD  - Allied Health and Human Performance, University of South Australia, City East 
      Campus, Adelaide, South Australia 5001, Australia. Electronic address: 
      Carol.Maher@unisa.edu.au.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230701
PL  - United States
TA  - J Biomed Inform
JT  - Journal of biomedical informatics
JID - 100970413
SB  - IM
MH  - Humans
MH  - *Exercise
MH  - Health Behavior
MH  - *Telemedicine/methods
MH  - Machine Learning
MH  - Algorithms
OTO - NOTNLM
OT  - Artificial intelligence
OT  - Behaviour change
OT  - Chatbot
OT  - Conversational agent
OT  - Exercise
OT  - Intervention
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2023/07/03 00:41
MHDA- 2023/08/11 06:43
CRDT- 2023/07/02 19:24
PHST- 2023/01/19 00:00 [received]
PHST- 2023/06/26 00:00 [revised]
PHST- 2023/06/28 00:00 [accepted]
PHST- 2023/08/11 06:43 [medline]
PHST- 2023/07/03 00:41 [pubmed]
PHST- 2023/07/02 19:24 [entrez]
AID - S1532-0464(23)00156-9 [pii]
AID - 10.1016/j.jbi.2023.104435 [doi]
PST - ppublish
SO  - J Biomed Inform. 2023 Aug;144:104435. doi: 10.1016/j.jbi.2023.104435. Epub 2023 
      Jul 1.

PMID- 38276872
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240303
IS  - 1929-073X (Print)
IS  - 1929-073X (Electronic)
IS  - 1929-073X (Linking)
VI  - 13
DP  - 2024 Feb 15
TI  - A Preliminary Checklist (METRICS) to Standardize the Design and Reporting of 
      Studies on Generative Artificial Intelligence-Based Models in Health Care 
      Education and Practice: Development Study Involving a Literature Review.
PG  - e54704
LID - 10.2196/54704 [doi]
LID - e54704
AB  - BACKGROUND: Adherence to evidence-based practice is indispensable in health care. 
      Recently, the utility of generative artificial intelligence (AI) models in health 
      care has been evaluated extensively. However, the lack of consensus guidelines on 
      the design and reporting of findings of these studies poses a challenge for the 
      interpretation and synthesis of evidence. OBJECTIVE: This study aimed to develop 
      a preliminary checklist to standardize the reporting of generative AI-based 
      studies in health care education and practice. METHODS: A literature review was 
      conducted in Scopus, PubMed, and Google Scholar. Published records with 
      "ChatGPT," "Bing," or "Bard" in the title were retrieved. Careful examination of 
      the methodologies employed in the included records was conducted to identify the 
      common pertinent themes and the possible gaps in reporting. A panel discussion 
      was held to establish a unified and thorough checklist for the reporting of AI 
      studies in health care. The finalized checklist was used to evaluate the included 
      records by 2 independent raters. Cohen κ was used as the method to evaluate the 
      interrater reliability. RESULTS: The final data set that formed the basis for 
      pertinent theme identification and analysis comprised a total of 34 records. The 
      finalized checklist included 9 pertinent themes collectively referred to as 
      METRICS (Model, Evaluation, Timing, Range/Randomization, Individual factors, 
      Count, and Specificity of prompts and language). Their details are as follows: 
      (1) Model used and its exact settings; (2) Evaluation approach for the generated 
      content; (3) Timing of testing the model; (4) Transparency of the data source; 
      (5) Range of tested topics; (6) Randomization of selecting the queries; (7) 
      Individual factors in selecting the queries and interrater reliability; (8) Count 
      of queries executed to test the model; and (9) Specificity of the prompts and 
      language used. The overall mean METRICS score was 3.0 (SD 0.58). The tested 
      METRICS score was acceptable, with the range of Cohen κ of 0.558 to 0.962 (P&lt;.001 
      for the 9 tested items). With classification per item, the highest average 
      METRICS score was recorded for the "Model" item, followed by the "Specificity" 
      item, while the lowest scores were recorded for the "Randomization" item 
      (classified as suboptimal) and "Individual factors" item (classified as 
      satisfactory). CONCLUSIONS: The METRICS checklist can facilitate the design of 
      studies guiding researchers toward best practices in reporting results. The 
      findings highlight the need for standardized reporting algorithms for generative 
      AI-based studies in health care, considering the variability observed in 
      methodologies and reporting. The proposed METRICS checklist could be a 
      preliminary helpful base to establish a universally accepted approach to 
      standardize the design and reporting of generative AI-based studies in health 
      care, which is a swiftly evolving research topic.
CI  - ©Malik Sallam, Muna Barakat, Mohammed Sallam. Originally published in the 
      Interactive Journal of Medical Research (https://www.i-jmr.org/), 15.02.2024.
FAU - Sallam, Malik
AU  - Sallam M
AUID- ORCID: 0000-0002-0165-9670
AD  - Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, 
      The University of Jordan, Amman, Jordan.
AD  - Department of Clinical Laboratories and Forensic Medicine, Jordan University 
      Hospital, Amman, Jordan.
AD  - Department of Translational Medicine, Faculty of Medicine, Lund University, 
      Malmo, Sweden.
FAU - Barakat, Muna
AU  - Barakat M
AUID- ORCID: 0000-0002-7966-1172
AD  - Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied 
      Science Private University, Amman, Jordan.
FAU - Sallam, Mohammed
AU  - Sallam M
AUID- ORCID: 0000-0003-3273-524X
AD  - Department of Pharmacy, Mediclinic Parkview Hospital, Mediclinic Middle East, 
      Dubai, United Arab Emirates.
LA  - eng
PT  - Journal Article
DEP - 20240215
PL  - Canada
TA  - Interact J Med Res
JT  - Interactive journal of medical research
JID - 101598421
PMC - PMC10905357
OTO - NOTNLM
OT  - decision support
OT  - evaluation
OT  - guidelines
OT  - large language models
OT  - meaningful analytics
COIS- Conflicts of Interest: None declared.
EDAT- 2024/01/26 12:43
MHDA- 2024/01/26 12:44
PMCR- 2024/02/15
CRDT- 2024/01/26 09:42
PHST- 2023/11/19 00:00 [received]
PHST- 2024/01/26 00:00 [accepted]
PHST- 2023/12/18 00:00 [revised]
PHST- 2024/01/26 12:44 [medline]
PHST- 2024/01/26 12:43 [pubmed]
PHST- 2024/01/26 09:42 [entrez]
PHST- 2024/02/15 00:00 [pmc-release]
AID - v13i1e54704 [pii]
AID - 10.2196/54704 [doi]
PST - epublish
SO  - Interact J Med Res. 2024 Feb 15;13:e54704. doi: 10.2196/54704.

PMID- 38261580
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240127
IS  - 2767-3170 (Electronic)
IS  - 2767-3170 (Linking)
VI  - 3
IP  - 1
DP  - 2024 Jan
TI  - Performance of Generative Pretrained Transformer on the National Medical 
      Licensing Examination in Japan.
PG  - e0000433
LID - 10.1371/journal.pdig.0000433 [doi]
LID - e0000433
AB  - The remarkable performance of ChatGPT, launched in November 2022, has 
      significantly impacted the field of natural language processing, inspiring the 
      application of large language models as supportive tools in clinical practice and 
      research worldwide. Although GPT-3.5 recently scored high on the United States 
      Medical Licensing Examination, its performance on medical licensing examinations 
      of other nations, especially non-English speaking nations, has not been 
      sufficiently evaluated. This study assessed GPT's performance on the National 
      Medical Licensing Examination (NMLE) in Japan and compared it with the actual 
      minimal passing rate for this exam. In particular, the performances of both the 
      GPT-3.5 and GPT-4 models were considered for the comparative analysis. We 
      initially used the GPT models and several prompts for 290 questions without image 
      data from the 116th NMLE (held in February 2022 in Japan) to maximize the 
      performance for delivering correct answers and explanations of the questions. 
      Thereafter, we tested the performance of the best GPT model (GPT-4) with 
      optimized prompts on a dataset of 262 questions without images from the latest 
      117th NMLE (held in February 2023). The best model with the optimized prompts 
      scored 82.7% for the essential questions and 77.2% for the basic and clinical 
      questions, both of which sufficed the minimum passing scoring rates of 80.0% and 
      74.6%, respectively. After an exploratory analysis of 56 incorrect answers from 
      the model, we identified the three major factors contributing to the generation 
      of the incorrect answers-insufficient medical knowledge, information on 
      Japan-specific medical system and guidelines, and mathematical errors. In 
      conclusion, GPT-4 with our optimized prompts achieved a minimum passing scoring 
      rate in the latest 117th NMLE in Japan. Beyond its original design of answering 
      examination questions for humans, these artificial intelligence (AI) models can 
      serve as one of the best "sidekicks" for solving problems and addressing the 
      unmet needs in the medical and healthcare fields.
CI  - Copyright: © 2024 Tanaka et al. This is an open access article distributed under 
      the terms of the Creative Commons Attribution License, which permits unrestricted 
      use, distribution, and reproduction in any medium, provided the original author 
      and source are credited.
FAU - Tanaka, Yudai
AU  - Tanaka Y
AUID- ORCID: 0000-0003-4101-9886
AD  - School of Medicine, Kanazawa University, Kanazawa, Japan.
AD  - Department of Health Promotion and Medicine of the Future, Kanazawa University 
      Graduate School of Medicine, Kanazawa, Japan.
AD  - Department of Molecular and Cellular Pathology, Graduate School of Medical 
      Sciences, Kanazawa University, Kanazawa, Japan.
FAU - Nakata, Takuto
AU  - Nakata T
AUID- ORCID: 0000-0002-8743-9184
AD  - School of Medicine, Kanazawa University, Kanazawa, Japan.
AD  - Department of Health Promotion and Medicine of the Future, Kanazawa University 
      Graduate School of Medicine, Kanazawa, Japan.
AD  - Department of Molecular and Cellular Pathology, Graduate School of Medical 
      Sciences, Kanazawa University, Kanazawa, Japan.
FAU - Aiga, Ko
AU  - Aiga K
AD  - Department of Health Promotion and Medicine of the Future, Kanazawa University 
      Graduate School of Medicine, Kanazawa, Japan.
FAU - Etani, Takahide
AU  - Etani T
AUID- ORCID: 0000-0003-0027-2551
AD  - School of Medicine, Kanazawa University, Kanazawa, Japan.
AD  - Graduate School of Media and Governance, Keio University, Fujisawa, Japan.
AD  - Advanced Research Center for Human Sciences, Waseda University, Saitama, Japan.
FAU - Muramatsu, Ryota
AU  - Muramatsu R
AUID- ORCID: 0009-0008-2445-1195
AD  - School of Medicine, Kanazawa University, Kanazawa, Japan.
AD  - Department of Molecular and Cellular Pathology, Graduate School of Medical 
      Sciences, Kanazawa University, Kanazawa, Japan.
FAU - Katagiri, Shun
AU  - Katagiri S
AD  - School of Medicine, Kanazawa University, Kanazawa, Japan.
FAU - Kawai, Hiroyuki
AU  - Kawai H
AD  - School of Medicine, Kanazawa University, Kanazawa, Japan.
FAU - Higashino, Fumiya
AU  - Higashino F
AD  - School of Medicine, Kanazawa University, Kanazawa, Japan.
FAU - Enomoto, Masahiro
AU  - Enomoto M
AD  - School of Medicine, Kanazawa University, Kanazawa, Japan.
FAU - Noda, Masao
AU  - Noda M
AUID- ORCID: 0000-0001-6281-2782
AD  - Department of Otolaryngology and Head and Neck Surgery, Jichi Medical University, 
      Tochigi, Japan.
FAU - Kometani, Mitsuhiro
AU  - Kometani M
AUID- ORCID: 0000-0003-0461-3018
AD  - Department of Health Promotion and Medicine of the Future, Kanazawa University 
      Graduate School of Medicine, Kanazawa, Japan.
FAU - Takamura, Masayuki
AU  - Takamura M
AUID- ORCID: 0000-0002-1540-4417
AD  - Department of Cardiovascular Medicine, Kanazawa University Graduate School of 
      Medical Sciences, Kanazawa, Japan.
FAU - Yoneda, Takashi
AU  - Yoneda T
AUID- ORCID: 0000-0002-0921-158X
AD  - Department of Health Promotion and Medicine of the Future, Kanazawa University 
      Graduate School of Medicine, Kanazawa, Japan.
AD  - College of Transdisciplinary Sciences for Innovation, Kanazawa University, 
      Kanazawa Japan.
FAU - Kakizaki, Hiroaki
AU  - Kakizaki H
AD  - MICIN, Inc., Tokyo, Co.
FAU - Nomura, Akihiro
AU  - Nomura A
AUID- ORCID: 0000-0001-6647-8240
AD  - Department of Health Promotion and Medicine of the Future, Kanazawa University 
      Graduate School of Medicine, Kanazawa, Japan.
AD  - Department of Cardiovascular Medicine, Kanazawa University Graduate School of 
      Medical Sciences, Kanazawa, Japan.
AD  - College of Transdisciplinary Sciences for Innovation, Kanazawa University, 
      Kanazawa Japan.
AD  - Frontier Institute for Tourism Science, Kanazawa University, Kanazawa, Japan.
AD  - Department of Biomedical Informatics, CureApp Institute, Karuizawa, Japan.
LA  - eng
PT  - Journal Article
DEP - 20240123
PL  - United States
TA  - PLOS Digit Health
JT  - PLOS digital health
JID - 9918335064206676
PMC - PMC10805303
COIS- The authors have declared that no competing interests exist.
EDAT- 2024/01/23 18:42
MHDA- 2024/01/23 18:43
PMCR- 2024/01/23
CRDT- 2024/01/23 13:34
PHST- 2023/04/18 00:00 [received]
PHST- 2023/12/19 00:00 [accepted]
PHST- 2024/01/23 18:43 [medline]
PHST- 2024/01/23 18:42 [pubmed]
PHST- 2024/01/23 13:34 [entrez]
PHST- 2024/01/23 00:00 [pmc-release]
AID - PDIG-D-23-00146 [pii]
AID - 10.1371/journal.pdig.0000433 [doi]
PST - epublish
SO  - PLOS Digit Health. 2024 Jan 23;3(1):e0000433. doi: 10.1371/journal.pdig.0000433. 
      eCollection 2024 Jan.

PMID- 37973919
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240210
IS  - 2398-6352 (Electronic)
IS  - 2398-6352 (Linking)
VI  - 6
IP  - 1
DP  - 2023 Nov 16
TI  - A study of generative large language model for medical research and healthcare.
PG  - 210
LID - 10.1038/s41746-023-00958-w [doi]
LID - 210
AB  - There are enormous enthusiasm and concerns in applying large language models 
      (LLMs) to healthcare. Yet current assumptions are based on general-purpose LLMs 
      such as ChatGPT, which are not developed for medical use. This study develops a 
      generative clinical LLM, GatorTronGPT, using 277 billion words of text including 
      (1) 82 billion words of clinical text from 126 clinical departments and 
      approximately 2 million patients at the University of Florida Health and (2) 195 
      billion words of diverse general English text. We train GatorTronGPT using a 
      GPT-3 architecture with up to 20 billion parameters and evaluate its utility for 
      biomedical natural language processing (NLP) and healthcare text generation. 
      GatorTronGPT improves biomedical natural language processing. We apply 
      GatorTronGPT to generate 20 billion words of synthetic text. Synthetic NLP models 
      trained using synthetic text generated by GatorTronGPT outperform models trained 
      using real-world clinical text. Physicians' Turing test using 1 (worst) to 9 
      (best) scale shows that there are no significant differences in linguistic 
      readability (p = 0.22; 6.57 of GatorTronGPT compared with 6.93 of human) and 
      clinical relevance (p = 0.91; 7.0 of GatorTronGPT compared with 6.97 of human) 
      and that physicians cannot differentiate them (p &lt; 0.001). This study provides 
      insights into the opportunities and challenges of LLMs for medical research and 
      healthcare.
CI  - © 2023. The Author(s).
FAU - Peng, Cheng
AU  - Peng C
AUID- ORCID: 0000-0002-1994-893X
AD  - Department of Health Outcomes and Biomedical Informatics, College of Medicine, 
      University of Florida, Gainesville, FL, USA.
FAU - Yang, Xi
AU  - Yang X
AD  - Department of Health Outcomes and Biomedical Informatics, College of Medicine, 
      University of Florida, Gainesville, FL, USA.
AD  - Cancer Informatics Shared Resource, University of Florida Health Cancer Center, 
      Gainesville, FL, USA.
FAU - Chen, Aokun
AU  - Chen A
AD  - Department of Health Outcomes and Biomedical Informatics, College of Medicine, 
      University of Florida, Gainesville, FL, USA.
AD  - Cancer Informatics Shared Resource, University of Florida Health Cancer Center, 
      Gainesville, FL, USA.
FAU - Smith, Kaleb E
AU  - Smith KE
AD  - NVIDIA, Santa Clara, CA, USA.
FAU - PourNejatian, Nima
AU  - PourNejatian N
AD  - NVIDIA, Santa Clara, CA, USA.
FAU - Costa, Anthony B
AU  - Costa AB
AD  - NVIDIA, Santa Clara, CA, USA.
FAU - Martin, Cheryl
AU  - Martin C
AD  - NVIDIA, Santa Clara, CA, USA.
FAU - Flores, Mona G
AU  - Flores MG
AUID- ORCID: 0000-0002-7362-3044
AD  - NVIDIA, Santa Clara, CA, USA.
FAU - Zhang, Ying
AU  - Zhang Y
AUID- ORCID: 0000-0003-4210-2104
AD  - Research Computing, University of Florida, Gainesville, FL, USA.
FAU - Magoc, Tanja
AU  - Magoc T
AD  - Integrated Data Repository Research Services, University of Florida, Gainesville, 
      FL, USA.
FAU - Lipori, Gloria
AU  - Lipori G
AUID- ORCID: 0000-0001-5616-2701
AD  - Integrated Data Repository Research Services, University of Florida, Gainesville, 
      FL, USA.
AD  - Lillian S. Wells Department of Neurosurgery, Clinical and Translational Science 
      Institute, University of Florida, Gainesville, FL, USA.
FAU - Mitchell, Duane A
AU  - Mitchell DA
AUID- ORCID: 0000-0001-6049-213X
AD  - Lillian S. Wells Department of Neurosurgery, Clinical and Translational Science 
      Institute, University of Florida, Gainesville, FL, USA.
FAU - Ospina, Naykky S
AU  - Ospina NS
AD  - Division of Endocrinology, Department of Medicine, College of Medicine, 
      University of Florida, Gainesville, FL, USA.
FAU - Ahmed, Mustafa M
AU  - Ahmed MM
AD  - Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, 
      University of Florida, Gainesville, FL, USA.
FAU - Hogan, William R
AU  - Hogan WR
AUID- ORCID: 0000-0002-9881-1017
AD  - Department of Health Outcomes and Biomedical Informatics, College of Medicine, 
      University of Florida, Gainesville, FL, USA.
FAU - Shenkman, Elizabeth A
AU  - Shenkman EA
AUID- ORCID: 0000-0003-4903-1804
AD  - Department of Health Outcomes and Biomedical Informatics, College of Medicine, 
      University of Florida, Gainesville, FL, USA.
FAU - Guo, Yi
AU  - Guo Y
AUID- ORCID: 0000-0003-0587-4105
AD  - Department of Health Outcomes and Biomedical Informatics, College of Medicine, 
      University of Florida, Gainesville, FL, USA.
AD  - Cancer Informatics Shared Resource, University of Florida Health Cancer Center, 
      Gainesville, FL, USA.
FAU - Bian, Jiang
AU  - Bian J
AUID- ORCID: 0000-0002-2238-5429
AD  - Department of Health Outcomes and Biomedical Informatics, College of Medicine, 
      University of Florida, Gainesville, FL, USA.
AD  - Cancer Informatics Shared Resource, University of Florida Health Cancer Center, 
      Gainesville, FL, USA.
FAU - Wu, Yonghui
AU  - Wu Y
AUID- ORCID: 0000-0002-6780-6135
AD  - Department of Health Outcomes and Biomedical Informatics, College of Medicine, 
      University of Florida, Gainesville, FL, USA. yonghui.wu@ufl.edu.
AD  - Cancer Informatics Shared Resource, University of Florida Health Cancer Center, 
      Gainesville, FL, USA. yonghui.wu@ufl.edu.
LA  - eng
GR  - R01 AG080624/AG/NIA NIH HHS/United States
GR  - R01 CA246418/CA/NCI NIH HHS/United States
GR  - R56 AG069880/AG/NIA NIH HHS/United States
PT  - Journal Article
DEP - 20231116
PL  - England
TA  - NPJ Digit Med
JT  - NPJ digital medicine
JID - 101731738
PMC - PMC10654385
COIS- K.E.S., N.P.N., A.B.C., C.M., and M.G.F. are employed by NVIDIA. There are no 
      other competing financial or non-financial interests. The work presented in this 
      study was conducted exclusively within the University of Florida Health.
EDAT- 2023/11/17 15:24
MHDA- 2023/11/17 15:25
PMCR- 2023/11/16
CRDT- 2023/11/17 01:09
PHST- 2023/06/05 00:00 [received]
PHST- 2023/11/01 00:00 [accepted]
PHST- 2023/11/17 15:25 [medline]
PHST- 2023/11/17 15:24 [pubmed]
PHST- 2023/11/17 01:09 [entrez]
PHST- 2023/11/16 00:00 [pmc-release]
AID - 10.1038/s41746-023-00958-w [pii]
AID - 958 [pii]
AID - 10.1038/s41746-023-00958-w [doi]
PST - epublish
SO  - NPJ Digit Med. 2023 Nov 16;6(1):210. doi: 10.1038/s41746-023-00958-w.

PMID- 38564079
OWN - NLM
STAT- Publisher
LR  - 20240402
IS  - 1573-2584 (Electronic)
IS  - 0301-1623 (Linking)
DP  - 2024 Apr 2
TI  - Adequacy of prostate cancer prevention and screening recommendations provided by 
      an artificial intelligence-powered large language model.
LID - 10.1007/s11255-024-04009-5 [doi]
AB  - PURPOSE: We aimed to assess the appropriateness of ChatGPT in providing answers 
      related to prostate cancer (PCa) screening, comparing GPT-3.5 and GPT-4. METHODS: 
      A committee of five reviewers designed 30 questions related to PCa screening, 
      categorized into three difficulty levels. The questions were formulated 
      identically for both GPTs three times, varying the prompts. Each reviewer 
      assigned a score for accuracy, clarity, and conciseness. The readability was 
      assessed by the Flesch Kincaid Grade (FKG) and Flesch Reading Ease (FRE). The 
      mean scores were extracted and compared using the Wilcoxon test. We compared the 
      readability across the three different prompts by ANOVA. RESULTS: In GPT-3.5 the 
      mean score (SD) for accuracy, clarity, and conciseness was 1.5 (0.59), 1.7 
      (0.45), 1.7 (0.49), respectively for easy questions; 1.3 (0.67), 1.6 (0.69), 1.3 
      (0.65) for medium; 1.3 (0.62), 1.6 (0.56), 1.4 (0.56) for hard. In GPT-4 was 2.0 
      (0), 2.0 (0), 2.0 (0.14), respectively for easy questions; 1.7 (0.66), 1.8 
      (0.61), 1.7 (0.64) for medium; 2.0 (0.24), 1.8 (0.37), 1.9 (0.27) for hard. GPT-4 
      performed better for all three qualities and difficulty levels than GPT-3.5. The 
      FKG mean for GPT-3.5 and GPT-4 answers were 12.8 (1.75) and 10.8 (1.72), 
      respectively; the FRE for GPT-3.5 and GPT-4 was 37.3 (9.65) and 47.6 (9.88), 
      respectively. The 2nd prompt has achieved better results in terms of clarity (all 
      p &lt; 0.05). CONCLUSIONS: GPT-4 displayed superior accuracy, clarity, conciseness, 
      and readability than GPT-3.5. Though prompts influenced the quality response in 
      both GPTs, their impact was significant only for clarity.
CI  - © 2024. The Author(s), under exclusive licence to Springer Nature B.V.
FAU - Chiarelli, Giuseppe
AU  - Chiarelli G
AD  - VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health 
      System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
AD  - Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, 
      Milan, Italy.
FAU - Stephens, Alex
AU  - Stephens A
AD  - Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.
FAU - Finati, Marco
AU  - Finati M
AD  - VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health 
      System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
AD  - Department of Urology and Renal Transplantation, University of Foggia, Foggia, 
      Italy.
FAU - Cirulli, Giuseppe Ottone
AU  - Cirulli GO
AD  - VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health 
      System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
AD  - Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute 
      San Raffaele University, Milan, Italy.
FAU - Beatrici, Edoardo
AU  - Beatrici E
AD  - Division of Urological Surgery and Center for Surgery and Public Health, Brigham 
      and Women's Hospital, Harvard Medical School, Boston, MA, USA.
AD  - Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, 
      Milan, Italy.
FAU - Filipas, Dejan K
AU  - Filipas DK
AD  - Division of Urological Surgery and Center for Surgery and Public Health, Brigham 
      and Women's Hospital, Harvard Medical School, Boston, MA, USA.
AD  - Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, 
      Germany.
FAU - Arora, Sohrab
AU  - Arora S
AD  - VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health 
      System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
FAU - Tinsley, Shane
AU  - Tinsley S
AD  - VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health 
      System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
FAU - Bhandari, Mahendra
AU  - Bhandari M
AD  - VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health 
      System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
FAU - Carrieri, Giuseppe
AU  - Carrieri G
AD  - Department of Urology and Renal Transplantation, University of Foggia, Foggia, 
      Italy.
FAU - Trinh, Quoc-Dien
AU  - Trinh QD
AD  - Division of Urological Surgery and Center for Surgery and Public Health, Brigham 
      and Women's Hospital, Harvard Medical School, Boston, MA, USA.
FAU - Briganti, Alberto
AU  - Briganti A
AD  - Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute 
      San Raffaele University, Milan, Italy.
FAU - Montorsi, Francesco
AU  - Montorsi F
AD  - Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute 
      San Raffaele University, Milan, Italy.
FAU - Lughezzani, Giovanni
AU  - Lughezzani G
AD  - Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, 
      Milan, Italy.
FAU - Buffi, Nicolò
AU  - Buffi N
AD  - Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, 
      Milan, Italy.
FAU - Rogers, Craig
AU  - Rogers C
AD  - VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health 
      System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
FAU - Abdollah, Firas
AU  - Abdollah F
AUID- ORCID: 0000-0003-1298-8231
AD  - VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health 
      System, 2799 W Grand Blvd, Detroit, MI, 48202, USA. firas.abdollah@gmail.com.
LA  - eng
PT  - Journal Article
DEP - 20240402
PL  - Netherlands
TA  - Int Urol Nephrol
JT  - International urology and nephrology
JID - 0262521
SB  - IM
OTO - NOTNLM
OT  - Artificial intelligence
OT  - Cancer screening
OT  - Preventive health service
OT  - Prostatic neoplasm
EDAT- 2024/04/02 12:48
MHDA- 2024/04/02 12:48
CRDT- 2024/04/02 11:20
PHST- 2024/01/15 00:00 [received]
PHST- 2024/02/26 00:00 [accepted]
PHST- 2024/04/02 12:48 [medline]
PHST- 2024/04/02 12:48 [pubmed]
PHST- 2024/04/02 11:20 [entrez]
AID - 10.1007/s11255-024-04009-5 [pii]
AID - 10.1007/s11255-024-04009-5 [doi]
PST - aheadofprint
SO  - Int Urol Nephrol. 2024 Apr 2. doi: 10.1007/s11255-024-04009-5.

PMID- 37998082
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231126
IS  - 2313-433X (Electronic)
IS  - 2313-433X (Linking)
VI  - 9
IP  - 11
DP  - 2023 Oct 25
TI  - Empowering Deaf-Hearing Communication: Exploring Synergies between Predictive and 
      Generative AI-Based Strategies towards (Portuguese) Sign Language Interpretation.
LID - 10.3390/jimaging9110235 [doi]
LID - 235
AB  - Communication between Deaf and hearing individuals remains a persistent challenge 
      requiring attention to foster inclusivity. Despite notable efforts in the 
      development of digital solutions for sign language recognition (SLR), several 
      issues persist, such as cross-platform interoperability and strategies for 
      tokenizing signs to enable continuous conversations and coherent sentence 
      construction. To address such issues, this paper proposes a non-invasive 
      Portuguese Sign Language (Língua Gestual Portuguesa or LGP) interpretation 
      system-as-a-service, leveraging skeletal posture sequence inference powered by 
      long-short term memory (LSTM) architectures. To address the scarcity of examples 
      during machine learning (ML) model training, dataset augmentation strategies are 
      explored. Additionally, a buffer-based interaction technique is introduced to 
      facilitate LGP terms tokenization. This technique provides real-time feedback to 
      users, allowing them to gauge the time remaining to complete a sign, which aids 
      in the construction of grammatically coherent sentences based on inferred 
      terms/words. To support human-like conditioning rules for interpretation, a large 
      language model (LLM) service is integrated. Experiments reveal that LSTM-based 
      neural networks, trained with 50 LGP terms and subjected to data augmentation, 
      achieved accuracy levels ranging from 80% to 95.6%. Users unanimously reported a 
      high level of intuition when using the buffer-based interaction strategy for 
      terms/words tokenization. Furthermore, tests with an LLM-specifically 
      ChatGPT-demonstrated promising semantic correlation rates in generated sentences, 
      comparable to expected sentences.
FAU - Adão, Telmo
AU  - Adão T
AUID- ORCID: 0000-0002-2727-0014
AD  - Department of Engineering, School of Sciences and Technology, University of 
      Trás-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal.
AD  - ALGORITMI Research Centre/LASI, University of Minho, 4800-058 Guimarães, 
      Portugal.
FAU - Oliveira, João
AU  - Oliveira J
AD  - Centro de Computação Gráfica-CCG/zgdv, University of Minho, Campus de Azurém, 
      Edifício 14, 4800-058 Guimarães, Portugal.
FAU - Shahrabadi, Somayeh
AU  - Shahrabadi S
AD  - Centro de Computação Gráfica-CCG/zgdv, University of Minho, Campus de Azurém, 
      Edifício 14, 4800-058 Guimarães, Portugal.
FAU - Jesus, Hugo
AU  - Jesus H
AD  - Centro de Computação Gráfica-CCG/zgdv, University of Minho, Campus de Azurém, 
      Edifício 14, 4800-058 Guimarães, Portugal.
FAU - Fernandes, Marco
AU  - Fernandes M
AD  - Polytechnic Institute of Bragança, School of Communication, Administration and 
      Tourism, Campus do Cruzeiro, 5370-202 Mirandela, Portugal.
FAU - Costa, Ângelo
AU  - Costa Â
AD  - Associação Portuguesa de Surdos (APS), 1600-796 Lisboa, Portugal.
FAU - Ferreira, Vânia
AU  - Ferreira V
AD  - Associação Portuguesa de Surdos (APS), 1600-796 Lisboa, Portugal.
FAU - Gonçalves, Martinho Fradeira
AU  - Gonçalves MF
AD  - Polytechnic Institute of Bragança, School of Communication, Administration and 
      Tourism, Campus do Cruzeiro, 5370-202 Mirandela, Portugal.
FAU - Lopéz, Miguel A Guevara
AU  - Lopéz MAG
AUID- ORCID: 0000-0001-7814-1653
AD  - ALGORITMI Research Centre/LASI, University of Minho, 4800-058 Guimarães, 
      Portugal.
AD  - Instituto Politécnico de Setúbal, Escola Superior de Tecnologia de Setúbal, 
      2914-508 Setúbal, Portugal.
FAU - Peres, Emanuel
AU  - Peres E
AUID- ORCID: 0000-0001-5669-7976
AD  - Department of Engineering, School of Sciences and Technology, University of 
      Trás-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal.
AD  - Centre for the Research and Technology of Agro-Environmental and Biological 
      Sciences, University of Trás-os-Montes e Alto Douro, 5000-801 Vila Real, 
      Portugal.
AD  - Institute for Innovation, Capacity Building and Sustainability of Agri-Food 
      Production, University of Trás-os-Montes e Alto Douro, 5000-801 Vila Real, 
      Portugal.
FAU - Magalhães, Luís Gonzaga
AU  - Magalhães LG
AD  - ALGORITMI Research Centre/LASI, University of Minho, 4800-058 Guimarães, 
      Portugal.
LA  - eng
GR  - POCI-01-0247-FEDER-068605/Portugal 2020, under the Competitiveness and 
      Internationalization Operational Program (POCI), and by the European Regional 
      Development Fund (ERDF)/
GR  - C644866286-00000011/Vine&amp;Wine Portugal Project, co-financed by the RRP - Recovery 
      and Resilience Plan and the Eu-ropean NextGeneration EU Funds/
PT  - Journal Article
DEP - 20231025
PL  - Switzerland
TA  - J Imaging
JT  - Journal of imaging
JID - 101698819
PMC - PMC10672430
OTO - NOTNLM
OT  - Portuguese Sign Language
OT  - deaf-hearing communication
OT  - generative pre-trained transformer (GPT)
OT  - inclusion
OT  - large language models (LLM)
OT  - long-short term memory (LSTM)
OT  - machine learning (ML)
OT  - sign language recognition (SLR)
OT  - video-based motion analytics
COIS- The authors declare no conflict of interest.
EDAT- 2023/11/24 12:42
MHDA- 2023/11/24 12:43
PMCR- 2023/10/25
CRDT- 2023/11/24 09:33
PHST- 2023/09/16 00:00 [received]
PHST- 2023/10/14 00:00 [revised]
PHST- 2023/10/19 00:00 [accepted]
PHST- 2023/11/24 12:43 [medline]
PHST- 2023/11/24 12:42 [pubmed]
PHST- 2023/11/24 09:33 [entrez]
PHST- 2023/10/25 00:00 [pmc-release]
AID - jimaging9110235 [pii]
AID - jimaging-09-00235 [pii]
AID - 10.3390/jimaging9110235 [doi]
PST - epublish
SO  - J Imaging. 2023 Oct 25;9(11):235. doi: 10.3390/jimaging9110235.

PMID- 38343631
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240226
IS  - 2836-9386 (Electronic)
IS  - 2836-9386 (Linking)
VI  - 1
IP  - 2
DP  - 2024 Feb
TI  - Almanac - Retrieval-Augmented Language Models for Clinical Medicine.
LID - 10.1056/aioa2300068 [doi]
AB  - BACKGROUND: Large language models (LLMs) have recently shown impressive zero-shot 
      capabilities, whereby they can use auxiliary data, without the availability of 
      task-specific training examples, to complete a variety of natural language tasks, 
      such as summarization, dialogue generation, and question answering. However, 
      despite many promising applications of LLMs in clinical medicine, adoption of 
      these models has been limited by their tendency to generate incorrect and 
      sometimes even harmful statements. METHODS: We tasked a panel of eight 
      board-certified clinicians and two health care practitioners with evaluating 
      Almanac, an LLM framework augmented with retrieval capabilities from curated 
      medical resources for medical guideline and treatment recommendations. The panel 
      compared responses from Almanac and standard LLMs (ChatGPT-4, Bing, and Bard) 
      versus a novel data set of 314 clinical questions spanning nine medical 
      specialties. RESULTS: Almanac showed a significant improvement in performance 
      compared with the standard LLMs across axes of factuality, completeness, user 
      preference, and adversarial safety. CONCLUSIONS: Our results show the potential 
      for LLMs with access to domain-specific corpora to be effective in clinical 
      decision-making. The findings also underscore the importance of carefully testing 
      LLMs before deployment to mitigate their shortcomings. (Funded by the National 
      Institutes of Health, National Heart, Lung, and Blood Institute.).
FAU - Zakka, Cyril
AU  - Zakka C
AUID- ORCID: 0000-0001-8446-2349
AD  - Department of Cardiothoracic Surgery, Stanford Medicine, Stanford, CA.
FAU - Shad, Rohan
AU  - Shad R
AUID- ORCID: 0000-0002-0453-9041
AD  - Division of Cardiovascular Surgery, Penn Medicine, Philadelphia.
FAU - Chaurasia, Akash
AU  - Chaurasia A
AUID- ORCID: 0000-0003-3438-3313
AD  - Department of Computer Science, Stanford University, Stanford, CA.
FAU - Dalal, Alex R
AU  - Dalal AR
AUID- ORCID: 0000-0002-9993-3817
AD  - Department of Cardiothoracic Surgery, Stanford Medicine, Stanford, CA.
FAU - Kim, Jennifer L
AU  - Kim JL
AUID- ORCID: 0000-0002-2313-2685
AD  - Department of Cardiothoracic Surgery, Stanford Medicine, Stanford, CA.
FAU - Moor, Michael
AU  - Moor M
AUID- ORCID: 0000-0003-4911-6437
AD  - Department of Computer Science, Stanford University, Stanford, CA.
FAU - Fong, Robyn
AU  - Fong R
AUID- ORCID: 0000-0002-7953-5109
AD  - Department of Computer Science, Stanford University, Stanford, CA.
FAU - Phillips, Curran
AU  - Phillips C
AUID- ORCID: 0009-0008-8316-6765
AD  - Department of Cardiothoracic Surgery, Stanford Medicine, Stanford, CA.
FAU - Alexander, Kevin
AU  - Alexander K
AUID- ORCID: 0000-0003-4024-3691
AD  - Division of Cardiovascular Medicine, Stanford Medicine, Stanford, CA.
FAU - Ashley, Euan
AU  - Ashley E
AUID- ORCID: 0000-0001-9418-9577
AD  - Division of Cardiovascular Medicine, Stanford Medicine, Stanford, CA.
FAU - Boyd, Jack
AU  - Boyd J
AUID- ORCID: 0000-0002-3020-5280
AD  - Department of Cardiothoracic Surgery, Stanford Medicine, Stanford, CA.
FAU - Boyd, Kathleen
AU  - Boyd K
AUID- ORCID: 0009-0007-9366-754X
AD  - Department of Pediatrics, Stanford Medicine, Stanford, CA.
FAU - Hirsch, Karen
AU  - Hirsch K
AUID- ORCID: 0000-0002-5474-3243
AD  - Department of Neurology, Stanford Medicine, Stanford, CA.
FAU - Langlotz, Curt
AU  - Langlotz C
AUID- ORCID: 0000-0002-8972-8051
AD  - Department of Radiology and Biomedical Informatics, Stanford Medicine, Stanford, 
      CA.
FAU - Lee, Rita
AU  - Lee R
AUID- ORCID: 0009-0007-8868-6447
AD  - Department of Cardiothoracic Surgery, Stanford Medicine, Stanford, CA.
FAU - Melia, Joanna
AU  - Melia J
AUID- ORCID: 0000-0002-0984-4600
AD  - Division of Gastroenterology and Hepatology, Johns Hopkins Medicine, Baltimore.
FAU - Nelson, Joanna
AU  - Nelson J
AUID- ORCID: 0000-0003-2152-2847
AD  - Division of Infectious Diseases, Stanford Medicine, Stanford, CA.
FAU - Sallam, Karim
AU  - Sallam K
AUID- ORCID: 0000-0003-3469-6571
AD  - Division of Cardiovascular Medicine, Stanford Medicine, Stanford, CA.
FAU - Tullis, Stacey
AU  - Tullis S
AUID- ORCID: 0009-0000-8950-5790
AD  - Department of Cardiothoracic Surgery, Stanford Medicine, Stanford, CA.
FAU - Vogelsong, Melissa Ann
AU  - Vogelsong MA
AUID- ORCID: 0000-0003-0601-3542
AD  - Division of Anesthesia, Stanford Medicine, Stanford, CA.
FAU - Cunningham, John Patrick
AU  - Cunningham JP
AUID- ORCID: 0000-0001-9125-3027
AD  - Department of Statistics, Columbia University, New York.
FAU - Hiesinger, William
AU  - Hiesinger W
AUID- ORCID: 0000-0002-3548-2578
AD  - Department of Cardiothoracic Surgery, Stanford Medicine, Stanford, CA.
LA  - eng
GR  - R01 HL157235/HL/NHLBI NIH HHS/United States
PT  - Journal Article
DEP - 20240125
PL  - United States
TA  - NEJM AI
JT  - NEJM AI
JID - 9918752186406676
UOF - Res Sq. 2023 May 02;:. PMID: 37205549
PMC - PMC10857783
MID - NIHMS1962112
EDAT- 2024/02/12 15:42
MHDA- 2024/02/12 15:43
PMCR- 2024/02/09
CRDT- 2024/02/12 04:08
PHST- 2024/02/12 15:43 [medline]
PHST- 2024/02/12 15:42 [pubmed]
PHST- 2024/02/12 04:08 [entrez]
PHST- 2024/02/09 00:00 [pmc-release]
AID - 10.1056/aioa2300068 [doi]
PST - ppublish
SO  - NEJM AI. 2024 Feb;1(2):10.1056/aioa2300068. doi: 10.1056/aioa2300068. Epub 2024 
      Jan 25.

PMID- 37812419
OWN - NLM
STAT- MEDLINE
DCOM- 20231011
LR  - 20231017
IS  - 2574-3805 (Electronic)
IS  - 2574-3805 (Linking)
VI  - 6
IP  - 10
DP  - 2023 Oct 2
TI  - Large Language Model-Based Chatbot vs Surgeon-Generated Informed Consent 
      Documentation for Common Procedures.
PG  - e2336997
LID - 10.1001/jamanetworkopen.2023.36997 [doi]
LID - e2336997
AB  - IMPORTANCE: Informed consent is a critical component of patient care before 
      invasive procedures, yet it is frequently inadequate. Electronic consent forms 
      have the potential to facilitate patient comprehension if they provide 
      information that is readable, accurate, and complete; it is not known if large 
      language model (LLM)-based chatbots may improve informed consent documentation by 
      generating accurate and complete information that is easily understood by 
      patients. OBJECTIVE: To compare the readability, accuracy, and completeness of 
      LLM-based chatbot- vs surgeon-generated information on the risks, benefits, and 
      alternatives (RBAs) of common surgical procedures. DESIGN, SETTING, AND 
      PARTICIPANTS: This cross-sectional study compared randomly selected 
      surgeon-generated RBAs used in signed electronic consent forms at an academic 
      referral center in San Francisco with LLM-based chatbot-generated (ChatGPT-3.5, 
      OpenAI) RBAs for 6 surgical procedures (colectomy, coronary artery bypass graft, 
      laparoscopic cholecystectomy, inguinal hernia repair, knee arthroplasty, and 
      spinal fusion). MAIN OUTCOMES AND MEASURES: Readability was measured using 
      previously validated scales (Flesh-Kincaid grade level, Gunning Fog index, the 
      Simple Measure of Gobbledygook, and the Coleman-Liau index). Scores range from 0 
      to greater than 20 to indicate the years of education required to understand a 
      text. Accuracy and completeness were assessed using a rubric developed with 
      recommendations from LeapFrog, the Joint Commission, and the American College of 
      Surgeons. Both composite and RBA subgroup scores were compared. RESULTS: The 
      total sample consisted of 36 RBAs, with 1 RBA generated by the LLM-based chatbot 
      and 5 RBAs generated by a surgeon for each of the 6 surgical procedures. The mean 
      (SD) readability score for the LLM-based chatbot RBAs was 12.9 (2.0) vs 15.7 
      (4.0) for surgeon-generated RBAs (P = .10). The mean (SD) composite completeness 
      and accuracy score was lower for surgeons' RBAs at 1.6 (0.5) than for LLM-based 
      chatbot RBAs at 2.2 (0.4) (P &lt; .001). The LLM-based chatbot scores were higher 
      than the surgeon-generated scores for descriptions of the benefits of surgery 
      (2.3 [0.7] vs 1.4 [0.7]; P &lt; .001) and alternatives to surgery (2.7 [0.5] vs 1.4 
      [0.7]; P &lt; .001). There was no significant difference in chatbot vs surgeon RBA 
      scores for risks of surgery (1.7 [0.5] vs 1.7 [0.4]; P = .38). CONCLUSIONS AND 
      RELEVANCE: The findings of this cross-sectional study suggest that despite not 
      being perfect, LLM-based chatbots have the potential to enhance informed consent 
      documentation. If an LLM were embedded in electronic health records in a manner 
      compliant with the Health Insurance Portability and Accountability Act, it could 
      be used to provide personalized risk information while easing documentation 
      burden for physicians.
FAU - Decker, Hannah
AU  - Decker H
AD  - Department of Surgery, University of California, San Francisco.
FAU - Trang, Karen
AU  - Trang K
AD  - Department of Surgery, University of California, San Francisco.
FAU - Ramirez, Joel
AU  - Ramirez J
AD  - Department of Surgery, University of California, San Francisco.
FAU - Colley, Alexis
AU  - Colley A
AD  - Department of Surgery, University of California, San Francisco.
FAU - Pierce, Logan
AU  - Pierce L
AD  - Department of Medicine, University of California, San Francisco.
FAU - Coleman, Melissa
AU  - Coleman M
AD  - Department of Surgery, University of California, San Francisco.
FAU - Bongiovanni, Tasce
AU  - Bongiovanni T
AD  - Department of Surgery, University of California, San Francisco.
FAU - Melton, Genevieve B
AU  - Melton GB
AD  - Department of Surgery, Institute for Health Informatics, and Center for Learning 
      Health System Sciences, University of Minnesota, Minneapolis.
FAU - Wick, Elizabeth
AU  - Wick E
AD  - Department of Surgery, University of California, San Francisco.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20231002
PL  - United States
TA  - JAMA Netw Open
JT  - JAMA network open
JID - 101729235
SB  - IM
MH  - Humans
MH  - Cross-Sectional Studies
MH  - Documentation
MH  - Informed Consent
MH  - Language
MH  - *Surgeons
MH  - United States
PMC - PMC10562939
COIS- Conflict of Interest Disclosures: Dr Decker reported personal fees from Moon 
      Surgical and being part of the National Clinician Scholars Program outside the 
      submitted work. Dr Melton reported grants from the Agency for Healthcare Research 
      and Quality, the US National Institutes of Health (NIH), the US Department of 
      Defense, and the Minnesota Partnership, all outside the submitted work. Dr Wick 
      reported grants from the NIH outside the submitted work. No other disclosures 
      were reported.
EDAT- 2023/10/09 12:43
MHDA- 2023/10/10 06:41
PMCR- 2023/10/09
CRDT- 2023/10/09 11:33
PHST- 2023/10/10 06:41 [medline]
PHST- 2023/10/09 12:43 [pubmed]
PHST- 2023/10/09 11:33 [entrez]
PHST- 2023/10/09 00:00 [pmc-release]
AID - 2810364 [pii]
AID - zoi231078 [pii]
AID - 10.1001/jamanetworkopen.2023.36997 [doi]
PST - epublish
SO  - JAMA Netw Open. 2023 Oct 2;6(10):e2336997. doi: 
      10.1001/jamanetworkopen.2023.36997.

PMID- 37794316
OWN - NLM
STAT- MEDLINE
DCOM- 20231006
LR  - 20231122
IS  - 1471-2261 (Electronic)
IS  - 1471-2261 (Linking)
VI  - 23
IP  - 1
DP  - 2023 Oct 4
TI  - The insufficiency of recreational exercises in improving cardiovascular fitness: 
      an investigation of ventricular systolic and diastolic parameters and left atrial 
      mechanical functions.
PG  - 486
LID - 10.1186/s12872-023-03508-0 [doi]
LID - 486
AB  - AIM: This study aimed to compare the left ventricular (LV) systolic and diastolic 
      parameters and left atrial (LA) mechanical functions of individuals engaging in 
      recreational sports and resistance exercises on a weekly basis. METHODS: A total 
      of 43 male amateur athletes were included in this study, of which 24 performed 
      resistance exercises (REs) (29.70 ± 8.74 year, weight: 81.70 ± 12.64&nbsp;kg, height: 
      176.05 ± 7.73&nbsp;cm, BMI: 27.64 ± 4.97&nbsp;kg/m(2)), and 19 participated in recreational 
      football training and were included in the recreational sports group 
      (31.73 ± 6.82 year, weight: 86.00 ± 18.52&nbsp;kg, height: 178.62 ± 4.95&nbsp;cm, BMI: 
      25.55 ± 3.42&nbsp;kg/m(2)). The exercises were standardized according to the weekly 
      exercise frequency and volume. After recording the participants' demographic 
      information, the LV systolic and diastolic parameters and LA mechanical functions 
      were measured using echocardiography (ECHO) and Tissue Doppler Imaging. RESULTS: 
      Significant differences were observed in various cardiac parameters between the 
      recreational sports group (REG) and resistance exercise Group (RSG). 
      Specifically, the left ventricular (LV) diastolic diameter, LV end diastolic 
      volume index (LVEDVi), and stroke volume index were notably higher in the REG 
      compared to the RSG (t = 2.804, p = .010, effect size (ES) = 2.10; t = 3.174, 
      p = .003, ES = 0.98; t = 3.36, p = .002, ES = 1.02, respectively). Notably, the 
      RSG exhibited higher values for LV mass index (LVMi) and isovolumic relaxation 
      time (IVRT) than the REG (t = 2.843, p = .007, ES = 0.87; t = 2.517, p = .016, 
      ES = 0.76) in terms of LV systolic and diastolic parameters. Regarding left 
      atrial (LA) mechanics, the REG demonstrated increased LA total emptying volume 
      index, LA maximum volume index, LA volume before systole measured at the onset of 
      the p-wave index, and conduit volume index compared to RSG (t = 2.419, p = .020, 
      ES = 0.75; t = 2.669, p = .011, ES = 0.81; t = 2.111, p = .041, ES = 0.64; 
      t = 2.757, p = .009, ES = 0.84, respectively). CONCLUSION: Our study revealed 
      significant variations in LV and LA functions between REG and RSG. Our data 
      suggest that REs led to substantial cardiac remodeling, altering myocardial 
      structure and function. In contrast, the effect of recreational exercise on 
      cardiac adaptation was less pronounced than that of resistance exercise. 
      Consequently, we propose that individuals engaging in recreational exercise 
      should consider modalities that impose higher cardiovascular demand for more 
      effective cardiac conditioning.
CI  - © 2023. BioMed Central Ltd., part of Springer Nature.
FAU - Akgümüş, Alkame
AU  - Akgümüş A
AD  - Department of Cardiology, Medical Faculty, Bandirma Onyedi Eylul University, 
      Bandırma, 10200, Turkey.
FAU - Kurtoğlu, Ahmet
AU  - Kurtoğlu A
AD  - Department of Coaching Education, Faculty of Sport Science, Bandirma Onyedi Eylul 
      University, Bandırma, 10200, Turkey.
FAU - Aydın, Engin
AU  - Aydın E
AD  - Department of Pediadrics, Medical Faculty, Bandirma Onyedi Eylul University, 
      Bandırma, 10200, Turkey.
FAU - Balun, Ahmet
AU  - Balun A
AD  - Department of Cardiology, Medical Faculty, Bandirma Onyedi Eylul University, 
      Bandırma, 10200, Turkey.
FAU - Çar, Bekir
AU  - Çar B
AD  - Department of Physical Education and Sport Teaching, Faculty of Sport Sciences, 
      Bandirma Onyedi Eylul University, Bandırma, 10200, Turkey.
FAU - Eken, Özgür
AU  - Eken Ö
AD  - Department of Physical Education and Sport Teaching, Faculty of Sports Sciences, 
      Inonu University, Malatya, Turkey.
FAU - Aldhahi, Monira I
AU  - Aldhahi MI
AD  - Department of Rehabilitation Sciences, College of Health and Rehabilitation 
      Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 
      11671, Saudi Arabia. Mialdhahi@pnu.edu.sa.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20231004
PL  - England
TA  - BMC Cardiovasc Disord
JT  - BMC cardiovascular disorders
JID - 100968539
SB  - IM
MH  - Humans
MH  - Male
MH  - Systole
MH  - *Atrial Fibrillation
MH  - Echocardiography
MH  - Diastole
MH  - Stroke Volume
MH  - Ventricular Function, Left
MH  - *Ventricular Dysfunction, Left
PMC - PMC10552377
OTO - NOTNLM
OT  - Athletics
OT  - Atrial mechanical functions
OT  - Diastolic
OT  - Electrocardiography
OT  - Recreation
OT  - Resistance exercise
OT  - Sports
OT  - Systolic
OT  - Ventricular function
COIS- We declare that we have no financial or personal relationships among the authors 
      that could potentially influence or bias the content of this study. None of the 
      authors have any financial interests or conflicts of interest concerning the 
      ChatGPT or NLM technologies discussed in this manuscript. Moreover, there have 
      been no collaborations or consultations with individuals or organizations with 
      financial or other interests in ChatGPT or NLM technologies [52].
EDAT- 2023/10/05 01:00
MHDA- 2023/10/06 06:42
PMCR- 2023/10/04
CRDT- 2023/10/04 23:36
PHST- 2023/06/06 00:00 [received]
PHST- 2023/09/12 00:00 [accepted]
PHST- 2023/10/06 06:42 [medline]
PHST- 2023/10/05 01:00 [pubmed]
PHST- 2023/10/04 23:36 [entrez]
PHST- 2023/10/04 00:00 [pmc-release]
AID - 10.1186/s12872-023-03508-0 [pii]
AID - 3508 [pii]
AID - 10.1186/s12872-023-03508-0 [doi]
PST - epublish
SO  - BMC Cardiovasc Disord. 2023 Oct 4;23(1):486. doi: 10.1186/s12872-023-03508-0.

PMID- 38402209
OWN - NLM
STAT- MEDLINE
DCOM- 20240226
LR  - 20240227
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 14
IP  - 1
DP  - 2024 Feb 24
TI  - Impact of motor task conditions on end-point kinematics and trunk movements 
      during goal-directed arm reach.
PG  - 4520
LID - 10.1038/s41598-024-54723-4 [doi]
LID - 4520
AB  - Task conditions significantly impact human motor control. We investigated how 
      task type, difficulty, and constraints influence the kinematics of goal-directed 
      arm reaching. Non-disabled young adults performed two distinct goal-directed arm 
      reaching tasks: pointing and picking up an object with chopsticks. These tasks 
      were carried out under various conditions, including constrained and 
      unconstrained elbow extension and two different task difficulties. We collected 
      kinematic data using a 3-D motion capture system and analyzed the effects of 
      different task conditions on kinematic variables using linear mixed-effects 
      regression analysis. Our findings revealed statistically significant differences 
      in kinematics between the two tasks. Arm reaching during the picking-up task was 
      slower and exhibited jerkier movements compared to the pointing task. 
      Additionally, when arm reaching was performed with constrained elbow extension, 
      it led to slower and jerkier movements, with an increased involvement of trunk 
      movements compared to the unconstrained condition. These findings show that 
      complex manipulative motor tasks requiring higher hand dexterity necessitate 
      feedback-based control of arm reaching, but simple pointing tasks requiring less 
      hand dexterity do not. In conclusion, our study sheds light on the influence of 
      task conditions on goal-directed arm reaching kinematics and provides valuable 
      insights into the motor control strategies involved in different tasks.
CI  - © 2024. This is a U.S. Government work and not under copyright protection in the 
      US; foreign copyright protection may apply.
FAU - Kim, Bokkyu
AU  - Kim B
AD  - Department of Physical Therapy Education, College of Health Professions, SUNY 
      Upstate Medical University, Syracuse, NY, 13066, USA. kimbo@upstate.edu.
FAU - Girnis, Jaimie
AU  - Girnis J
AD  - Department of Physical Therapy Education, College of Health Professions, SUNY 
      Upstate Medical University, Syracuse, NY, 13066, USA.
FAU - Sweet, Vanessa
AU  - Sweet V
AD  - Department of Physical Therapy Education, College of Health Professions, SUNY 
      Upstate Medical University, Syracuse, NY, 13066, USA.
AD  - Jones Memorial Hospital, Wellsville, NY, USA.
FAU - Nobiling, Tobias
AU  - Nobiling T
AD  - Department of Physical Therapy Education, College of Health Professions, SUNY 
      Upstate Medical University, Syracuse, NY, 13066, USA.
AD  - University of Rochester Medical Center, Rochester, NY, USA.
FAU - Agag, Tarek
AU  - Agag T
AD  - Department of Physical Therapy Education, College of Health Professions, SUNY 
      Upstate Medical University, Syracuse, NY, 13066, USA.
FAU - Neville, Christopher
AU  - Neville C
AD  - Department of Physical Therapy Education, College of Health Professions, SUNY 
      Upstate Medical University, Syracuse, NY, 13066, USA.
LA  - eng
PT  - Journal Article
DEP - 20240224
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
SB  - IM
MH  - Young Adult
MH  - Humans
MH  - *Arm
MH  - Biomechanical Phenomena
MH  - *Goals
MH  - Movement
MH  - Elbow
MH  - Psychomotor Performance
PMC - PMC10894230
COIS- Generative AI services, including Quillbot, Grammarly, and ChatGPT version 3.5 
      were employed for proofreading purposes in the preparation of this manuscript. 
      The authors declare no competing interests.
EDAT- 2024/02/25 00:42
MHDA- 2024/02/26 06:43
PMCR- 2024/02/24
CRDT- 2024/02/24 23:17
PHST- 2023/08/31 00:00 [received]
PHST- 2024/02/15 00:00 [accepted]
PHST- 2024/02/26 06:43 [medline]
PHST- 2024/02/25 00:42 [pubmed]
PHST- 2024/02/24 23:17 [entrez]
PHST- 2024/02/24 00:00 [pmc-release]
AID - 10.1038/s41598-024-54723-4 [pii]
AID - 54723 [pii]
AID - 10.1038/s41598-024-54723-4 [doi]
PST - epublish
SO  - Sci Rep. 2024 Feb 24;14(1):4520. doi: 10.1038/s41598-024-54723-4.

PMID- 37948788
OWN - NLM
STAT- MEDLINE
DCOM- 20231216
LR  - 20240105
IS  - 1873-4200 (Electronic)
IS  - 0301-4622 (Linking)
VI  - 304
DP  - 2024 Jan
TI  - TPE conjugated islet amyloid polypeptide probe for detection of peptide 
      oligomers.
PG  - 107129
LID - S0301-4622(23)00180-1 [pii]
LID - 10.1016/j.bpc.2023.107129 [doi]
AB  - Islet amyloid polypeptide (IAPP), also known as amylin, is a polypeptide hormone 
      co-secreted with insulin by pancreatic β-cells. In general, IAPP is soluble and 
      lacks a defined structure. However, under certain conditions, these peptides tend 
      to aggregate into soluble oligomers, eventually forming insoluble amyloid fibrils 
      with typical cross-β-sheet structures. Amylin aggregates, therefore, have been 
      regarded as one of the hallmarks of type II diabetes (T2D). Among these 
      aggregated species, oligomers were shown to exhibit significant cytotoxicity, 
      leading to impaired β-cell function and reduced β-cell mass. Monitoring of 
      oligomer appearance during IAPP fibrillation is of particular interest. In this 
      study, we successfully grafted an aggregation-induced emission molecule, 
      tetraphenylethylene (TPE), at the N-terminus of IAPP. By mixing a small amount of 
      TPE-labeled IAPP with unlabeled IAPP, we were able to detect an increase in TPE 
      fluorescence during the nucleation phase of IAPP aggregation in vitro. It may 
      enable real-time monitoring of IAPP oligomer formation and is further applied in 
      the diagnosis of T2D.
CI  - Copyright © 2023 Elsevier B.V. All rights reserved.
FAU - Tsai, Hsiao-Chieh
AU  - Tsai HC
AD  - Department of Chemistry, National Taiwan Normal University, Taipei 11677, Taiwan.
FAU - Huang, Ching-Hong
AU  - Huang CH
AD  - Department of Chemistry, National Taiwan Normal University, Taipei 11677, Taiwan.
FAU - Tu, Ling-Hsien
AU  - Tu LH
AD  - Department of Chemistry, National Taiwan Normal University, Taipei 11677, Taiwan. 
      Electronic address: litu@gapps.ntnu.edu.tw.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20231031
PL  - Netherlands
TA  - Biophys Chem
JT  - Biophysical chemistry
JID - 0403171
RN  - 0 (Islet Amyloid Polypeptide)
RN  - 0 (Amyloid)
RN  - 0 (Insulin)
SB  - IM
MH  - Humans
MH  - Islet Amyloid Polypeptide/chemistry
MH  - *Diabetes Mellitus, Type 2
MH  - Amyloid/chemistry
MH  - *Insulin-Secreting Cells
MH  - Insulin
OTO - NOTNLM
OT  - Aggregation-induced emission
OT  - Amyloid probes
OT  - Islet amyloid polypeptide
OT  - Oligomers
OT  - Type II diabetes
COIS- Declaration of Competing Interest During the preparation of this work the authors 
      used chatGPT in order to reword the scientific writing. After using this 
      tool/service, the authors reviewed and edited the content as needed and take full 
      responsibility for the content of the publication.
EDAT- 2023/11/10 18:43
MHDA- 2023/12/17 09:44
CRDT- 2023/11/10 18:00
PHST- 2023/08/23 00:00 [received]
PHST- 2023/10/26 00:00 [revised]
PHST- 2023/10/28 00:00 [accepted]
PHST- 2023/12/17 09:44 [medline]
PHST- 2023/11/10 18:43 [pubmed]
PHST- 2023/11/10 18:00 [entrez]
AID - S0301-4622(23)00180-1 [pii]
AID - 10.1016/j.bpc.2023.107129 [doi]
PST - ppublish
SO  - Biophys Chem. 2024 Jan;304:107129. doi: 10.1016/j.bpc.2023.107129. Epub 2023 Oct 
      31.

PMID- 38251407
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240124
IS  - 2226-4787 (Electronic)
IS  - 2226-4787 (Linking)
VI  - 12
IP  - 1
DP  - 2024 Jan 12
TI  - Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK 
      Psychoactive Act 2016 to Present Using Analytical and Social Listening 
      Techniques.
LID - 10.3390/pharmacy12010013 [doi]
LID - 13
AB  - INTRODUCTION: The designer benzodiazepine (DBZD) market continues to expand 
      whilst evading regulatory controls. The widespread adoption of social media by 
      pro-drug use communities encourages positive discussions around DBZD use/misuse, 
      driving demand. This research addresses the evolution of three popular DBZDs, 
      etizolam (E), flubromazepam (F), and pyrazolam (P), available on the drug market 
      for over a decade, comparing the quantitative chemical analyses of tablet 
      samples, purchased from the internet prior to the implementation of the 
      Psychoactive Substances Act UK 2016, with the thematic netnographic analyses of 
      social media content. METHOD: Drug samples were purchased from the internet in 
      early 2016. The characterisation of all drug batches were performed using 
      UHPLC-MS and supported with (1)H NMR. In addition, netnographic studies across 
      the platforms X (formerly Twitter) and Reddit, between 2016-2023, were conducted. 
      The latter was supported by both manual and artificial intelligence (AI)-driven 
      thematic analyses, using numerous.ai and ChatGPT, of social media threads and 
      discussions. RESULTS: UHPLC-MS confirmed the expected drug in every sample, 
      showing remarkable inter/intra batch variability across all batches (E = 13.8 ± 
      0.6 to 24.7 ± 0.9 mg; F = 4.0 ± 0.2 to 23.5 ± 0.8 mg; P = 5.2 ± 0.2 to 11.5 ± 0.4 
      mg). (1)H NMR could not confirm etizolam as a lone compound in any etizolam 
      batch. Thematic analyses showed etizolam dominated social media discussions (59% 
      of all posts), with 24.2% of posts involving sale/purchase and 17.8% detailing 
      new administration trends/poly-drug use scenarios. Artificial intelligence 
      confirmed three of the top five trends identified manually. CONCLUSIONS: Purity 
      variability identified across all tested samples emphasises the increased 
      potential health risks associated with DBZD consumption. We propose the global 
      DBZD market is exacerbated by surface web social media discussions, recorded 
      across X and Reddit. Despite the appearance of newer analogues, these three DBZDs 
      remain prevalent and popularised. Reporting themes on harm/effects and new 
      developments in poly-drug use trends, demand for DBZDs continues to grow, despite 
      their potent nature and potential risk to life. It is proposed that greater 
      controls and constant live monitoring of social media user content is warranted 
      to drive active regulation strategies and targeted, effective, harm reduction 
      strategies.
FAU - Mullin, Anthony
AU  - Mullin A
AUID- ORCID: 0000-0001-6854-6171
AD  - Psychopharmacology, Drug Misuse &amp; Novel Psychoactive Substances Research Unit, 
      University of Hertfordshire, Hatfield AL10 9AB, UK.
FAU - Scott, Mark
AU  - Scott M
AD  - Psychopharmacology, Drug Misuse &amp; Novel Psychoactive Substances Research Unit, 
      University of Hertfordshire, Hatfield AL10 9AB, UK.
FAU - Vaccaro, Giorgia
AU  - Vaccaro G
AD  - Psychopharmacology, Drug Misuse &amp; Novel Psychoactive Substances Research Unit, 
      University of Hertfordshire, Hatfield AL10 9AB, UK.
FAU - Floresta, Giuseppe
AU  - Floresta G
AUID- ORCID: 0000-0002-0668-1260
AD  - Psychopharmacology, Drug Misuse &amp; Novel Psychoactive Substances Research Unit, 
      University of Hertfordshire, Hatfield AL10 9AB, UK.
AD  - Department of Drug and Health Sciences, University of Catania, 95131 Catania, 
      Italy.
FAU - Arillotta, Davide
AU  - Arillotta D
AUID- ORCID: 0000-0002-8843-0595
AD  - School of Clinical Pharmacology and Toxicology, University of Florence, 50121 
      Florence, Italy.
FAU - Catalani, Valeria
AU  - Catalani V
AUID- ORCID: 0000-0001-6338-8653
AD  - Psychopharmacology, Drug Misuse &amp; Novel Psychoactive Substances Research Unit, 
      University of Hertfordshire, Hatfield AL10 9AB, UK.
FAU - Corkery, John M
AU  - Corkery JM
AUID- ORCID: 0000-0002-3849-817X
AD  - Psychopharmacology, Drug Misuse &amp; Novel Psychoactive Substances Research Unit, 
      University of Hertfordshire, Hatfield AL10 9AB, UK.
FAU - Stair, Jacqueline L
AU  - Stair JL
AUID- ORCID: 0000-0001-8365-5894
AD  - Psychopharmacology, Drug Misuse &amp; Novel Psychoactive Substances Research Unit, 
      University of Hertfordshire, Hatfield AL10 9AB, UK.
FAU - Schifano, Fabrizio
AU  - Schifano F
AUID- ORCID: 0000-0002-4178-5401
AD  - Psychopharmacology, Drug Misuse &amp; Novel Psychoactive Substances Research Unit, 
      University of Hertfordshire, Hatfield AL10 9AB, UK.
FAU - Guirguis, Amira
AU  - Guirguis A
AUID- ORCID: 0000-0001-8255-0660
AD  - Pharmacy, Medical School, The Grove Extension, Swansea University, Swansea SA2 
      8PP, UK.
LA  - eng
GR  - JUST/2013/DPIP/AG/4823; JUST/2013/ISEC/DRUGS/AG/6429; 11.101336.3367/European 
      Commission; Interpol; University of Hertfordshire/
PT  - Journal Article
DEP - 20240112
PL  - Switzerland
TA  - Pharmacy (Basel)
JT  - Pharmacy (Basel, Switzerland)
JID - 101678532
PMC - PMC10801481
OTO - NOTNLM
OT  - analytical characterisation
OT  - designer benzodiazepines
OT  - poly-drug use
OT  - social media
COIS- F.S. was a member of the UK Advisory Council on the Misuse of Drugs (ACMD; 
      2011–2019) and is currently a member of the EMA Advisory Board (Psychiatry). 
      J.M.C. is a co-opted member of the ACMD’s Technical and Novel Psychoactive 
      Substances Committees. A.M., A.G., G.V., D.A., G.F., V.C., J.L.S. and M.S. 
      declare no conflicts of interest. None of the views or opinions expressed here 
      are necessarily those of the contributors’ employers, the ACMD or the EMA.
EDAT- 2024/01/22 06:43
MHDA- 2024/01/22 06:44
PMCR- 2024/01/12
CRDT- 2024/01/22 05:45
PHST- 2023/10/27 00:00 [received]
PHST- 2024/01/01 00:00 [revised]
PHST- 2024/01/04 00:00 [accepted]
PHST- 2024/01/22 06:44 [medline]
PHST- 2024/01/22 06:43 [pubmed]
PHST- 2024/01/22 05:45 [entrez]
PHST- 2024/01/12 00:00 [pmc-release]
AID - pharmacy12010013 [pii]
AID - pharmacy-12-00013 [pii]
AID - 10.3390/pharmacy12010013 [doi]
PST - epublish
SO  - Pharmacy (Basel). 2024 Jan 12;12(1):13. doi: 10.3390/pharmacy12010013.

PMID- 38228575
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240310
IS  - 1929-0748 (Print)
IS  - 1929-0748 (Electronic)
IS  - 1929-0748 (Linking)
VI  - 13
DP  - 2024 Feb 15
TI  - Implementation of Chatbot Technology in Health Care: Protocol for a Bibliometric 
      Analysis.
PG  - e54349
LID - 10.2196/54349 [doi]
LID - e54349
AB  - BACKGROUND: Chatbots have the potential to increase people's access to quality 
      health care. However, the implementation of chatbot technology in the health care 
      system is unclear due to the scarce analysis of publications on the adoption of 
      chatbot in health and medical settings. OBJECTIVE: This paper presents a protocol 
      of a bibliometric analysis aimed at offering the public insights into the current 
      state and emerging trends in research related to the use of chatbot technology 
      for promoting health. METHODS: In this bibliometric analysis, we will select 
      published papers from the databases of CINAHL, IEEE Xplore, PubMed, Scopus, and 
      Web of Science that pertain to chatbot technology and its applications in health 
      care. Our search strategy includes keywords such as "chatbot," "virtual agent," 
      "virtual assistant," "conversational agent," "conversational AI," "interactive 
      agent," "health," and "healthcare." Five researchers who are AI engineers and 
      clinicians will independently review the titles and abstracts of selected papers 
      to determine their eligibility for a full-text review. The corresponding author 
      (ZN) will serve as a mediator to address any discrepancies and disputes among the 
      5 reviewers. Our analysis will encompass various publication patterns of chatbot 
      research, including the number of annual publications, their geographic or 
      institutional distribution, and the number of annual grants supporting chatbot 
      research, and further summarize the methodologies used in the development of 
      health-related chatbots, along with their features and applications in health 
      care settings. Software tool VOSViewer (version 1.6.19; Leiden University) will 
      be used to construct and visualize bibliometric networks. RESULTS: The 
      preparation for the bibliometric analysis began on December 3, 2021, when the 
      research team started the process of familiarizing themselves with the software 
      tools that may be used in this analysis, VOSViewer and CiteSpace, during which 
      they consulted 3 librarians at the Yale University regarding search terms and 
      tentative results. Tentative searches on the aforementioned databases yielded a 
      total of 2340 papers. The official search phase started on July 27, 2023. Our 
      goal is to complete the screening of papers and the analysis by February 15, 
      2024. CONCLUSIONS: Artificial intelligence chatbots, such as ChatGPT (OpenAI 
      Inc), have sparked numerous discussions within the health care industry regarding 
      their impact on human health. Chatbot technology holds substantial promise for 
      advancing health care systems worldwide. However, developing a sophisticated 
      chatbot capable of precise interaction with health care consumers, delivering 
      personalized care, and providing accurate health-related information and 
      knowledge remain considerable challenges. This bibliometric analysis seeks to 
      fill the knowledge gap in the existing literature on health-related chatbots, 
      entailing their applications, the software used in their development, and their 
      preferred functionalities among users. INTERNATIONAL REGISTERED REPORT IDENTIFIER 
      (IRRID): PRR1-10.2196/54349.
CI  - ©Zhao Ni, Mary L Peng, Vimala Balakrishnan, Vincent Tee, Iskandar Azwa, Rumana 
      Saifi, LaRon E Nelson, David Vlahov, Frederick L Altice. Originally published in 
      JMIR Research Protocols (https://www.researchprotocols.org), 15.02.2024.
FAU - Ni, Zhao
AU  - Ni Z
AUID- ORCID: 0000-0002-9185-9894
AD  - School of Nursing, Yale University, Orange, CT, United States.
AD  - Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, 
      United States.
FAU - Peng, Mary L
AU  - Peng ML
AUID- ORCID: 0000-0001-9360-5487
AD  - Department of Global Health and Social Medicine, Harvard Medical School, Harvard 
      University, Boston, MA, United States.
FAU - Balakrishnan, Vimala
AU  - Balakrishnan V
AUID- ORCID: 0000-0002-6859-4488
AD  - Department of Information Systems, Faculty of Computer Science and Information 
      Technology, Unversity of Malaya, Kuala Lumpur, Malaysia.
FAU - Tee, Vincent
AU  - Tee V
AUID- ORCID: 0000-0002-6562-2666
AD  - Centre of Excellence for Research in AIDS, Faculty of Medicine, University of 
      Malaya, Kuala Lumpur, Malaysia.
FAU - Azwa, Iskandar
AU  - Azwa I
AUID- ORCID: 0000-0003-1977-6709
AD  - Centre of Excellence for Research in AIDS, Faculty of Medicine, University of 
      Malaya, Kuala Lumpur, Malaysia.
AD  - Infectious Disease Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, 
      Malaysia.
FAU - Saifi, Rumana
AU  - Saifi R
AUID- ORCID: 0000-0001-9114-4728
AD  - Centre of Excellence for Research in AIDS, Faculty of Medicine, University of 
      Malaya, Kuala Lumpur, Malaysia.
FAU - Nelson, LaRon E
AU  - Nelson LE
AUID- ORCID: 0000-0002-2630-602X
AD  - School of Nursing, Yale University, Orange, CT, United States.
AD  - Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, 
      United States.
FAU - Vlahov, David
AU  - Vlahov D
AUID- ORCID: 0000-0002-3449-8068
AD  - School of Nursing, Yale University, Orange, CT, United States.
AD  - Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, 
      United States.
FAU - Altice, Frederick L
AU  - Altice FL
AUID- ORCID: 0000-0002-7860-693X
AD  - Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, 
      United States.
AD  - Centre of Excellence for Research in AIDS, Faculty of Medicine, University of 
      Malaya, Kuala Lumpur, Malaysia.
AD  - Section of Infectious Disease, Department of Internal Medicine, Yale School of 
      Medicine, New Haven, CT, United States.
AD  - Division of Epidemiology of Microbial Diseases, Yale School of Public Health, New 
      Haven, CT, United States.
LA  - eng
GR  - D43 TW011324/TW/FIC NIH HHS/United States
GR  - R21 TW011663/TW/FIC NIH HHS/United States
GR  - R33 TW011663/TW/FIC NIH HHS/United States
GR  - UL1 TR001863/TR/NCATS NIH HHS/United States
PT  - Journal Article
DEP - 20240215
PL  - Canada
TA  - JMIR Res Protoc
JT  - JMIR research protocols
JID - 101599504
PMC - PMC10905346
OTO - NOTNLM
OT  - AI
OT  - artificial intelligence
OT  - bibliometric analysis
OT  - chatbots
OT  - health care
OT  - health promotion
COIS- Conflicts of Interest: None declared.
EDAT- 2024/01/17 00:41
MHDA- 2024/01/17 00:42
PMCR- 2024/02/15
CRDT- 2024/01/16 23:03
PHST- 2023/11/07 00:00 [received]
PHST- 2024/01/16 00:00 [accepted]
PHST- 2023/12/07 00:00 [revised]
PHST- 2024/01/17 00:42 [medline]
PHST- 2024/01/17 00:41 [pubmed]
PHST- 2024/01/16 23:03 [entrez]
PHST- 2024/02/15 00:00 [pmc-release]
AID - v13i1e54349 [pii]
AID - 10.2196/54349 [doi]
PST - epublish
SO  - JMIR Res Protoc. 2024 Feb 15;13:e54349. doi: 10.2196/54349.

PMID- 38329526
OWN - NLM
STAT- MEDLINE
DCOM- 20240318
LR  - 20240402
IS  - 1434-4726 (Electronic)
IS  - 0937-4477 (Linking)
VI  - 281
IP  - 4
DP  - 2024 Apr
TI  - Is generative pre-trained transformer artificial intelligence (Chat-GPT) a 
      reliable tool for guidelines synthesis? A preliminary evaluation for biologic 
      CRSwNP therapy.
PG  - 2167-2173
LID - 10.1007/s00405-024-08464-9 [doi]
AB  - INTRODUCTION: Biologic therapies for Chronic Rhinosinusitis with Nasal Polyps 
      (CRSwNP) have emerged as an auspicious treatment alternative. However, the ideal 
      patient population, dosage, and treatment duration are yet to be well-defined. 
      Moreover, biologic therapy has disadvantages, such as high costs and limited 
      access. The proposal of a novel Artificial Intelligence (AI) algorithm offers an 
      intriguing solution for optimizing decision-making protocols. METHODS: The AI 
      algorithm was initially programmed to conduct a systematic literature review 
      searching for the current primary guidelines on biologics' clinical efficacy and 
      safety in treating CRSwNP. The review included a total of 12 studies: 6 
      systematic reviews, 4 expert consensus guidelines, and 2 surveys. Simultaneously, 
      two independent human researchers conducted a literature search to compare the 
      results. Subsequently, the AI was tasked to critically analyze the identified 
      papers, highlighting strengths and weaknesses, thereby creating a decision-making 
      algorithm and pyramid flow chart. RESULTS: The studies evaluated various 
      biologics, including monoclonal antibodies targeting Interleukin-5 (IL-5), IL-4, 
      IL-13, and Immunoglobulin E (IgE), assessing their effectiveness in different 
      patient populations, such as those with comorbid asthma or refractory CRSwNP. 
      Dupilumab, a monoclonal antibody targeting the IL-4 receptor alpha subunit, 
      demonstrated significant improvement in nasal symptoms and quality of life in 
      patients with CRSwNP in several randomized controlled trials and systematic 
      reviews. Similarly, mepolizumab and reslizumab, which target IL-5, have also 
      shown efficacy in reducing nasal polyp burden and improving symptoms in patients 
      with CRSwNP, particularly those with comorbid asthma. However, additional studies 
      are required to confirm the long-term efficacy and safety of these biologics in 
      treating CRSwNP. CONCLUSIONS: Biologic therapies have surfaced as a promising 
      treatment option for patients with severe or refractory CRSwNP; however, the 
      optimal patient population, dosage, and treatment duration are yet to be defined. 
      The application of AI in decision-making protocols and the creation of 
      therapeutic algorithms for biologic drug selection, could offer fascinating 
      future prospects in the management of CRSwNP.
CI  - © 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, 
      part of Springer Nature.
FAU - Maniaci, Antonino
AU  - Maniaci A
AUID- ORCID: 0000-0002-1251-0185
AD  - Faculty of Medicine and Surgery, "Kore" University of Enna, Enna, Italy. 
      antonino.maniaci@phd.unict.it.
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France. 
      antonino.maniaci@phd.unict.it.
FAU - Saibene, Alberto Maria
AU  - Saibene AM
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - Otolaryngology Unit, Santi Paolo E Carlo Hospital, Department of Health Sciences, 
      Università Degli Studi Di Milano, Milan, Italy.
FAU - Calvo-Henriquez, Christian
AU  - Calvo-Henriquez C
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - Service of Otolaryngology, Hospital Complex of Santiago de Compostela, Santiago 
      de Compostela, Spain.
FAU - Vaira, Luigi
AU  - Vaira L
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - Maxillofacial Surgery Unit, University Hospital of Sassari, Sassari, Italy.
FAU - Radulesco, Thomas
AU  - Radulesco T
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - ENT Surgeon, Department of Oto-Rhino-Laryngology Head and Neck Surgery, La 
      Conception University Hospital, Aix-Marseille Univesity, 147 Bd Baille, 13005, 
      Marseille, France.
FAU - Michel, Justin
AU  - Michel J
AD  - ENT Surgeon, Department of Oto-Rhino-Laryngology Head and Neck Surgery, La 
      Conception University Hospital, Aix-Marseille Univesity, 147 Bd Baille, 13005, 
      Marseille, France.
FAU - Chiesa-Estomba, Carlos
AU  - Chiesa-Estomba C
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - ENT-Head and Neck Department, Hospital Universitario Donostia, San Sebastián, 
      Spain.
FAU - Sowerby, Leigh
AU  - Sowerby L
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - Department of Otolaryngology - Head and Neck Surgery, Schulich School of 
      Medicine, Western University, London, UK.
FAU - Lobo Duro, David
AU  - Lobo Duro D
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - Rhinology, Endoscopic Sinus and Skull Base Surgery, Hospital Universitario 
      Marqués de Valdecilla, Santander, Spain.
AD  - Valdecilla Biomedical Research Institute, IDIVAL, Santander, Spain.
FAU - Mayo-Yanez, Miguel
AU  - Mayo-Yanez M
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - Department of Otorhinolaryngology, A Coruña University Hospital Complex, 15006, A 
      Coruña, Spain.
FAU - Maza-Solano, Juan
AU  - Maza-Solano J
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - Servicio de Otorrinolaringología, Hospital Universitario Virgen Macarena, 
      Sevilla. Hospital Quirónsalud Sagrado Corazón, Seville. Departamento de Cirugía, 
      Universidad de Sevilla, Seville, Spain.
FAU - Lechien, Jerome Rene
AU  - Lechien JR
AD  - Rhynology Study Group of the Young-Otolaryngologists of the International 
      Federations of Otorhino-Laryngological Societies (YO-IFOS), Paris, France.
AD  - Department of Anatomy and Experimental Oncology, Mons School of Medicine, UMONS 
      Research Institute for Health Sciences and Technology, University of Mons 
      (UMons), Mons, Belgium.
FAU - La Mantia, Ignazio
AU  - La Mantia I
AD  - Deparment of Medical, Surgical Sciences and Advanced Technologies G.F.Ingrassia, 
      University of Catania, 95123, Catania, Italy.
FAU - Cocuzza, Salvatore
AU  - Cocuzza S
AD  - Deparment of Medical, Surgical Sciences and Advanced Technologies G.F.Ingrassia, 
      University of Catania, 95123, Catania, Italy.
LA  - eng
PT  - Journal Article
PT  - Systematic Review
DEP - 20240208
PL  - Germany
TA  - Eur Arch Otorhinolaryngol
JT  - European archives of oto-rhino-laryngology : official journal of the European 
      Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the 
      German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
JID - 9002937
RN  - 0 (Interleukin-5)
RN  - 0 (Biological Products)
SB  - IM
MH  - Humans
MH  - Interleukin-5
MH  - *Rhinitis/complications/drug therapy
MH  - Artificial Intelligence
MH  - Quality of Life
MH  - *Asthma/epidemiology
MH  - *Nasal Polyps/complications/drug therapy/epidemiology
MH  - Chronic Disease
MH  - *Sinusitis/complications/drug therapy/epidemiology
MH  - *Biological Products/therapeutic use
MH  - Biological Therapy
OTO - NOTNLM
OT  - Artificial intelligence
OT  - Biologic CRSwNP therapy
OT  - Generative pre-trained transformer (GPT)
OT  - Guidelines synthesis
OT  - Preliminary evaluation
EDAT- 2024/02/08 12:43
MHDA- 2024/03/18 06:43
CRDT- 2024/02/08 11:06
PHST- 2023/11/15 00:00 [received]
PHST- 2024/01/08 00:00 [accepted]
PHST- 2024/03/18 06:43 [medline]
PHST- 2024/02/08 12:43 [pubmed]
PHST- 2024/02/08 11:06 [entrez]
AID - 10.1007/s00405-024-08464-9 [pii]
AID - 10.1007/s00405-024-08464-9 [doi]
PST - ppublish
SO  - Eur Arch Otorhinolaryngol. 2024 Apr;281(4):2167-2173. doi: 
      10.1007/s00405-024-08464-9. Epub 2024 Feb 8.

PMID- 38397498
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240227
IS  - 2304-8158 (Print)
IS  - 2304-8158 (Electronic)
IS  - 2304-8158 (Linking)
VI  - 13
IP  - 4
DP  - 2024 Feb 8
TI  - Generational Differences in Food Choices and Consumer Behaviors in the Context of 
      Sustainable Development.
LID - 10.3390/foods13040521 [doi]
LID - 521
AB  - (1) Background: This study examines diverse food choices and sustainable 
      consumption behavior across four generations of Poles: Baby Boomers, Generation 
      X, Generation Y, and Generation Z. (2) Methods: The research employed an online 
      survey with a quota sample of 1000 individuals, representing the Polish 
      population in terms of gender, residence, and education (categorized into two 
      groups). (3) Results: For Poles, the crucial factors in food selection were 
      product quality (69.0%), price (68.6%), and information about the product's 
      composition (41.0%). Older cohorts (Baby Boomers and Generation X) prioritized 
      food quality, while younger generations (Generation Y and Generation Z) 
      emphasized price. Statistically significant differences emerged between 
      generations regarding the product's country of origin, with older generations 
      emphasizing its importance more. The oldest group (Baby Boomers) considered 
      ecological certification most important. As much as 85.9% of Poles checked 
      product expiration dates while buying products, and 82.8% bought only as much as 
      they needed. Baby Boomers most often exhibited these two behaviors and can be 
      considered the most responsible among all generations. (4) Conclusions: This 
      article highlights the importance of comprehensive sustainability efforts in the 
      context of food choices. It takes into account the socio-cultural and historical 
      circumstances of each generation that influence their consumer habits.
FAU - Makowska, Marta
AU  - Makowska M
AUID- ORCID: 0000-0002-0785-6237
AD  - Department of Economic Psychology, Kozminski University, Jagiellońska 57/59 St., 
      03-301 Warsaw, Poland.
FAU - Boguszewski, Rafał
AU  - Boguszewski R
AUID- ORCID: 0000-0002-1831-4265
AD  - Institute of Sociological Sciences and Pedagogy, Warsaw University of Life 
      Sciences, Nowoursynowska 166 St., 02-787 Warsaw, Poland.
FAU - Hrehorowicz, Arleta
AU  - Hrehorowicz A
AUID- ORCID: 0000-0003-1656-5252
AD  - Institute of Sociological Sciences and Pedagogy, Warsaw University of Life 
      Sciences, Nowoursynowska 166 St., 02-787 Warsaw, Poland.
LA  - eng
PT  - Journal Article
DEP - 20240208
PL  - Switzerland
TA  - Foods
JT  - Foods (Basel, Switzerland)
JID - 101670569
PMC - PMC10888481
OTO - NOTNLM
OT  - Poland
OT  - generations
OT  - sustainability
COIS- The authors declare no conflicts of interest. During the preparation of this 
      work, the authors used ChatGPT in order to translate and proofread the written 
      text. After using this tool, the authors reviewed and edited the content as 
      needed and take full responsibility for the content of the publication.
EDAT- 2024/02/24 11:43
MHDA- 2024/02/24 11:44
PMCR- 2024/02/08
CRDT- 2024/02/24 01:07
PHST- 2023/12/12 00:00 [received]
PHST- 2024/01/18 00:00 [revised]
PHST- 2024/02/06 00:00 [accepted]
PHST- 2024/02/24 11:44 [medline]
PHST- 2024/02/24 11:43 [pubmed]
PHST- 2024/02/24 01:07 [entrez]
PHST- 2024/02/08 00:00 [pmc-release]
AID - foods13040521 [pii]
AID - foods-13-00521 [pii]
AID - 10.3390/foods13040521 [doi]
PST - epublish
SO  - Foods. 2024 Feb 8;13(4):521. doi: 10.3390/foods13040521.

PMID- 38246117
OWN - NLM
STAT- MEDLINE
DCOM- 20240304
LR  - 20240304
IS  - 1872-8952 (Electronic)
IS  - 1388-2457 (Linking)
VI  - 159
DP  - 2024 Mar
TI  - Artificial intelligence for automatic classification of needle EMG signals: A 
      scoping review.
PG  - 41-55
LID - S1388-2457(23)00939-2 [pii]
LID - 10.1016/j.clinph.2023.12.134 [doi]
AB  - OBJECTIVE: This scoping review provides an overview of artificial intelligence 
      (AI), including machine and deep learning techniques, in the interpretation of 
      clinical needle electromyography (nEMG) signals. METHODS: A comprehensive search 
      of Medline, Embase and Web of Science was conducted to find peer-reviewed journal 
      articles. All papers published after 2010 were included. The methodological 
      quality of the included studies was assessed with CLAIM (checklist for artificial 
      intelligence in medical imaging). RESULTS: 51 studies were identified that 
      fulfilled the inclusion criteria. 61% used open-source EMGlab data set to develop 
      models to classify nEMG signal in healthy, amyotrophic lateral sclerosis (ALS) 
      and myopathy (25 subjects). Only two articles developed models to classify 
      signals recorded at rest. Most articles reported high performance accuracies, but 
      many were subject to bias and overtraining. CONCLUSIONS: Current AI-models of 
      nEMG signals are not sufficient for clinical implementation. Suggestions for 
      future research include emphasizing the need for an optimal training and 
      validation approach using large datasets of clinical nEMG data from a diverse 
      patient population. SIGNIFICANCE: The outcomes of this study and the suggestions 
      made aim to contribute to developing AI-models that can effectively handle signal 
      quality variability and are suitable for daily clinical practice in interpreting 
      nEMG signals.
CI  - Copyright © 2024 International Federation of Clinical Neurophysiology. Published 
      by Elsevier B.V. All rights reserved.
FAU - de Jonge, S
AU  - de Jonge S
AD  - Department of Neurology and Clinical Neurophysiology, Amsterdam Neuroscience, 
      Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The 
      Netherlands.
FAU - Potters, W V
AU  - Potters WV
AD  - Department of Neurology and Clinical Neurophysiology, Amsterdam Neuroscience, 
      Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The 
      Netherlands; TrianecT, Padualaan 8, Utrecht, The Netherlands.
FAU - Verhamme, C
AU  - Verhamme C
AD  - Department of Neurology and Clinical Neurophysiology, Amsterdam Neuroscience, 
      Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The 
      Netherlands. Electronic address: c.verhamme@amsterdamumc.nl.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20240103
PL  - Netherlands
TA  - Clin Neurophysiol
JT  - Clinical neurophysiology : official journal of the International Federation of 
      Clinical Neurophysiology
JID - 100883319
SB  - IM
MH  - Humans
MH  - *Artificial Intelligence
MH  - *Amyotrophic Lateral Sclerosis
MH  - Electromyography
MH  - Needles
OTO - NOTNLM
OT  - Artificial intelligence
OT  - Classification
OT  - Machine learning
OT  - Needle electromyography
OT  - Neuromuscular disorders
COIS- Declaration of generative AI and AI-assisted technologies in the writing process 
      During the preparation of this work the authors used ChatGPT from OpenAI in order 
      to improve language and readability of parts of the text. After using this tool, 
      the authors reviewed and edited the content as needed and take full 
      responsibility for the content of the publication.
EDAT- 2024/01/22 00:42
MHDA- 2024/03/04 06:45
CRDT- 2024/01/21 18:10
PHST- 2023/07/22 00:00 [received]
PHST- 2023/12/01 00:00 [revised]
PHST- 2023/12/16 00:00 [accepted]
PHST- 2024/03/04 06:45 [medline]
PHST- 2024/01/22 00:42 [pubmed]
PHST- 2024/01/21 18:10 [entrez]
AID - S1388-2457(23)00939-2 [pii]
AID - 10.1016/j.clinph.2023.12.134 [doi]
PST - ppublish
SO  - Clin Neurophysiol. 2024 Mar;159:41-55. doi: 10.1016/j.clinph.2023.12.134. Epub 
      2024 Jan 3.

PMID- 38521241
OWN - NLM
STAT- Publisher
LR  - 20240323
IS  - 2468-7855 (Electronic)
IS  - 2468-7855 (Linking)
DP  - 2024 Mar 21
TI  - Shaping the 4D frontier in maxillofacial surgery with faceMesh evolution.
PG  - 101843
LID - S2468-7855(24)00079-X [pii]
LID - 10.1016/j.jormas.2024.101843 [doi]
AB  - OBJECTIVES: This work aims to introduce a Python-based algorithm and delve into 
      the recent paradigm shift in Maxillofacial Surgery propelled by technological 
      advancement. The provided code exemplifies the utilization of the MediaPipe 
      library, created by Google in C++, with an additional Python interface available 
      as a binding. TECHNICAL NOTE: The advent of FaceMesh coupled with artificial 
      intelligence (AI), has brought about a transformative wave in contemporary 
      maxillofacial surgery. This cutting-edge deep neural network, seamlessly 
      integrated with Virtual Surgical Planning (VSP), offers surgeons precise 4D 
      facial mapping capabilities. It accurately identifies facial landmarks, tailoring 
      surgical interventions to individual patients, and streamlining the overall 
      surgical procedure. CONCLUSION: FaceMesh emerges as a revolutionary tool in 
      modern maxillofacial surgery. This deep neural network empowers surgeons with 
      detailed insights into facial morphology, aiding in personalized interventions 
      and optimizing surgical outcomes. The real-time assessment of facial dynamics 
      contributes to improved aesthetic and functional results, particularly in complex 
      cases like facial asymmetries or reconstructions. Additionally, FaceMesh has the 
      potential for early detection of medical conditions and disease prediction, 
      further enhancing patient care. Ongoing refinement and validation are essential 
      to address limitations and ensure the reliability and effectiveness of FaceMesh 
      in clinical settings.
CI  - Copyright © 2024. Published by Elsevier Masson SAS.
FAU - Grillo, Ricardo
AU  - Grillo R
AD  - Department of Oral and Maxillofacial Surgery, University of São Paulo School of 
      Dentistry, São Paulo SP, Brazil; Department of Oral and Maxillofacial Surgery, 
      Faculdade Patos de Minas, Brasília DF, Brazil. Electronic address: grillo@usp.br.
FAU - Reis, Bruno Alvarez Quinta
AU  - Reis BAQ
AD  - Private Practice in Oral and Maxillofacial Surgery, São Paulo SP, Brazil.
FAU - Lima, Bernardo Correia
AU  - Lima BC
AD  - Department of Oral and Maxillofacial Surgery, University of São Paulo School of 
      Dentistry, São Paulo SP, Brazil.
FAU - Melhem-Elias, Fernando
AU  - Melhem-Elias F
AD  - Department of Oral and Maxillofacial Surgery, University of São Paulo School of 
      Dentistry, São Paulo SP, Brazil; Private Practice in Oral and Maxillofacial 
      Surgery, São Paulo SP, Brazil.
LA  - eng
PT  - Journal Article
DEP - 20240321
PL  - France
TA  - J Stomatol Oral Maxillofac Surg
JT  - Journal of stomatology, oral and maxillofacial surgery
JID - 101701089
SB  - IM
OTO - NOTNLM
OT  - Artificial intelligence
OT  - Digital planning
OT  - Facial recognition
OT  - Orthognathic surgery
OT  - Virtual planning
COIS- Declaration of competing interest The authors declare no conflicts of interest to 
      disclose. During the preparation of this work the authors used ChatGPT in order 
      to translate parts of the manuscript. After using this tool, the authors reviewed 
      and edited the content as needed and take full responsibility for the content of 
      the publication.
EDAT- 2024/03/24 00:42
MHDA- 2024/03/24 00:42
CRDT- 2024/03/23 20:39
PHST- 2024/02/01 00:00 [received]
PHST- 2024/03/19 00:00 [revised]
PHST- 2024/03/20 00:00 [accepted]
PHST- 2024/03/24 00:42 [medline]
PHST- 2024/03/24 00:42 [pubmed]
PHST- 2024/03/23 20:39 [entrez]
AID - S2468-7855(24)00079-X [pii]
AID - 10.1016/j.jormas.2024.101843 [doi]
PST - aheadofprint
SO  - J Stomatol Oral Maxillofac Surg. 2024 Mar 21:101843. doi: 
      10.1016/j.jormas.2024.101843.

PMID- 38399078
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240227
IS  - 1996-1944 (Print)
IS  - 1996-1944 (Electronic)
IS  - 1996-1944 (Linking)
VI  - 17
IP  - 4
DP  - 2024 Feb 8
TI  - Analysis of the Rheological Properties of Natural Hydraulic Lime-Based 
      Suspensions for Sustainable Construction and Heritage Conservation.
LID - 10.3390/ma17040825 [doi]
LID - 825
AB  - Natural hydraulic lime (NHL)-based binders play a crucial role in preserving 
      cultural heritage structures, ensuring integrity and longevity. Beyond 
      traditional uses, these binders exhibit potential for integration into both 
      non-structural and structural components, being compatible with innovative 
      manufacturing processes such as digital fabrication. Meticulously designed 
      grouts, with applicability in their fresh and hardened states, are essential for 
      heritage stability. This study explores the relationships between mineral 
      additions, chemical admixtures, and lime for grout formulations, aiming to 
      advance our understanding and inform the optimization of materials for heritage 
      restoration. Key questions include the influence of natural volcanic pozzolan 
      (NVP) and metakaolin (MK) on rheology and the impact of varying ratios of 
      superplasticizer on NHL-based grout's rheological behavior. This systematic 
      evaluation of rheological parameters aims to innovate mix designs, expanding 
      NHL-based binders' applicability in construction and science. Our hypotheses 
      suggest that well-designed lime grout formulations, incorporating NVP and MK, can 
      enhance rheological properties, addressing challenges in sustainable construction 
      and heritage conservation. This research provides valuable insights for 
      optimizing lime-based materials, fostering advancements in heritage restoration, 
      and promoting wider NHL-based binder adoption in diverse construction 
      applications.
FAU - De La Rosa, Ángel
AU  - De La Rosa Á
AUID- ORCID: 0000-0002-5862-8605
AD  - ETS de Ingenieros de Caminos, C. y P., Universidad de Castilla-La Mancha, Av. 
      Camilo José Cela 2, 13071 Ciudad Real, Spain.
FAU - Ruiz, Gonzalo
AU  - Ruiz G
AUID- ORCID: 0000-0002-0352-0701
AD  - ETS de Ingenieros de Caminos, C. y P., Universidad de Castilla-La Mancha, Av. 
      Camilo José Cela 2, 13071 Ciudad Real, Spain.
FAU - Moreno, Rodrigo
AU  - Moreno R
AUID- ORCID: 0000-0002-4826-5193
AD  - Instituto de Cerámica y Vidrio (CSIC), C. Kelsen 5, Campus de Cantoblanco, 28049 
      Madrid, Spain.
LA  - eng
GR  - PID2019-110928RB-C31 and PID2021-124521OB-I00/Ministerio de Ciencia e Innovación/
GR  - 2022-GRIN-34124/University of Castilla-La Mancha/
PT  - Journal Article
DEP - 20240208
PL  - Switzerland
TA  - Materials (Basel)
JT  - Materials (Basel, Switzerland)
JID - 101555929
PMC - PMC10890018
OTO - NOTNLM
OT  - heritage conservation
OT  - natural hydraulic lime-based suspension
OT  - processing technology
OT  - rheology
OT  - sustainable construction
COIS- Declaration of generative AI and AI-assisted technologies in the writing process: 
      The authors of this work would like to declare the use of ChatGPT 3.5—a 
      generative AI and AI-assisted technology—during the writing process to enhance 
      the language and readability of the content. However, please note that the 
      authors reviewed and edited the content as necessary and take full responsibility 
      for the final publication.
EDAT- 2024/02/24 11:45
MHDA- 2024/02/24 11:46
PMCR- 2024/02/08
CRDT- 2024/02/24 01:17
PHST- 2024/01/16 00:00 [received]
PHST- 2024/02/02 00:00 [revised]
PHST- 2024/02/05 00:00 [accepted]
PHST- 2024/02/24 11:46 [medline]
PHST- 2024/02/24 11:45 [pubmed]
PHST- 2024/02/24 01:17 [entrez]
PHST- 2024/02/08 00:00 [pmc-release]
AID - ma17040825 [pii]
AID - materials-17-00825 [pii]
AID - 10.3390/ma17040825 [doi]
PST - epublish
SO  - Materials (Basel). 2024 Feb 8;17(4):825. doi: 10.3390/ma17040825.

PMID- 38473838
OWN - NLM
STAT- MEDLINE
DCOM- 20240314
LR  - 20240315
IS  - 1422-0067 (Electronic)
IS  - 1422-0067 (Linking)
VI  - 25
IP  - 5
DP  - 2024 Feb 23
TI  - Age-Dependent Changes in the Occurrence and Segregation of GABA and Acetylcholine 
      in the Rat Superior Cervical Ganglia.
LID - 10.3390/ijms25052588 [doi]
LID - 2588
AB  - The occurrence, inhibitory modulation, and trophic effects of GABA have been 
      identified in the peripheral sympathetic nervous system. We have demonstrated 
      that GABA and acetylcholine (ACh) may colocalize in the same axonal varicosities 
      or be segregated into separate ones in the rat superior cervical ganglia (SCG). 
      Neurotransmitter segregation varies with age and the presence of neurotrophic 
      factors. Here, we explored age-dependent changes in the occurrence and 
      segregation of GABA and ACh in rats ranging from 2 weeks old (wo) to 12 months 
      old or older. Using immunohistochemistry, we characterized the expression of 
      L-glutamic acid decarboxylase of 67 kDa (GAD67) and vesicular acetylcholine 
      transporter (VAChT) in the rat SCG at 2, 4, 8, 12 wo and 12 months old or older. 
      Our findings revealed that GAD67 was greater at 2 wo compared with the other 
      ages, whereas VAChT levels were greater at 4 wo than at 12 wo and 12 months old 
      or older. The segregation of these neurotransmitters was more pronounced at 2 and 
      4 wo. We observed a caudo-rostral gradient of segregation degree at 8 and 12 wo. 
      Data point out that the occurrence and segregation of GABA and ACh exhibit 
      developmental adaptative changes throughout the lifetime of rats. We hypothesize 
      that during the early postnatal period, the increase in GABA and GABA-ACh 
      segregation promotes the release of GABA alone which might play a role in trophic 
      actions.
FAU - Hernández, Alfredo
AU  - Hernández A
AD  - Departamento de Biología Celular and Fisiología, Instituto de Investigaciones 
      Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, 
      Mexico.
FAU - González-Sierra, Constanza
AU  - González-Sierra C
AD  - Departamento de Biología Celular and Fisiología, Instituto de Investigaciones 
      Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, 
      Mexico.
FAU - Zetina, María Elena
AU  - Zetina ME
AD  - Departamento de Biología Celular and Fisiología, Instituto de Investigaciones 
      Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, 
      Mexico.
FAU - Cifuentes, Fredy
AU  - Cifuentes F
AD  - Departamento de Biología Celular and Fisiología, Instituto de Investigaciones 
      Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, 
      Mexico.
FAU - Morales, Miguel Angel
AU  - Morales MA
AD  - Departamento de Biología Celular and Fisiología, Instituto de Investigaciones 
      Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, 
      Mexico.
LA  - eng
GR  - IN213622/Universidad Nacional Autónoma de México/
GR  - CF-2023-1-2195/Consejo Nacional de Humanidades, Ciencias y Tecnologías/
PT  - Journal Article
DEP - 20240223
PL  - Switzerland
TA  - Int J Mol Sci
JT  - International journal of molecular sciences
JID - 101092791
RN  - N9YNS0M02X (Acetylcholine)
RN  - 56-12-2 (gamma-Aminobutyric Acid)
SB  - IM
MH  - Rats
MH  - Animals
MH  - *Superior Cervical Ganglion
MH  - *Acetylcholine/metabolism
MH  - Axons/metabolism
MH  - gamma-Aminobutyric Acid/metabolism
PMC - PMC10931708
OTO - NOTNLM
OT  - aging
OT  - cotransmission
OT  - development
OT  - neurotransmitters
OT  - sympathetic
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest. During the preparation of this work, the authors used 
      ChatGPT tool (https://chat.openai.com/auth/login, accessed on 9 October 2023) to 
      review the English edition. After using this tool, the authors reviewed and 
      edited the content as needed and take full responsibility for the content of the 
      publication.
EDAT- 2024/03/13 06:47
MHDA- 2024/03/14 06:47
PMCR- 2024/02/23
CRDT- 2024/03/13 01:22
PHST- 2023/10/11 00:00 [received]
PHST- 2023/11/22 00:00 [revised]
PHST- 2023/11/28 00:00 [accepted]
PHST- 2024/03/14 06:47 [medline]
PHST- 2024/03/13 06:47 [pubmed]
PHST- 2024/03/13 01:22 [entrez]
PHST- 2024/02/23 00:00 [pmc-release]
AID - ijms25052588 [pii]
AID - ijms-25-02588 [pii]
AID - 10.3390/ijms25052588 [doi]
PST - epublish
SO  - Int J Mol Sci. 2024 Feb 23;25(5):2588. doi: 10.3390/ijms25052588.

PMID- 38408584
OWN - NLM
STAT- MEDLINE
DCOM- 20240327
LR  - 20240327
IS  - 1879-0003 (Electronic)
IS  - 0141-8130 (Linking)
VI  - 263
IP  - Pt 2
DP  - 2024 Apr
TI  - Localized trans-browning and pro-angiogenesis inductive self-assembled collagen 
      resveratrol bio-matrix for tissue repair and regeneration in obese conditions.
PG  - 130322
LID - S0141-8130(24)01125-5 [pii]
LID - 10.1016/j.ijbiomac.2024.130322 [doi]
AB  - The present study probes into the complexities of wound management in obesity by 
      proposing a novel biomaterial designed to reprogram the altered skin physiology 
      prevalent in obese conditions. The strategy involves the development of a 
      multifunctional biomaterial addressing issues such as excessive exudate, pressure 
      ulcers, and reduced vascularity. The bio-matrix demonstrates the localized 
      transformation of white adipocytes through trans-browning, coupled with the 
      simultaneous induction of angiogenesis at obese wound sites, resulting in 
      expedited wound closure. The collagen bio-matrices, stabilized with Resveratrol 
      (Rsv), exhibit remarkable thermal, mechanical, and biological stability. The 
      porous 3D microstructure of the Rsv-stabilized collagen bio-matrix closely 
      resembled the natural extracellular matrix, facilitating effective cell adhesion. 
      The bio-matrix exhibited the unique capability to induce localized thermogenesis 
      in the subcutaneous fat layer while concurrently activating angiogenesis. In vivo 
      wound healing studies conducted on DIO-C57BL6 mice demonstrated complete healing 
      within 10&nbsp;days, showcasing accelerated tissue regeneration, blood vessel 
      formation, robust collagen deposition, and significant activation of browning in 
      the subcutaneous adipose layer. This study introduces the concept of tailored 
      regenerative biomaterials with the ability to reprogram the challenging wound 
      environment associated with obesity. This innovative approach opens up new 
      avenues for enhanced wound care strategies, particularly for bariatric patients.
CI  - Copyright © 2024 Elsevier B.V. All rights reserved.
FAU - Sreekumar, Sreelekshmi
AU  - Sreekumar S
AD  - Biological Materials Laboratory, Council of Scientific and Industrial 
      Research-Central Leather Research Institute, Chennai, Tamil Nadu 600020, India; 
      Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
FAU - Kiran, Manikantan Syamala
AU  - Kiran MS
AD  - Biological Materials Laboratory, Council of Scientific and Industrial 
      Research-Central Leather Research Institute, Chennai, Tamil Nadu 600020, India; 
      Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. 
      Electronic address: kiran@clri.res.in.
LA  - eng
PT  - Journal Article
DEP - 20240224
PL  - Netherlands
TA  - Int J Biol Macromol
JT  - International journal of biological macromolecules
JID - 7909578
RN  - Q369O8926L (Resveratrol)
RN  - 9007-34-5 (Collagen)
RN  - 0 (Biocompatible Materials)
SB  - IM
MH  - Humans
MH  - Animals
MH  - Mice
MH  - Resveratrol/pharmacology
MH  - *Angiogenesis
MH  - Mice, Inbred C57BL
MH  - *Wound Healing
MH  - Collagen/metabolism
MH  - Biocompatible Materials/pharmacology
MH  - Obesity/drug therapy
OTO - NOTNLM
OT  - Biomaterial
OT  - Browning
OT  - Collagen
OT  - Obesity
OT  - Resveratrol
COIS- Declaration of competing interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper. During the preparation of the 
      manuscript, the authors used ChatGPT and Paperpal to correct typographical and 
      grammatical errors. After using this tool, the authors reviewed and edited the 
      content as needed and takes full responsibility for the content of the 
      publication.
EDAT- 2024/02/27 00:42
MHDA- 2024/03/27 06:44
CRDT- 2024/02/26 19:14
PHST- 2023/12/18 00:00 [received]
PHST- 2024/02/18 00:00 [accepted]
PHST- 2024/03/27 06:44 [medline]
PHST- 2024/02/27 00:42 [pubmed]
PHST- 2024/02/26 19:14 [entrez]
AID - S0141-8130(24)01125-5 [pii]
AID - 10.1016/j.ijbiomac.2024.130322 [doi]
PST - ppublish
SO  - Int J Biol Macromol. 2024 Apr;263(Pt 2):130322. doi: 
      10.1016/j.ijbiomac.2024.130322. Epub 2024 Feb 24.

PMID- 37103054
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230501
IS  - 2308-3425 (Electronic)
IS  - 2308-3425 (Linking)
VI  - 10
IP  - 4
DP  - 2023 Apr 17
TI  - Current and Future Use of Artificial Intelligence in Electrocardiography.
LID - 10.3390/jcdd10040175 [doi]
LID - 175
AB  - Artificial intelligence (AI) is increasingly used in electrocardiography (ECG) to 
      assist in diagnosis, stratification, and management. AI algorithms can help 
      clinicians in the following areas: (1) interpretation and detection of 
      arrhythmias, ST-segment changes, QT prolongation, and other ECG abnormalities; 
      (2) risk prediction integrated with or without clinical variables (to predict 
      arrhythmias, sudden cardiac death, stroke, and other cardiovascular events); (3) 
      monitoring ECG signals from cardiac implantable electronic devices and wearable 
      devices in real time and alerting clinicians or patients when significant changes 
      occur according to timing, duration, and situation; (4) signal processing, 
      improving ECG quality and accuracy by removing noise/artifacts/interference, and 
      extracting features not visible to the human eye (heart rate variability, 
      beat-to-beat intervals, wavelet transforms, sample-level resolution, etc.); (5) 
      therapy guidance, assisting in patient selection, optimizing treatments, 
      improving symptom-to-treatment times, and cost effectiveness (earlier activation 
      of code infarction in patients with ST-segment elevation, predicting the response 
      to antiarrhythmic drugs or cardiac implantable devices therapies, reducing the 
      risk of cardiac toxicity, etc.); (6) facilitating the integration of ECG data 
      with other modalities (imaging, genomics, proteomics, biomarkers, etc.). In the 
      future, AI is expected to play an increasingly important role in ECG diagnosis 
      and management, as more data become available and more sophisticated algorithms 
      are developed.
FAU - Martínez-Sellés, Manuel
AU  - Martínez-Sellés M
AUID- ORCID: 0000-0003-0289-6229
AD  - Cardiology Department, Hospital General Universitario Gregorio Marañón, Calle 
      Doctor Esquerdo, 46, 28007 Madrid, Spain.
AD  - Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares (CIBERCV), 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
AD  - Facultad de Ciencias de la Salud, Universidad Europea, Villaviciosa de Odón, 
      28670 Madrid, Spain.
AD  - Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain.
FAU - Marina-Breysse, Manuel
AU  - Marina-Breysse M
AD  - Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares (CIBERCV), 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
AD  - IDOVEN Research, 28013 Madrid, Spain.
AD  - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Myocardial 
      Pathophysiology Area, 28029 Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230417
PL  - Switzerland
TA  - J Cardiovasc Dev Dis
JT  - Journal of cardiovascular development and disease
JID - 101651414
PMC - PMC10145690
OTO - NOTNLM
OT  - artificial intelligence
OT  - cost effectiveness
OT  - deep learning
OT  - diagnosis
OT  - electrocardiography
OT  - machine learning
OT  - prognosis
COIS- Manuel Marina-Breysse is a founding member of IDOVEN. ChatGPT was used but only 
      in the last sentence of the conclusion “In the future, artificial intelligence is 
      expected to play an increasingly important role in ECG diagnosis and management, 
      as more data become available and more sophisticated algorithms are developed”. 
      This sentence has been copied verbatim. As our focus is artificial intelligence 
      in electrocardiography, we thought it appropriate to keep the exact words 
      obtained by this open artificial intelligence chat. The authors declare no other 
      conflict of interest.
EDAT- 2023/04/27 12:41
MHDA- 2023/04/27 12:42
PMCR- 2023/04/17
CRDT- 2023/04/27 10:33
PHST- 2023/03/26 00:00 [received]
PHST- 2023/04/14 00:00 [revised]
PHST- 2023/04/16 00:00 [accepted]
PHST- 2023/04/27 12:42 [medline]
PHST- 2023/04/27 12:41 [pubmed]
PHST- 2023/04/27 10:33 [entrez]
PHST- 2023/04/17 00:00 [pmc-release]
AID - jcdd10040175 [pii]
AID - jcdd-10-00175 [pii]
AID - 10.3390/jcdd10040175 [doi]
PST - epublish
SO  - J Cardiovasc Dev Dis. 2023 Apr 17;10(4):175. doi: 10.3390/jcdd10040175.

PMID- 37956558
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231122
IS  - 1873-3573 (Electronic)
IS  - 0039-9140 (Linking)
VI  - 268
IP  - Pt 2
DP  - 2024 Feb 1
TI  - Boron quantification using ion chromatography tandem triple quadrupole mass 
      spectrometry. Application to retention analysis in boron-treated wood.
PG  - 125377
LID - S0039-9140(23)01128-1 [pii]
LID - 10.1016/j.talanta.2023.125377 [doi]
AB  - Boron compounds play a crucial role in various industries, and accurate 
      quantification of boron is essential for quality control and environmental 
      monitoring. This study presents a simple, rapid, and reliable method for 
      determining boron in aqueous solutions using suppressed ion chromatography 
      coupled to electrospray ionisation-triple quadrupole mass spectrometry 
      (IC-ESI-QqQ-MS). Boric acid (B(OH)(3)) was retained as the tetrahydroxyborate ion 
      (B(OH)(4)(-)) on a CarboPac PA300-4&nbsp;μm anion-exchange column using isocratic 
      elution with 40&nbsp;mM KOH. During the neutralization process at the suppressor, 
      B(OH)(4)(-) was converted to B(OH)(3), which subsequently generated the 
      metaborate ion [BO(2)](-) (m/z 43) within the electrospray ionisation source. By 
      employing a pseudo-selected reaction monitoring (SRM) transition from m/z 43 to 
      m/z 43, the method achieved a limit of detection (LOD) of 2.45&nbsp;μg/L of boron, the 
      lowest reported in the literature to-date for an IC-based method. The analytical 
      performance of the method demonstrated no carry-over issues, no matrix 
      interferences, and excellent intra- and inter-run repeatability of 2.03% and 
      3.41%, respectively. The method was applied to the evaluation of boron uptake and 
      retention by Tasmanian Oak timber blocks, treated by dip-diffusion in a boric 
      acid solution of 2.5% Boric Acid Equivalent (BAE, m/m) under controlled 
      laboratory conditions. Quantitative determination of the retained and unretained 
      boron allowed a mass balance evaluation and confirmed the accuracy and 
      reliability of the method, with recoveries ranging from 99.3% to 100.2%.
CI  - Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
FAU - Sanz Rodriguez, Estrella
AU  - Sanz Rodriguez E
AD  - Australian Centre for Research on Separation Science (ACROSS), Chemistry, School 
      of Natural Sciences, College of Sciences and Engineering, University of Tasmania, 
      Hobart, Tasmania, 7001, Australia. Electronic address: 
      Estrella.SanzRodriguez@utas.edu.au.
FAU - Wood, Kyra
AU  - Wood K
AD  - Centre for Sustainable Architecture with Wood, School of Architecture and Design, 
      College of Sciences and Engineering, University of Tasmania, Newnham, Tasmania, 
      7248, Australia.
FAU - Haddad, Paul R
AU  - Haddad PR
AD  - Australian Centre for Research on Separation Science (ACROSS), Chemistry, School 
      of Natural Sciences, College of Sciences and Engineering, University of Tasmania, 
      Hobart, Tasmania, 7001, Australia.
FAU - Paull, Brett
AU  - Paull B
AD  - Australian Centre for Research on Separation Science (ACROSS), Chemistry, School 
      of Natural Sciences, College of Sciences and Engineering, University of Tasmania, 
      Hobart, Tasmania, 7001, Australia.
LA  - eng
PT  - Journal Article
DEP - 20231107
PL  - Netherlands
TA  - Talanta
JT  - Talanta
JID - 2984816R
SB  - IM
OTO - NOTNLM
OT  - Boron quantification
OT  - Boron retention
OT  - Ion chromatography
OT  - Mass spectrometry
OT  - Preservative-treated wood
COIS- Declaration of competing interest There are no conflicts to declare. During the 
      preparation of this work the author(s) used ChatGPT in order to improve language 
      and readability of a few sentences. After using this tool/service, the author(s) 
      reviewed and edited the content as needed and take(s) full responsibility for the 
      content of the publication.
EDAT- 2023/11/14 00:42
MHDA- 2023/11/14 00:43
CRDT- 2023/11/13 18:06
PHST- 2023/07/12 00:00 [received]
PHST- 2023/10/16 00:00 [revised]
PHST- 2023/10/31 00:00 [accepted]
PHST- 2023/11/14 00:43 [medline]
PHST- 2023/11/14 00:42 [pubmed]
PHST- 2023/11/13 18:06 [entrez]
AID - S0039-9140(23)01128-1 [pii]
AID - 10.1016/j.talanta.2023.125377 [doi]
PST - ppublish
SO  - Talanta. 2024 Feb 1;268(Pt 2):125377. doi: 10.1016/j.talanta.2023.125377. Epub 
      2023 Nov 7.

PMID- 37558532
OWN - NLM
STAT- MEDLINE
DCOM- 20231106
LR  - 20231107
IS  - 2152-2669 (Electronic)
IS  - 2152-2669 (Linking)
VI  - 23
IP  - 11
DP  - 2023 Nov
TI  - Clinical Application of (18)F-FDG-PET Quantification in Hematological 
      Malignancies: Emphasizing Multiple Myeloma, Lymphoma and Chronic Lymphocytic 
      Leukemia.
PG  - 800-814
LID - S2152-2650(23)00227-6 [pii]
LID - 10.1016/j.clml.2023.07.008 [doi]
AB  - Most hematological malignancies display heightened glycolytic activity, leading 
      to their detectability through (18)F-FDG-PET imaging. PET quantification enables 
      the extraction of metabolic information from tumors. Among various PET 
      measurements, maximum standardized uptake value (SUVmax), which indicates the 
      highest value of (18)F-FDG uptake within the tumor, has emerged as the commonly 
      used parameter in clinical oncology. This is because of SUVmax ease of 
      calculation using most available commercial workstations, as well as its 
      simplicity and independence from observer interpretation. Nonetheless, SUVmax 
      represents the increase in activity within a specific small area, which may not 
      fully capture the overall tumor uptake. Volumetric PET parameters have been 
      identified as a potential solution to overcome certain limitations associated 
      with SUVmax. However, these parameters are influenced by the low spatial 
      resolution of PET when assessing small lesions. Another challenge is the high 
      number of lesions observed in some patients, leading to a time-consuming process 
      for evaluating all focal lesions. Some institutions recently have started 
      advocating for CT-based segmentation as a method for measuring radiotracer uptake 
      in the bone marrow and overall bone of the patients. This review article aims to 
      provide insights into clinical application of PET quantification specifically 
      focusing on 3 major hematologic malignancies: multiple myeloma, lymphoma, and 
      chronic lymphocytic leukemia.
CI  - Copyright © 2023 Elsevier Inc. All rights reserved.
FAU - Zirakchian Zadeh, Mahdi
AU  - Zirakchian Zadeh M
AD  - Molecular Imaging and Therapy and Interventional Radiology Services, Department 
      of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic 
      address: mehdi.zirak@gmail.com.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230728
PL  - United States
TA  - Clin Lymphoma Myeloma Leuk
JT  - Clinical lymphoma, myeloma &amp; leukemia
JID - 101525386
RN  - 0Z5B2CJX4D (Fluorodeoxyglucose F18)
RN  - 0 (Radiopharmaceuticals)
SB  - IM
MH  - Humans
MH  - Fluorodeoxyglucose F18
MH  - *Multiple Myeloma/diagnostic imaging/pathology
MH  - *Leukemia, Lymphocytic, Chronic, B-Cell/diagnostic imaging
MH  - Positron-Emission Tomography
MH  - Radiopharmaceuticals
MH  - Tomography, X-Ray Computed
MH  - *Lymphoma
MH  - *Hematologic Neoplasms
MH  - Positron Emission Tomography Computed Tomography
OTO - NOTNLM
OT  - Blood cancers
OT  - Positron emission tomography
OT  - Quantitative analysis
OT  - SUVmax
OT  - Volumetric and CT-based PET metrics
COIS- Disclosure MZZ declares that he has no conflict of interest for this publication. 
      Declaration of Generative AI and AI-assisted technologies: During the preparation 
      of this work, the author used AI language/ChatGPT soley to enhance language 
      precision. After using this tool/service, the author reviewed and edited the 
      content as needed and takes full responsibility for the content of 
      the publication. None of the scientific evidence in this article generated using 
      AI technology.
EDAT- 2023/08/10 00:42
MHDA- 2023/11/06 06:42
CRDT- 2023/08/09 21:57
PHST- 2023/05/31 00:00 [received]
PHST- 2023/07/15 00:00 [revised]
PHST- 2023/07/20 00:00 [accepted]
PHST- 2023/11/06 06:42 [medline]
PHST- 2023/08/10 00:42 [pubmed]
PHST- 2023/08/09 21:57 [entrez]
AID - S2152-2650(23)00227-6 [pii]
AID - 10.1016/j.clml.2023.07.008 [doi]
PST - ppublish
SO  - Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):800-814. doi: 
      10.1016/j.clml.2023.07.008. Epub 2023 Jul 28.

PMID- 38560589
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240403
IS  - 0972-978X (Print)
IS  - 0972-978X (Electronic)
IS  - 0972-978X (Linking)
VI  - 54
DP  - 2024 Aug
TI  - Amputation surgery associated with shortened survival in patients with localized 
      extremity bone sarcoma.
PG  - 124-130
LID - 10.1016/j.jor.2024.03.017 [doi]
AB  - BACKGROUND: This study assesses survival rates among patients with localized 
      extremity bone sarcoma who have undergone amputation, pinpointing subpopulations 
      that are disproportionately affected by amputation-related survival disparities. 
      METHODS: Examination of data was conducted using the Surveillance, Epidemiology, 
      and End Results (SEER) program, analyzing records of 3765 patients diagnosed with 
      localized extremity bone sarcoma between 2000 and 2019. Of these, 857 received 
      amputations (Amputation cohort), and 2908 underwent limb-sparing surgeries. 
      Propensity score matching, considering demographic and clinical features, was 
      utilized to ensure a fair comparison. RESULTS: Following propensity score 
      matching, the study focused on 1714 cases. The Amputation cohort was observed to 
      have significantly poorer survival rates (Cancer-Specific Survival [CSS]: Hazard 
      Ratio [HR]&nbsp;=&nbsp;1.28, 95% Confidence Interval [CI]: 1.05-1.55; Overall Survival 
      [OS]: HR&nbsp;=&nbsp;1.37, 95% CI: 1.15-1.63). Subsequent subgroup analysis indicated that 
      individuals with tumors exceeding 8&nbsp;cm in size or those located in the lower 
      limbs were notably at a higher risk of shortened survival (for tumors &gt;8&nbsp;cm - 
      CSS: HR&nbsp;=&nbsp;1.32, 95% CI: 1.02-1.71; OS: HR&nbsp;=&nbsp;1.39, 95% CI: 1.09-1.76; for lower 
      limb tumors - CSS: HR&nbsp;=&nbsp;1.25, 95% CI: 1.01-1.54; OS: HR&nbsp;=&nbsp;1.33, 95% CI: 
      1.11-1.61). CONCLUSIONS: Our findings demonstrate that patients diagnosed with 
      localized extremity bone sarcoma undergoing amputation exhibit lower survival 
      rates, especially in cases involving tumors of greater size or those situated in 
      the lower limbs. In patient groups where amputation is inevitable, careful 
      follow-up is required after surgical intervention.
CI  - © 2024 Professor P K Surendran Memorial Education Foundation. Published by 
      Elsevier B.V. All rights reserved.
FAU - Yanagisawa, Nayuhito
AU  - Yanagisawa N
AD  - Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of 
      Medicine, Hokkaido University, North 15 West 7, Kita-Ku, Sapporo, Hokkaido 
      060-8638, Japan.
FAU - Matsuoka, Masatake
AU  - Matsuoka M
AD  - Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of 
      Medicine, Hokkaido University, North 15 West 7, Kita-Ku, Sapporo, Hokkaido 
      060-8638, Japan.
FAU - Onodera, Tomohiro
AU  - Onodera T
AD  - Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of 
      Medicine, Hokkaido University, North 15 West 7, Kita-Ku, Sapporo, Hokkaido 
      060-8638, Japan.
FAU - Iwasaki, Koji
AU  - Iwasaki K
AD  - Department of Functional Reconstruction for the Knee Joint, Hokkaido University, 
      Kita-15, Nish-7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan.
FAU - Hamasaki, Masanari
AU  - Hamasaki M
AD  - Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of 
      Medicine, Hokkaido University, North 15 West 7, Kita-Ku, Sapporo, Hokkaido 
      060-8638, Japan.
FAU - Ebata, Taku
AU  - Ebata T
AD  - Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of 
      Medicine, Hokkaido University, North 15 West 7, Kita-Ku, Sapporo, Hokkaido 
      060-8638, Japan.
FAU - Hosokawa, Yoshiaki
AU  - Hosokawa Y
AD  - Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of 
      Medicine, Hokkaido University, North 15 West 7, Kita-Ku, Sapporo, Hokkaido 
      060-8638, Japan.
FAU - Kondo, Eiji
AU  - Kondo E
AD  - Centre for Sports Medicine, Hokkaido University Hospital, North 15 West 7, 
      Kita-Ku, Sapporo, Hokkaido 060-8638, Japan.
FAU - Iwasaki, Norimasa
AU  - Iwasaki N
AD  - Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of 
      Medicine, Hokkaido University, North 15 West 7, Kita-Ku, Sapporo, Hokkaido 
      060-8638, Japan.
LA  - eng
PT  - Journal Article
DEP - 20240318
PL  - India
TA  - J Orthop
JT  - Journal of orthopaedics
JID - 101233220
PMC - PMC10979017
OTO - NOTNLM
OT  - Bone sarcoma
OT  - Neoplasm grading
OT  - Retrospective study
OT  - SEER program
OT  - Treatment outcome
COIS- In the course of crafting this document, the authors engaged the ChatGPT utility 
      for preliminary editorial assistance. Subsequent to this step, an exhaustive 
      examination and enhancement effort was conducted by the authors themselves to 
      ensure the document's precision and thoroughness. Responsibility for the 
      integrity of the published work rests entirely with the authors.
EDAT- 2024/04/01 18:42
MHDA- 2024/04/01 18:43
PMCR- 2025/08/01
CRDT- 2024/04/01 17:30
PHST- 2024/03/08 00:00 [received]
PHST- 2024/03/12 00:00 [accepted]
PHST- 2025/08/01 00:00 [pmc-release]
PHST- 2024/04/01 18:43 [medline]
PHST- 2024/04/01 18:42 [pubmed]
PHST- 2024/04/01 17:30 [entrez]
AID - S0972-978X(24)00097-7 [pii]
AID - 10.1016/j.jor.2024.03.017 [doi]
PST - epublish
SO  - J Orthop. 2024 Mar 18;54:124-130. doi: 10.1016/j.jor.2024.03.017. eCollection 
      2024 Aug.

PMID- 38282327
OWN - NLM
STAT- Publisher
LR  - 20240129
IS  - 1938-7636 (Electronic)
IS  - 1938-6400 (Linking)
DP  - 2024 Jan 28
TI  - Advancements in Managing Wound Biofilm: A Systematic Review and Meta-analysis of 
      Randomized Controlled Trials on Topical Modalities.
PG  - 19386400231225708
LID - 10.1177/19386400231225708 [doi]
AB  - Despite numerous available agents claiming anti-biofilm properties on wounds, the 
      substantiating evidence remains inconclusive. This study aimed to assess the 
      immediate impact of topical wound treatments on wound biofilm and healing 
      outcomes in acute and chronic ulcers. We comprehensively searched PubMed, 
      ClinicalTrials.gov, and Google Scholar. In addition, eligible gray literature was 
      incorporated. English-language randomized controlled trials (RCTs), 
      observational, cohort, and case-control studies targeting biofilm prevention, 
      inhibition, or elimination across diverse wound types were included. Primary 
      outcomes included biofilm presence and elimination, supplemented by secondary 
      outcomes encompassing reduced wound size, complete closure, and diminished 
      infection indicators. Bacterial load reduction and biofilm presence were also 
      assessed. Twenty-eight articles met the inclusion criteria. Various modalities 
      were identified, including biofilm-visualization techniques, such as wound 
      blotting and handheld autofluorescence imaging. Pooled analysis for the primary 
      outcomes was infeasible due to limited eligible studies and data-reporting 
      challenges. As for the secondary outcomes, the pooled analysis for complete 
      surgical wound closure (2 RCTs, yielding n=284) and presence of surgical site 
      infections/inflammation (2 RCTs, yielding n=284) showed no significant 
      difference, with a log odds ratio (LOD) of 0.58 (95% confidence interval [CI]: 
      -.33, 1.50) and LOD -0.95 (95% CI: -3.54, 1.64; τ(2) = 2.32, Q = 2.71, P = .10), 
      respectively. Our findings suggest insufficient evidence to support anti-biofilm 
      claims of topical modalities. Clinicians' skill appears to play a pivotal role in 
      biofilm elimination and wound healing enhancement, with potential optimization 
      through visual-guided techniques, such as wound blotting and autofluorescence 
      imaging. More rigorous clinical trials are warranted to ascertain the efficacy of 
      these techniques.Level of Evidence: Therapeutic, 1A.
FAU - Astrada, Adam
AU  - Astrada A
AUID- ORCID: 0000-0002-3582-7556
AD  - School of Nursing, Faculty of Health Sciences, Esa Unggul University, Jakarta 
      Barat, Indonesia.
FAU - Pamungkas, Rian Adi
AU  - Pamungkas RA
AD  - School of Nursing, Faculty of Health Sciences, Esa Unggul University, Jakarta 
      Barat, Indonesia.
AD  - School of Nursing, University of Michigan, Ann Arbor, Michigan.
FAU - Abidin, Khoirul Rista
AU  - Abidin KR
AD  - Department of Medical Laboratory Technology, Politeknik 'Aisyiyah Pontianak, 
      Pontianak City, Indonesia.
AD  - Department of Biotechnology, Postgraduate School, Padjadjaran University, 
      Indonesia.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20240128
PL  - United States
TA  - Foot Ankle Spec
JT  - Foot &amp; ankle specialist
JID - 101473598
SB  - IM
OTO - NOTNLM
OT  - acute wound
OT  - anti-biofilm
OT  - chronic wound
OT  - dressing
OT  - topical therapy
OT  - wound biofilm
COIS- Declaration of Conflicting InterestsThe author(s) declared the following 
      potential conflicts of interest with respect to the research, authorship, and/or 
      publication of this article: The authors declare that no conflict of interest 
      might affect the integrity of this work. While preparing this work, the authors 
      used ChatGPT August 3 version to improve the readability of the text. After using 
      this tool/service, the authors reviewed and edited the content as needed and take 
      full responsibility for the publication’s content.
EDAT- 2024/01/29 06:44
MHDA- 2024/01/29 06:44
CRDT- 2024/01/29 01:03
PHST- 2024/01/29 06:44 [medline]
PHST- 2024/01/29 06:44 [pubmed]
PHST- 2024/01/29 01:03 [entrez]
AID - 10.1177/19386400231225708 [doi]
PST - aheadofprint
SO  - Foot Ankle Spec. 2024 Jan 28:19386400231225708. doi: 10.1177/19386400231225708.

PMID- 38076325
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231211
IS  - 2666-6065 (Electronic)
IS  - 2666-6065 (Linking)
VI  - 43
DP  - 2024 Feb
TI  - Effectiveness of health checkup with depression screening on depression treatment 
      and outcomes in middle-aged and older adults: a target trial emulation study.
PG  - 100978
LID - 10.1016/j.lanwpc.2023.100978 [doi]
LID - 100978
AB  - BACKGROUND: Adult preventive health checkups with depression screening were 
      launched in August 2011 in Taiwan; however, its impact has not yet been 
      evaluated. This study aimed to use real-world data to assess the effectiveness of 
      depression screening among middle-aged and older adults. METHODS: A total of 
      4,972,228 adults aged 40 years and above who participated in a health checkup 
      with depression screening between 2013 and 2019 and the same number of unscreened 
      counterparts were included. The target trial emulation study was conducted to 
      estimate the hazard ratios (HRs) for newly treated depression, psychiatric 
      hospitalisation, and suicide. The changes in HRs during the study period were 
      assessed using interval Cox models. FINDINGS: The screening group had a higher 
      rate of newly treated depression (HR 1.63 [95% CI 1.62, 1.64]) and a lower risk 
      of psychiatric hospitalisation (HR 0.93 [95% CI 0.91, 0.95]). There was a null 
      association between depression screening and suicide; however, a higher suicide 
      risk was found in screened older adults aged 65 years and above. Only 10.8% 
      received depression treatment during the study period among the screen-positive 
      individuals. INTERPRETATION: Health checkups with depression screening could 
      potentially promote depression treatment and reduce the risk of psychiatric 
      hospitalisation; however, there was no effect on suicide. The treatment rate for 
      depression remained low after screening for depression. Further attention to 
      enhance referral and treatment is required. FUNDING: The study was funded by the 
      National Health Research Institutes, Taiwan.
CI  - © 2023 The Author(s).
FAU - Chen, Yu-Ling
AU  - Chen YL
AD  - National Center for Geriatrics and Welfare Research, National Health Research 
      Institutes, Zhunan, Taiwan.
AD  - Department of Physical Education, National Taiwan University of Sport, Taichung, 
      Taiwan.
FAU - Wu, Ming-Shiang
AU  - Wu MS
AD  - National Center for Geriatrics and Welfare Research, National Health Research 
      Institutes, Zhunan, Taiwan.
FAU - Wang, Shih-Heng
AU  - Wang SH
AD  - National Center for Geriatrics and Welfare Research, National Health Research 
      Institutes, Zhunan, Taiwan.
AD  - Department of Occupational Safety and Health, College of Public Health, China 
      Medical University, Taichung, Taiwan.
FAU - Lien, Yin-Ju
AU  - Lien YJ
AD  - Department of Health Promotion and Health Education, National Taiwan Normal 
      University, Taipei, Taiwan.
FAU - Liao, Shih-Cheng
AU  - Liao SC
AD  - Department of Psychiatry, National Taiwan University Hospital, Hisn-Chu Branch, 
      Hsinchu, Taiwan.
AD  - Department of Psychiatry, College of Medicine, National Taiwan University, 
      Taipei, Taiwan.
FAU - Chang, Chia-Ming
AU  - Chang CM
AD  - Department of Psychiatry, Chang Gung Memorial Hospital at Linkou, Taoyuan, 
      Taiwan.
FAU - Huang, Wei-Lieh
AU  - Huang WL
AD  - Department of Psychiatry, College of Medicine, National Taiwan University, 
      Taipei, Taiwan.
AD  - Department of Psychiatry, National Taiwan University Hospital, Yunlin Branch, 
      Yunlin, Taiwan.
FAU - Wu, Chi-Shin
AU  - Wu CS
AD  - National Center for Geriatrics and Welfare Research, National Health Research 
      Institutes, Zhunan, Taiwan.
AD  - Department of Psychiatry, College of Medicine, National Taiwan University, 
      Taipei, Taiwan.
AD  - Department of Psychiatry, National Taiwan University Hospital, Yunlin Branch, 
      Yunlin, Taiwan.
FAU - Hsu, Chih-Cheng
AU  - Hsu CC
AD  - National Center for Geriatrics and Welfare Research, National Health Research 
      Institutes, Zhunan, Taiwan.
AD  - Institute of Population Health Sciences, National Health Research Institutes, 
      Zhunan, Taiwan.
LA  - eng
PT  - Journal Article
DEP - 20231123
PL  - England
TA  - Lancet Reg Health West Pac
JT  - The Lancet regional health. Western Pacific
JID - 101774968
PMC - PMC10701157
OTO - NOTNLM
OT  - Age
OT  - Hospitalization
OT  - Mass screening
OT  - Suicide
OT  - Treatment outcome
COIS- During preparing this work, the authors used ChatGPT-3.5 and Grammarly to enhance 
      writing quality and rectify grammar errors. Subsequently, the authors reviewed 
      and edited the content, assuming full responsibility for the publication's 
      integrity. The authors declared no relevant conflict of interest.
EDAT- 2023/12/11 12:43
MHDA- 2023/12/11 12:44
PMCR- 2023/11/23
CRDT- 2023/12/11 06:08
PHST- 2023/09/27 00:00 [received]
PHST- 2023/10/26 00:00 [revised]
PHST- 2023/11/10 00:00 [accepted]
PHST- 2023/12/11 12:44 [medline]
PHST- 2023/12/11 12:43 [pubmed]
PHST- 2023/12/11 06:08 [entrez]
PHST- 2023/11/23 00:00 [pmc-release]
AID - S2666-6065(23)00296-1 [pii]
AID - 100978 [pii]
AID - 10.1016/j.lanwpc.2023.100978 [doi]
PST - epublish
SO  - Lancet Reg Health West Pac. 2023 Nov 23;43:100978. doi: 
      10.1016/j.lanwpc.2023.100978. eCollection 2024 Feb.

PMID- 37611418
OWN - NLM
STAT- MEDLINE
DCOM- 20230927
LR  - 20230927
IS  - 1879-0534 (Electronic)
IS  - 0010-4825 (Linking)
VI  - 165
DP  - 2023 Oct
TI  - A precision medicine approach to personalized prescribing using genetic and 
      nongenetic factors for clinical decision-making.
PG  - 107329
LID - S0010-4825(23)00794-1 [pii]
LID - 10.1016/j.compbiomed.2023.107329 [doi]
AB  - Screening potential drug-drug interactions, drug-gene interactions, 
      contraindications, and other factors is crucial in clinical practice. However, 
      implementing these screening concepts in real-world settings poses challenges. 
      This work proposes an approach towards precision medicine that combines genetic 
      and nongenetic factors to facilitate clinical decision-making. The approach 
      focuses on raising the performance of four potential interaction screenings in 
      the prescribing process, including drug-drug interactions, drug-gene 
      interactions, drug-herb interactions, drug-social lifestyle interactions, and two 
      potential considerations for patients with liver or renal impairment. The work 
      describes the design of a curated knowledge-based model called the knowledge 
      model for potential interaction and consideration screening, the screening logic 
      for both the detection module and inference module, and the personalized 
      prescribing report. Three case studies have demonstrated the proof-of-concept and 
      effectiveness of this approach. The proposed approach aims to reduce 
      decision-making processes for healthcare professionals, reduce medication-related 
      harm, and enhance treatment effectiveness. Additionally, the recommendation with 
      a semantic network is suggested to assist in risk-benefit analysis when health 
      professionals plan therapeutic interventions with new medicines that have 
      insufficient evidence to establish explicit recommendations. This approach offers 
      a promising solution to implementing precision medicine in clinical practice.
CI  - Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
FAU - Jamrat, Samart
AU  - Jamrat S
AD  - Technology of Information System Management Division, Faculty of Engineering, 
      Mahidol University, Nakhon Pathom, 73170, Thailand; Artificial Intelligence and 
      Metabolomics Research Group, Faculty of Pharmacy, Silpakorn University, Nakhon 
      Pathom, 73000, Thailand.
FAU - Sukasem, Chonlaphat
AU  - Sukasem C
AD  - Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, 
      Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, 
      Thailand; Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical 
      Center, Ramathibodi Hospital, Bangkok, 10400, Thailand; Bumrungrad Genomic 
      Medicine Institute, Bumrungrad International Hospital, Bangkok, 10110, Thailand.
FAU - Sratthaphut, Lawan
AU  - Sratthaphut L
AD  - Artificial Intelligence and Metabolomics Research Group, Faculty of Pharmacy, 
      Silpakorn University, Nakhon Pathom, 73000, Thailand; Department of Biomedicine 
      and Health Informatics, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, 
      73000, Thailand.
FAU - Hongkaew, Yaowaluck
AU  - Hongkaew Y
AD  - Bumrungrad Genomic Medicine Institute, Bumrungrad International Hospital, 
      Bangkok, 10110, Thailand; Research and Development Laboratory, Bumrungrad 
      International Hospital, Bangkok, 10110, Thailand.
FAU - Samanchuen, Taweesak
AU  - Samanchuen T
AD  - Technology of Information System Management Division, Faculty of Engineering, 
      Mahidol University, Nakhon Pathom, 73170, Thailand. Electronic address: 
      taweesak.sam@mahidol.ac.th.
LA  - eng
PT  - Journal Article
DEP - 20230810
PL  - United States
TA  - Comput Biol Med
JT  - Computers in biology and medicine
JID - 1250250
SB  - IM
MH  - Humans
MH  - *Precision Medicine
MH  - *Clinical Decision-Making
OTO - NOTNLM
OT  - Decision making
OT  - Knowledge representation
OT  - Personalized prescribing
OT  - Pharmacogenomics
OT  - Polypharmacy
OT  - Precision medicine
COIS- Declaration of competing interest We wish to confirm that there are no known 
      conflicts of interest associated with this publication and there has been no 
      significant financial support for this work that could have influenced its 
      outcome. We confirm that the manuscript has been read and approved by all named 
      authors and that there are no other persons who satisfied the criteria for 
      authorship but are not listed. We further confirm that the order of authors 
      listed in the manuscript has been approved by all of us. We confirm that we have 
      given due consideration to the protection of intellectual property associated 
      with this work and that there are no impediments to publication, including the 
      timing of publication, with respect to intellectual property. In so doing we 
      confirm that we have followed the regulations of our institutions concerning 
      intellectual property. During the preparation of this work the authors used 
      ChatGPT in order to correct grammatical mistakes. After using this tool/service, 
      the authors reviewed and edited the content as needed and take full 
      responsibility for the content of the publication. We understand that the 
      Corresponding Author is the sole contact for the Editorial process (including 
      Editorial Manager and direct communications with the office). He is responsible 
      for communicating with the other authors about progress, submissions of revisions 
      and final approval of proofs.
EDAT- 2023/08/24 00:42
MHDA- 2023/09/27 06:43
CRDT- 2023/08/23 18:03
PHST- 2023/06/06 00:00 [received]
PHST- 2023/07/14 00:00 [revised]
PHST- 2023/08/07 00:00 [accepted]
PHST- 2023/09/27 06:43 [medline]
PHST- 2023/08/24 00:42 [pubmed]
PHST- 2023/08/23 18:03 [entrez]
AID - S0010-4825(23)00794-1 [pii]
AID - 10.1016/j.compbiomed.2023.107329 [doi]
PST - ppublish
SO  - Comput Biol Med. 2023 Oct;165:107329. doi: 10.1016/j.compbiomed.2023.107329. Epub 
      2023 Aug 10.

PMID- 37298303
OWN - NLM
STAT- MEDLINE
DCOM- 20230612
LR  - 20230612
IS  - 1422-0067 (Electronic)
IS  - 1422-0067 (Linking)
VI  - 24
IP  - 11
DP  - 2023 May 27
TI  - Hyperglycemia and Oxidative Stress: An Integral, Updated and Critical Overview of 
      Their Metabolic Interconnections.
LID - 10.3390/ijms24119352 [doi]
LID - 9352
AB  - This review focuses on the multiple and reciprocal relationships that exist 
      between oxidative stress, hyperglycemia and diabetes and related metabolic 
      disorders. Human metabolism uses most of the consumed glucose under aerobic 
      conditions. Oxygen is needed in the mitochondria to obtain energy, as well as for 
      the action of microsomal oxidases and cytosolic pro-oxidant enzymes. This 
      relentlessly generates a certain amount of reactive oxygen species (ROS). 
      Although ROS are intracellular signals necessary for some physiological 
      processes, their accumulation leads to oxidative stress, hyperglycemia, and 
      progressive resistance to insulin. A cellular pro-oxidant versus an antioxidant 
      equilibrium would regulate ROS levels, but oxidative stress, hyperglycemia, and 
      pro-inflammatory conditions feed back to each other and the relevance of the 
      interconnections tends to increase those conditions. Hyperglycemia promotes 
      collateral glucose metabolism through protein kinase C, polyols and hexosamine 
      routes. In addition, it also facilitates spontaneous glucose auto-oxidation and 
      the formation of advanced glycation end products (AGEs), which in turn interact 
      with their receptors (RAGE). The mentioned processes undermine cellular 
      structures, finally giving place to a progressively greater degree of oxidative 
      stress with further hyperglycemia, metabolic alterations, and diabetes 
      complications. NFκB is the major transcription factor involved in the expression 
      of most of the pro-oxidant mediators, while Nrf2 is the major transcription 
      factor regulating the antioxidant response. FoxO is also involved in the 
      equilibrium, but its role is controversial. This review summarizes the key 
      factors linking the diverse glucose metabolic routes enhanced in hyperglycemia 
      with ROS formation and vice versa, emphasizing the role of the major 
      transcription factors involved in the desirable balance between pro-oxidant and 
      antioxidant proteins.
FAU - González, Patricia
AU  - González P
AD  - Department of Biochemistry, Molecular Biology B and Immunology, Faculty of 
      Chemistry, Campus de Espinardo, University of Murcia, 30100 Murcia, Spain.
AD  - Fresenius Kabi España, S.A.U., Marina 16-18, 08005 Barcelona, Spain.
FAU - Lozano, Pedro
AU  - Lozano P
AUID- ORCID: 0000-0001-6043-3893
AD  - Department of Biochemistry, Molecular Biology B and Immunology, Faculty of 
      Chemistry, Campus de Espinardo, University of Murcia, 30100 Murcia, Spain.
FAU - Ros, Gaspar
AU  - Ros G
AUID- ORCID: 0000-0002-8894-4481
AD  - Department of Food Technology, Nutrition and Bromatology, School of Veterinary, 
      Campus de Espinardo, University of Murcia, 30100 Murcia, Spain.
FAU - Solano, Francisco
AU  - Solano F
AUID- ORCID: 0000-0001-9612-761X
AD  - Department of Biochemistry, Molecular Biology B and Immunology, School of 
      Medicine-IMIB, Campus Ciencias de la Salud, University of Murcia, Avda. 
      Buenavista 32, El Palmar, 30120 Murcia, Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230527
PL  - Switzerland
TA  - Int J Mol Sci
JT  - International journal of molecular sciences
JID - 101092791
RN  - 0 (Reactive Oxygen Species)
RN  - 0 (Antioxidants)
RN  - 0 (Glycation End Products, Advanced)
RN  - IY9XDZ35W2 (Glucose)
RN  - 0 (Transcription Factors)
SB  - IM
MH  - Humans
MH  - Reactive Oxygen Species/metabolism
MH  - *Antioxidants/metabolism
MH  - *Hyperglycemia/metabolism
MH  - Oxidative Stress/physiology
MH  - Glycation End Products, Advanced/metabolism
MH  - Glucose
MH  - Transcription Factors/metabolism
PMC - PMC10253853
OTO - NOTNLM
OT  - AGE &amp; RAGE
OT  - NFκB
OT  - Nrf2
OT  - ROS
OT  - diabetes type II
OT  - hyperglycemia
OT  - insulin resistance
OT  - oxidative stress
OT  - pro-oxidant and antioxidant enzymes
OT  - protein glycation
COIS- The authors declare no conflict of interest and they did not use ChatGPT or any 
      other AI facility to organize and write this review.
EDAT- 2023/06/10 15:13
MHDA- 2023/06/12 06:43
PMCR- 2023/05/27
CRDT- 2023/06/10 01:11
PHST- 2023/05/09 00:00 [received]
PHST- 2023/05/24 00:00 [revised]
PHST- 2023/05/24 00:00 [accepted]
PHST- 2023/06/12 06:43 [medline]
PHST- 2023/06/10 15:13 [pubmed]
PHST- 2023/06/10 01:11 [entrez]
PHST- 2023/05/27 00:00 [pmc-release]
AID - ijms24119352 [pii]
AID - ijms-24-09352 [pii]
AID - 10.3390/ijms24119352 [doi]
PST - epublish
SO  - Int J Mol Sci. 2023 May 27;24(11):9352. doi: 10.3390/ijms24119352.

PMID- 38549836
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240330
IS  - 2772-6541 (Electronic)
IS  - 2772-6541 (Linking)
VI  - 4
IP  - 1
DP  - 2024 Mar
TI  - Ultrasound-detected effusion-synovitis is associated with greater limb loading 
      rate asymmetry during walking post-ACL reconstruction: A pilot study.
LID - 100175 [pii]
LID - 10.1016/j.ostima.2024.100175 [doi]
AB  - OBJECTIVE: Chronic inflammation and altered walking biomechanics are common after 
      ACL reconstruction (ACLR) and contribute to the development of osteoarthritis. 
      Clinically accessible techniques are needed to monitor inflammation 
      (ultrasound-assessed effusion-synovitis) and walking biomechanics 
      (force-measuring insoles), and they must improve the translation of these 
      assessments and determine whether inflammation and walking biomechanics are 
      related in patients after ACLR. This study aimed to determine the association 
      between ultrasound-detected knee effusion-synovitis and limb loading asymmetries 
      during walking in patients 1-5 years post-ACLR. DESIGN: 15 participants (9 women; 
      age: 26 ± 6yrs; mass: 71 ± 15 kg; height: 173 ± 9 cm; months post-ACLR: 29 ± 13) 
      were included in this cross-sectional study. Knee effusion-synovitis was assessed 
      using a standardized protocol and graded using a validated scoring atlas (0 = 
      absent, 1 = mild, 2 = moderate, 3 = severe) in the ACLR limb. Force-measuring 
      insoles were used to capture the vertical ground reaction force (vGRF) during a 
      one-minute treadmill walking trial. Limb symmetry indices (LSIs) were used to 
      quantify limb loading asymmetry for the peak vGRF and the instantaneous loading 
      rate (vGRF-LR). Spearman correlations determined whether effusion-synovitis grade 
      was associated with peak vGRF and vGRF-LR LSI. RESULTS: Effusion-synovitis was 
      present in the ACLR limb of 13/15 (87 %) participants (Grade 0: n = 2; Grade 1: n 
      = 8; Grade 2: n = 4, Grade 3: n = 1). Effusion-synovitis grade was not 
      significantly associated with peak vGRF LSI (mean±sd: 98.0 ± 5.6; ρ = 0.38, p = 
      0.162), but was significantly associated with vGRF-LR LSI (98.2 ± 11.4; ρ = 0.55, 
      p = 0.035). CONCLUSION: Most participants 1-5 years post-ACLR have 
      ultrasound-detected effusion-synovitis. Participants with more severe 
      effusion-synovitis load their ACLR limb more rapidly. This study highlights the 
      utility of clinically accessible techniques in assessing inflammation and walking 
      biomechanics in ACLR patients.
FAU - Harkey, Matthew S
AU  - Harkey MS
AD  - Michigan State University, 308W. Circle Drive 112, East Lansing 48824, MI, United 
      States.
FAU - Grozier, Corey D
AU  - Grozier CD
AD  - Michigan State University, 308W. Circle Drive 112, East Lansing 48824, MI, United 
      States.
FAU - Tolzman, Jessica
AU  - Tolzman J
AD  - Michigan State University, 308W. Circle Drive 112, East Lansing 48824, MI, United 
      States.
FAU - Parmar, Arjun
AU  - Parmar A
AD  - Michigan State University, 308W. Circle Drive 112, East Lansing 48824, MI, United 
      States.
FAU - Fagan, Molly
AU  - Fagan M
AD  - Grand Valley State University, United States.
FAU - Collins, Katherine
AU  - Collins K
AD  - University of North Carolina at Chapel Hill, United States.
FAU - Kuenze, Christopher
AU  - Kuenze C
AD  - University of Virginia, United States.
FAU - Fajardo, Ryan
AU  - Fajardo R
AD  - Lansing Radiology Associates, United States.
LA  - eng
GR  - K01 AR081389/AR/NIAMS NIH HHS/United States
PT  - Journal Article
DEP - 20240209
PL  - England
TA  - Osteoarthr Imaging
JT  - Osteoarthritis imaging
JID - 9918454385406676
PMC - PMC10976353
MID - NIHMS1967483
OTO - NOTNLM
OT  - Biomechanics
OT  - Early osteoarthritis
OT  - Gait
OT  - Inflammation
OT  - Knee
COIS- Declaration of competing interest This manuscript was prepared with assistance 
      from ChatGPT, a generative AI technology, which provided stylistic and 
      grammatical guidance to enhance the writing quality. The authors thoroughly 
      reviewed and revised the AI-generated content, ensuring it reflects their 
      original research and insights accurately. The authors are fully responsible for 
      this publication, adhering to ethical research and writing standards.
EDAT- 2024/03/29 06:46
MHDA- 2024/03/29 06:47
PMCR- 2024/03/28
CRDT- 2024/03/29 03:59
PHST- 2024/03/29 06:47 [medline]
PHST- 2024/03/29 06:46 [pubmed]
PHST- 2024/03/29 03:59 [entrez]
PHST- 2024/03/28 00:00 [pmc-release]
AID - 100175 [pii]
AID - 10.1016/j.ostima.2024.100175 [doi]
PST - ppublish
SO  - Osteoarthr Imaging. 2024 Mar;4(1):100175. doi: 10.1016/j.ostima.2024.100175. Epub 
      2024 Feb 9.

PMID- 38313196
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240210
IS  - 2331-8422 (Electronic)
IS  - 2331-8422 (Linking)
DP  - 2024 Jan 17
TI  - IVIM-Morph: Motion-compensated quantitative Intra-voxel Incoherent Motion (IVIM) 
      analysis for functional fetal lung maturity assessment from diffusion-weighted 
      MRI data.
LID - arXiv:2401.07126v2
AB  - Quantitative analysis of pseudo-diffusion in diffusion-weighted magnetic 
      resonance imaging (DWI) data shows potential for assessing fetal lung maturation 
      and generating valuable imaging biomarkers. Yet, the clinical utility of DWI data 
      is hindered by unavoidable fetal motion during acquisition. We present 
      IVIM-morph, a self-supervised deep neural network model for motion-corrected 
      quantitative analysis of DWI data using the Intra-voxel Incoherent Motion (IVIM) 
      model. IVIM-morph combines two sub-networks, a registration sub-network, and an 
      IVIM model fitting sub-network, enabling simultaneous estimation of IVIM model 
      parameters and motion. To promote physically plausible image registration, we 
      introduce a biophysically informed loss function that effectively balances 
      registration and model-fitting quality. We validated the efficacy of IVIM-morph 
      by establishing a correlation between the predicted IVIM model parameters of the 
      lung and gestational age (GA) using fetal DWI data of 39 subjects. Our approach 
      was compared against six baseline methods: 1) no motion compensation, 2) affine 
      registration of all DWI images to the initial image, 3) deformable registration 
      of all DWI images to the initial image, 4) deformable registration of each DWI 
      image to its preceding image in the sequence, 5) iterative deformable motion 
      compensation combined with IVIM model parameter estimation, and 6) 
      self-supervised deep-learning-based deformable registration. IVIM-morph exhibited 
      a notably improved correlation with gestational age (GA) when performing in-vivo 
      quantitative analysis of fetal lung DWI data during the canalicular phase. 
      Specifically, over 2 test groups of cases, it achieved an Rf2 of 0.44 and 0.52, 
      outperforming the values of 0.27 and 0.25, 0.25 and 0.00, 0.00 and 0.00, 0.38 and 
      0.00, and 0.07 and 0.14 obtained by other methods. IVIM-morph shows potential in 
      developing valuable biomarkers for non-invasive assessment of fetal lung maturity 
      with DWI data. Moreover, its adaptability opens the door to potential 
      applications in other clinical contexts where motion compensation is essential 
      for quantitative DWI analysis. The IVIM-morph code is readily available 
      at:https://github.com/TechnionComputationalMRILab/qDWI-Morph.
FAU - Kertes, Noga
AU  - Kertes N
AD  - Faculty of Biomedical Engineering, Technion, Haifa, Israel.
FAU - Zaffrani-Reznikov, Yael
AU  - Zaffrani-Reznikov Y
AD  - Faculty of Biomedical Engineering, Technion, Haifa, Israel.
FAU - Afacan, Onur
AU  - Afacan O
AD  - Boston Children's Hospital, Boston, MA, USA.
FAU - Kurugol, Sila
AU  - Kurugol S
AD  - Boston Children's Hospital, Boston, MA, USA.
FAU - Warfield, Simon K
AU  - Warfield SK
AD  - Boston Children's Hospital, Boston, MA, USA.
FAU - Freiman, Moti
AU  - Freiman M
AD  - Faculty of Biomedical Engineering, Technion, Haifa, Israel.
LA  - eng
GR  - R01 EB019483/EB/NIBIB NIH HHS/United States
GR  - R01 LM013608/LM/NLM NIH HHS/United States
GR  - R01 NS121657/NS/NINDS NIH HHS/United States
GR  - R01 NS124212/NS/NINDS NIH HHS/United States
PT  - Preprint
DEP - 20240117
PL  - United States
TA  - ArXiv
JT  - ArXiv
JID - 101759493
PMC - PMC10836081
COIS- Declaration of Generative AI During the preparation of this work, the author(s) 
      used ChatGPT in order to improve readability. After using this tool/service, the 
      author(s) reviewed and edited the content as needed and take(s) full 
      responsibility for the content of the publication.
EDAT- 2024/02/05 06:42
MHDA- 2024/02/05 06:43
PMCR- 2024/01/17
CRDT- 2024/02/05 04:34
PHST- 2024/02/05 06:42 [pubmed]
PHST- 2024/02/05 06:43 [medline]
PHST- 2024/02/05 04:34 [entrez]
PHST- 2024/01/17 00:00 [pmc-release]
AID - 2401.07126 [pii]
PST - epublish
SO  - ArXiv [Preprint]. 2024 Jan 17:arXiv:2401.07126v2.

PMID- 38521362
OWN - NLM
STAT- Publisher
LR  - 20240323
IS  - 1879-1220 (Electronic)
IS  - 0960-0760 (Linking)
DP  - 2024 Mar 21
TI  - Enzymatic synthesis of a skin active ingredient - glochidone by 3-ketosteroid 
      dehydrogenase from Sterolibacterium denitrificans.
PG  - 106513
LID - S0960-0760(24)00061-X [pii]
LID - 10.1016/j.jsbmb.2024.106513 [doi]
AB  - In this study, we applied AcmB2, sourced from Sterolibacterium denitrificans, to 
      catalyze the oxidative dehydrogenation of 3-ketolupeol (lupenone), a derivative 
      of lupeol, triterpene obtained from birch bark. This enzymatic 
      Δ(1)-dehydrogenation catalyzed by AcmB2 yielded glochidone, a bioactive compound 
      frequently obtained from medicinal plants like Salvia trichoclada and Maytenus 
      boria. Glochidone is known for its broad biological activities, including 
      antibacterial, antifungal, anti-inflammatory, anticancer, antidiabetic as well as 
      acetylcholinesterase inhibition. Our research demonstrates &gt;99% conversion 
      efficiency with 100% regioselectivity of the reaction. The effective conversion 
      to glochidone employed an electron acceptor e.g., potassium hexacyanoferrate III, 
      in mild, environmentally friendly conditions: 8-16% 
      2-hydroxypropyl-β-cyclodextrin, and 2-3% 2-methoxyethanol. AcmB2 reaction optimum 
      was determined at pH 8.0 and 30(o)C. Enzyme's biochemical attributes such as 
      electron acceptor type, concentration and steroid substrate specificity were 
      investigated. Among 4-, 5- and 6-ring steroid derivatives androst-4-en-3,17-dione 
      and testosterone propionate were determined as the best substrates of AcmB2. 
      Δ(1)-Dehydrogenation of substrates such as lupenone, diosgenone and 
      3-ketopetromyzonol was confirmed. We have assessed the antioxidant and 
      rejuvenating characteristics of glochidone as an active component in 
      formulations, considering its precursors, lupeol, and lupenone as well. 
      Glochidone exhibited limited antioxidant and chelating capabilities compared to 
      lupeol and reference compounds. However, it demonstrated robust rejuvenating 
      properties, with a sirtuin induction level of 61.5 ± 1.87%, notably surpassing 
      that of the reference substance, E-resveratrol (45.15 ± 0.09%). Additionally, 
      glochidone displayed 26.5±0.67 and 19.41±0.76% inhibition of elastase and 
      collagenase, respectively. The safety of all studied triterpenes was confirmed on 
      skin reconstructed human Epidermis model. These findings provide valuable 
      insights into the potential applications of glochidone in formulations aimed at 
      addressing skin health concerns. This research presents the first example of an 
      enzyme in the 3-ketosteroid dehydrogenase (KstD) family catalyzing the 
      Δ(1)-dehydrogenation of a pentacyclic triterpene. We also explored structural 
      differences between AcmB, AcmB2, and related KstDs pointing to G52 and P532 as 
      potentially responsible for the unique substrate specificity of AcmB2. Our 
      findings not only highlight the enzyme's capabilities but also present novel 
      enzymatic pathways for bioactive compound synthesis.
CI  - Copyright © 2024. Published by Elsevier Ltd.
FAU - Wojtkiewicz, Agnieszka M
AU  - Wojtkiewicz AM
AD  - Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of 
      Sciences, Niezapominajek 8, PL30239, Krakow, Poland. Electronic address: 
      agnieszka.wojtkiewicz@ikifp.edu.pl.
FAU - Oleksy, Gabriela
AU  - Oleksy G
AD  - Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of 
      Sciences, Niezapominajek 8, PL30239, Krakow, Poland.
FAU - Malinowska, Magdalena A
AU  - Malinowska MA
AD  - Organic Chemistry and Technology Department, Faculty of Chemical Engineering and 
      Technology, Cracow University of Technology, Warszawa 24, 31-155 Krakow, Poland.
FAU - Janeczko, Tomasz
AU  - Janeczko T
AD  - Department of Food Chemistry and Biocatalysis, Wrocław University of 
      Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland.
LA  - eng
PT  - Journal Article
DEP - 20240321
PL  - England
TA  - J Steroid Biochem Mol Biol
JT  - The Journal of steroid biochemistry and molecular biology
JID - 9015483
SB  - IM
OTO - NOTNLM
OT  - 1-dehydro-lupenone
OT  - 3-ketosteroid dehydrogenase
OT  - Sterolibacterium denitrificans
OT  - antiaging activity
OT  - cholest-4-en-3-one dehydrogenase 2
OT  - glochidone
OT  - pentacyclic triterpenoids
COIS- Conflict of interest The authors declare no competing interests. During the 
      preparation of this work the authors used ChatGPT 3.5 in order to improve 
      language and readability. After using this tool, the authors reviewed and edited 
      the content as needed and takes full responsibility for the content of the 
      publication.
EDAT- 2024/03/24 00:42
MHDA- 2024/03/24 00:42
CRDT- 2024/03/23 20:40
PHST- 2024/02/01 00:00 [received]
PHST- 2024/03/12 00:00 [revised]
PHST- 2024/03/21 00:00 [accepted]
PHST- 2024/03/24 00:42 [medline]
PHST- 2024/03/24 00:42 [pubmed]
PHST- 2024/03/23 20:40 [entrez]
AID - S0960-0760(24)00061-X [pii]
AID - 10.1016/j.jsbmb.2024.106513 [doi]
PST - aheadofprint
SO  - J Steroid Biochem Mol Biol. 2024 Mar 21:106513. doi: 10.1016/j.jsbmb.2024.106513.

PMID- 38000386
OWN - NLM
STAT- MEDLINE
DCOM- 20240111
LR  - 20240331
IS  - 1362-4962 (Electronic)
IS  - 0305-1048 (Print)
IS  - 0305-1048 (Linking)
VI  - 52
IP  - D1
DP  - 2024 Jan 5
TI  - The Monarch Initiative in 2024: an analytic platform integrating phenotypes, 
      genes&nbsp;and diseases across species.
PG  - D938-D949
LID - 10.1093/nar/gkad1082 [doi]
AB  - Bridging the gap between genetic variations, environmental determinants, and 
      phenotypic outcomes is critical for supporting clinical diagnosis and 
      understanding mechanisms of diseases. It requires integrating open data at a 
      global scale. The Monarch Initiative advances these goals by developing open 
      ontologies, semantic data models, and knowledge graphs for translational 
      research. The Monarch App is an integrated platform combining data about genes, 
      phenotypes, and diseases across species. Monarch's APIs enable access to 
      carefully curated datasets and advanced analysis tools that support the 
      understanding and diagnosis of disease for diverse applications such as variant 
      prioritization, deep phenotyping, and patient profile-matching. We have migrated 
      our system into a scalable, cloud-based infrastructure; simplified Monarch's data 
      ingestion and knowledge graph integration systems; enhanced data mapping and 
      integration standards; and developed a new user interface with novel search and 
      graph navigation features. Furthermore, we advanced Monarch's analytic tools by 
      developing a customized plugin for OpenAI's ChatGPT to increase the reliability 
      of its responses about phenotypic data, allowing us to interrogate the knowledge 
      in the Monarch graph using state-of-the-art Large Language Models. The resources 
      of the Monarch Initiative can be found at monarchinitiative.org and its 
      corresponding code repository at github.com/monarch-initiative/monarch-app.
CI  - © The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic 
      Acids Research.
FAU - Putman, Tim E
AU  - Putman TE
AUID- ORCID: 0000-0002-4291-0737
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Schaper, Kevin
AU  - Schaper K
AUID- ORCID: 0000-0003-3311-7320
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Matentzoglu, Nicolas
AU  - Matentzoglu N
AUID- ORCID: 0000-0002-7356-1779
AD  - Independent Consultant, Semanticly, Athens, Greece.
FAU - Rubinetti, Vincent P
AU  - Rubinetti VP
AUID- ORCID: 0000-0002-4655-3773
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Alquaddoomi, Faisal S
AU  - Alquaddoomi FS
AUID- ORCID: 0000-0003-4297-8747
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Cox, Corey
AU  - Cox C
AUID- ORCID: 0000-0001-9042-5982
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Caufield, J Harry
AU  - Caufield JH
AUID- ORCID: 0000-0001-5705-7831
AD  - Environmental Genomics and Systems Biology, Lawrence Berkeley National 
      Laboratory, Berkeley, CA&nbsp;94720, USA.
FAU - Elsarboukh, Glass
AU  - Elsarboukh G
AUID- ORCID: 0000-0001-8272-7198
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Gehrke, Sarah
AU  - Gehrke S
AUID- ORCID: 0000-0003-3245-2880
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Hegde, Harshad
AU  - Hegde H
AUID- ORCID: 0000-0002-2411-565X
AD  - Environmental Genomics and Systems Biology, Lawrence Berkeley National 
      Laboratory, Berkeley, CA&nbsp;94720, USA.
FAU - Reese, Justin T
AU  - Reese JT
AUID- ORCID: 0000-0002-2170-2250
AD  - Environmental Genomics and Systems Biology, Lawrence Berkeley National 
      Laboratory, Berkeley, CA&nbsp;94720, USA.
FAU - Braun, Ian
AU  - Braun I
AUID- ORCID: 0000-0002-2389-9288
AD  - Data Collaboration Center, Critical Path Institute, Tucson, AZ&nbsp;85718, USA.
FAU - Bruskiewich, Richard M
AU  - Bruskiewich RM
AUID- ORCID: 0000-0002-4447-5978
AD  - STAR Informatics, Delphinai Corporation, Sooke, BC&nbsp;V9Z 0M3, Canada.
FAU - Cappelletti, Luca
AU  - Cappelletti L
AUID- ORCID: 0000-0002-1269-2038
AD  - Biology, University of Fribourg, Fribourg, Switzerland.
FAU - Carbon, Seth
AU  - Carbon S
AUID- ORCID: 0000-0001-8244-1536
AD  - Environmental Genomics and Systems Biology, Lawrence Berkeley National 
      Laboratory, Berkeley, CA&nbsp;94720, USA.
FAU - Caron, Anita R
AU  - Caron AR
AUID- ORCID: 0000-0002-6523-4866
AD  - European Bioinformatics Institute (EMBL-EBI), Hinxton&nbsp;CB10 1SD, UK.
FAU - Chan, Lauren E
AU  - Chan LE
AUID- ORCID: 0000-0002-7463-6306
AD  - College of Public Health and Human Sciences, Oregon State University, Corvallis, 
      OR&nbsp;97331, USA.
FAU - Chute, Christopher G
AU  - Chute CG
AUID- ORCID: 0000-0001-5437-2545
AD  - Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, 
      Baltimore, MD&nbsp;21205, USA.
FAU - Cortes, Katherina G
AU  - Cortes KG
AUID- ORCID: 0000-0002-9489-3158
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - De Souza, Vinícius
AU  - De Souza V
AUID- ORCID: 0000-0003-3961-0247
AD  - European Bioinformatics Institute (EMBL-EBI), Hinxton&nbsp;CB10 1SD, UK.
FAU - Fontana, Tommaso
AU  - Fontana T
AUID- ORCID: 0000-0002-9806-3493
AD  - Dipartimento di Informatica, Università degli Studi di Milano Statale, Milano, 
      Italy.
FAU - Harris, Nomi L
AU  - Harris NL
AUID- ORCID: 0000-0001-6315-3707
AD  - Environmental Genomics and Systems Biology, Lawrence Berkeley National 
      Laboratory, Berkeley, CA&nbsp;94720, USA.
FAU - Hartley, Emily L
AU  - Hartley EL
AUID- ORCID: 0000-0001-5839-2535
AD  - Data Collaboration Center, Critical Path Institute, Tucson, AZ&nbsp;85718, USA.
FAU - Hurwitz, Eric
AU  - Hurwitz E
AUID- ORCID: 0000-0002-6581-7754
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Jacobsen, Julius O B
AU  - Jacobsen JOB
AUID- ORCID: 0000-0002-3265-1591
AD  - William Harvey Research Institute, Queen Mary University of London, London&nbsp;EC1M 
      6BQ, UK.
FAU - Krishnamurthy, Madan
AU  - Krishnamurthy M
AUID- ORCID: 0000-0002-9767-3636
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Laraway, Bryan J
AU  - Laraway BJ
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - McLaughlin, James A
AU  - McLaughlin JA
AUID- ORCID: 0000-0002-8361-2795
AD  - European Bioinformatics Institute (EMBL-EBI), Hinxton&nbsp;CB10 1SD, UK.
FAU - McMurry, Julie A
AU  - McMurry JA
AUID- ORCID: 0000-0002-9353-5498
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Moxon, Sierra A T
AU  - Moxon SAT
AUID- ORCID: 0000-0002-8719-7760
AD  - Environmental Genomics and Systems Biology, Lawrence Berkeley National 
      Laboratory, Berkeley, CA&nbsp;94720, USA.
FAU - Mullen, Kathleen R
AU  - Mullen KR
AUID- ORCID: 0000-0002-5002-8648
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - O'Neil, Shawn T
AU  - O'Neil ST
AUID- ORCID: 0000-0001-6220-7080
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Shefchek, Kent A
AU  - Shefchek KA
AUID- ORCID: 0000-0001-6439-2224
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Stefancsik, Ray
AU  - Stefancsik R
AUID- ORCID: 0000-0001-8314-2140
AD  - European Bioinformatics Institute (EMBL-EBI), Hinxton&nbsp;CB10 1SD, UK.
FAU - Toro, Sabrina
AU  - Toro S
AUID- ORCID: 0000-0002-4142-7153
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Vasilevsky, Nicole A
AU  - Vasilevsky NA
AUID- ORCID: 0000-0001-5208-3432
AD  - Data Collaboration Center, Critical Path Institute, Tucson, AZ&nbsp;85718, USA.
FAU - Walls, Ramona L
AU  - Walls RL
AUID- ORCID: 0000-0001-8815-0078
AD  - Data Collaboration Center, Critical Path Institute, Tucson, AZ&nbsp;85718, USA.
FAU - Whetzel, Patricia L
AU  - Whetzel PL
AUID- ORCID: 0000-0002-3458-4839
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Osumi-Sutherland, David
AU  - Osumi-Sutherland D
AD  - European Bioinformatics Institute (EMBL-EBI), Hinxton&nbsp;CB10 1SD, UK.
FAU - Smedley, Damian
AU  - Smedley D
AUID- ORCID: 0000-0002-5836-9850
AD  - William Harvey Research Institute, Queen Mary University of London, London&nbsp;EC1M 
      6BQ, UK.
FAU - Robinson, Peter N
AU  - Robinson PN
AUID- ORCID: 0000-0002-0736-9199
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, CT&nbsp;6032, USA.
FAU - Mungall, Christopher J
AU  - Mungall CJ
AUID- ORCID: 0000-0002-6601-2165
AD  - Environmental Genomics and Systems Biology, Lawrence Berkeley National 
      Laboratory, Berkeley, CA&nbsp;94720, USA.
FAU - Haendel, Melissa A
AU  - Haendel MA
AUID- ORCID: 0000-0001-9114-8737
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
FAU - Munoz-Torres, Monica C
AU  - Munoz-Torres MC
AUID- ORCID: 0000-0001-8430-6039
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO&nbsp;80045, USA.
LA  - eng
GR  - T15 LM009451/LM/NLM NIH HHS/United States
GR  - 5RM1HG010860-04/HG/NHGRI NIH HHS/United States
GR  - R24 OD011883/OD/NIH HHS/United States
GR  - U24 HG011449/HG/NHGRI NIH HHS/United States
GR  - RM1 HG010860/HG/NHGRI NIH HHS/United States
GR  - T15LM009451/LM/NLM NIH HHS/United States
PT  - Journal Article
PL  - England
TA  - Nucleic Acids Res
JT  - Nucleic acids research
JID - 0411011
SB  - IM
MH  - Humans
MH  - *Phenotype
MH  - Internet
MH  - *Databases, Factual/standards
MH  - Software
MH  - *Genes/genetics
MH  - *Disease/genetics
PMC - PMC10767791
EDAT- 2023/11/25 07:43
MHDA- 2024/01/08 06:43
PMCR- 2023/11/24
CRDT- 2023/11/24 19:05
PHST- 2023/11/02 00:00 [accepted]
PHST- 2023/10/21 00:00 [revised]
PHST- 2023/09/18 00:00 [received]
PHST- 2024/01/08 06:43 [medline]
PHST- 2023/11/25 07:43 [pubmed]
PHST- 2023/11/24 19:05 [entrez]
PHST- 2023/11/24 00:00 [pmc-release]
AID - 7449493 [pii]
AID - gkad1082 [pii]
AID - 10.1093/nar/gkad1082 [doi]
PST - ppublish
SO  - Nucleic Acids Res. 2024 Jan 5;52(D1):D938-D949. doi: 10.1093/nar/gkad1082.

PMID- 37900350
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231031
IS  - 2059-8661 (Electronic)
IS  - 2059-8661 (Linking)
VI  - 7
IP  - 1
DP  - 2023
TI  - An approach for collaborative development of a federated biomedical knowledge 
      graph-based question-answering system: Question-of-the-Month challenges.
PG  - e214
LID - 10.1017/cts.2023.619 [doi]
LID - e214
AB  - Knowledge graphs have become a common approach for knowledge representation. Yet, 
      the application of graph methodology is elusive due to the sheer number and 
      complexity of knowledge sources. In addition, semantic incompatibilities hinder 
      efforts to harmonize and integrate across these diverse sources. As part of The 
      Biomedical Translator Consortium, we have developed a knowledge graph-based 
      question-answering system designed to augment human reasoning and accelerate 
      translational scientific discovery: the Translator system. We have applied the 
      Translator system to answer biomedical questions in the context of a broad array 
      of diseases and syndromes, including Fanconi anemia, primary ciliary dyskinesia, 
      multiple sclerosis, and others. A variety of collaborative approaches have been 
      used to research and develop the Translator system. One recent approach involved 
      the establishment of a monthly "Question-of-the-Month (QotM) Challenge" series. 
      Herein, we describe the structure of the QotM Challenge; the six challenges that 
      have been conducted to date on drug-induced liver injury, cannabidiol toxicity, 
      coronavirus infection, diabetes, psoriatic arthritis, and ATP1A3-related 
      phenotypes; the scientific insights that have been gleaned during the challenges; 
      and the technical issues that were identified over the course of the challenges 
      and that can now be addressed to foster further development of the prototype 
      Translator system. We close with a discussion on Large Language Models such as 
      ChatGPT and highlight differences between those models and the Translator system.
CI  - © The Author(s) 2023.
FAU - Fecho, Karamarie
AU  - Fecho K
AUID- ORCID: 0000-0002-6704-9306
AD  - Renaissance Computing Institute (RENCI), University of North Carolina at Chapel 
      Hill, Chapel Hill, NC, USA.
AD  - Copperline Professional Solutions, Pittsboro, NC, USA.
FAU - Bizon, Chris
AU  - Bizon C
AUID- ORCID: 0000-0002-9491-7674
AD  - Renaissance Computing Institute (RENCI), University of North Carolina at Chapel 
      Hill, Chapel Hill, NC, USA.
FAU - Issabekova, Tursynay
AU  - Issabekova T
AUID- ORCID: 0000-0003-0842-7335
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO, USA.
FAU - Moxon, Sierra
AU  - Moxon S
AUID- ORCID: 0000-0002-8719-7760
AD  - Biosystems Data Science Department, Lawrence Berkeley National Laboratory, 
      Berkeley, CA, USA.
FAU - Thessen, Anne E
AU  - Thessen AE
AUID- ORCID: 0000-0002-2908-3327
AD  - Department of Biomedical Informatics, University of Colorado Anschutz Medical 
      Campus, Aurora, CO, USA.
FAU - Abdollahi, Shervin
AU  - Abdollahi S
AUID- ORCID: 0000-0002-2444-0014
AD  - Division of Preclinical Innovation, National Center for Advancing Translational 
      Sciences, National Institutes of Health, Rockville, MD, USA.
FAU - Baranzini, Sergio E
AU  - Baranzini SE
AUID- ORCID: 0000-0003-0067-194X
AD  - Department of Neurology, Weill Institute for Neuroscience, University of 
      California - San Francisco, San Francisco, CA, USA.
FAU - Belhu, Basazin
AU  - Belhu B
AD  - Institute for Systems Biology, Seattle, WA, USA.
FAU - Byrd, William E
AU  - Byrd WE
AUID- ORCID: 0000-0003-4730-5293
AD  - The Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, 
      Birmingham, AL, USA.
FAU - Chung, Lawrence
AU  - Chung L
AUID- ORCID: 0000-0002-6823-9275
AD  - The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
FAU - Crouse, Andrew
AU  - Crouse A
AUID- ORCID: 0000-0003-3499-6902
AD  - The Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, 
      Birmingham, AL, USA.
FAU - Duby, Marc P
AU  - Duby MP
AUID- ORCID: 0000-0002-3884-6680
AD  - The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
FAU - Ferguson, Stephen
AU  - Ferguson S
AUID- ORCID: 0000-0003-3172-8347
AD  - National Institute of Environmental Health Sciences, National Institutes of 
      Health, Research Triangle Park, NC, USA.
FAU - Foksinska, Aleksandra
AU  - Foksinska A
AUID- ORCID: 0000-0002-1035-3294
AD  - The Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, 
      Birmingham, AL, USA.
FAU - Forero, Laura
AU  - Forero L
AD  - Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San 
      Diego, CA, USA.
AD  - University of California at San Diego, San Diego, CA, USA.
FAU - Friedman, Jennifer
AU  - Friedman J
AD  - Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San 
      Diego, CA, USA.
AD  - University of California at San Diego, San Diego, CA, USA.
FAU - Gardner, Vicki
AU  - Gardner V
AD  - Renaissance Computing Institute (RENCI), University of North Carolina at Chapel 
      Hill, Chapel Hill, NC, USA.
FAU - Glusman, Gwênlyn
AU  - Glusman G
AUID- ORCID: 0000-0001-8060-5955
AD  - Institute for Systems Biology, Seattle, WA, USA.
FAU - Hadlock, Jennifer
AU  - Hadlock J
AUID- ORCID: 0000-0001-6103-7606
AD  - Institute for Systems Biology, Seattle, WA, USA.
FAU - Hanspers, Kristina
AU  - Hanspers K
AUID- ORCID: 0000-0001-5410-599X
AD  - Gladstone Institutes, University of California - San Francisco, San Francisco, 
      CA, USA.
FAU - Hinderer, Eugene
AU  - Hinderer E
AUID- ORCID: 0000-0001-8045-7083
AD  - Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, 
      MA, USA.
FAU - Hobbs, Charlotte
AU  - Hobbs C
AUID- ORCID: 0000-0002-3964-5952
AD  - Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San 
      Diego, CA, USA.
FAU - Hyde, Gregory
AU  - Hyde G
AUID- ORCID: 0000-0001-5608-5224
AD  - Thayer School of Engineering at Dartmouth College, Hanover, NH, USA.
FAU - Huang, Sui
AU  - Huang S
AUID- ORCID: 0000-0002-3545-4665
AD  - Institute for Systems Biology, Seattle, WA, USA.
FAU - Koslicki, David
AU  - Koslicki D
AUID- ORCID: 0000-0002-0640-954X
AD  - Departments of Computer Science and Engineering, Biology, and the Huck Institutes 
      of the Life Sciences, Penn State University, University Park, PA, USA.
FAU - Mease, Philip
AU  - Mease P
AUID- ORCID: 0000-0002-6620-0457
AD  - Swedish Medical Center, St. Joseph Health, Seattle, WA, USA.
AD  - University of Washington, Seattle, WA, USA.
FAU - Muller, Sandrine
AU  - Muller S
AUID- ORCID: 0000-0001-5998-3003
AD  - The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
FAU - Mungall, Christopher J
AU  - Mungall CJ
AUID- ORCID: 0000-0002-6601-2165
AD  - Biosystems Data Science Department, Lawrence Berkeley National Laboratory, 
      Berkeley, CA, USA.
FAU - Ramsey, Stephen A
AU  - Ramsey SA
AUID- ORCID: 0000-0002-2168-5403
AD  - Oregon State University, Corvallis, OR, USA.
FAU - Roach, Jared
AU  - Roach J
AUID- ORCID: 0000-0003-4524-0107
AD  - Institute for Systems Biology, Seattle, WA, USA.
FAU - Rubin, Irit
AU  - Rubin I
AUID- ORCID: 0000-0003-2377-3498
AD  - Institute for Systems Biology, Seattle, WA, USA.
FAU - Schurman, Shepherd H
AU  - Schurman SH
AUID- ORCID: 0000-0002-9133-7906
AD  - National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
FAU - Shalev, Anath
AU  - Shalev A
AUID- ORCID: 0000-0003-2869-7228
AD  - The Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, 
      Birmingham, AL, USA.
FAU - Smith, Brett
AU  - Smith B
AUID- ORCID: 0000-0002-2586-5014
AD  - Institute for Systems Biology, Seattle, WA, USA.
FAU - Soman, Karthik
AU  - Soman K
AUID- ORCID: 0000-0002-3490-9306
AD  - Department of Neurology, Weill Institute for Neuroscience, University of 
      California - San Francisco, San Francisco, CA, USA.
FAU - Stemann, Sarah
AU  - Stemann S
AD  - Division of Preclinical Innovation, National Center for Advancing Translational 
      Sciences, National Institutes of Health, Rockville, MD, USA.
FAU - Su, Andrew I
AU  - Su AI
AUID- ORCID: 0000-0002-9859-4104
AD  - The Scripps Research Institute, La Jolla, CA, USA.
FAU - Ta, Casey
AU  - Ta C
AUID- ORCID: 0000-0002-4679-805X
AD  - Columbia University Irving Medical Center, New York, NY, USA.
FAU - Watkins, Paul B
AU  - Watkins PB
AUID- ORCID: 0000-0001-9541-8917
AD  - Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of 
      Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
FAU - Williams, Mark D
AU  - Williams MD
AUID- ORCID: 0000-0001-8020-916X
AD  - Division of Preclinical Innovation, National Center for Advancing Translational 
      Sciences, National Institutes of Health, Rockville, MD, USA.
FAU - Wu, Chunlei
AU  - Wu C
AUID- ORCID: 0000-0002-2629-6124
AD  - The Scripps Research Institute, La Jolla, CA, USA.
FAU - Xu, Colleen H
AU  - Xu CH
AUID- ORCID: 0000-0003-2975-882X
AD  - The Scripps Research Institute, La Jolla, CA, USA.
CN  - Biomedical Data Translator Consortium
LA  - eng
PT  - Journal Article
DEP - 20230914
PL  - England
TA  - J Clin Transl Sci
JT  - Journal of clinical and translational science
JID - 101689953
PMC - PMC10603356
OTO - NOTNLM
OT  - Translational research
OT  - bioinformatics
OT  - knowledge graphs
OT  - semantic technology
OT  - team science
COIS- JF receives additional funding from the Rady Children’s Institute for Genomic 
      Medicine, and her spouse is Founder and Principal of Friedman Bioventure. JH 
      receives grant/contract support (paid to institution) from: Pfizer; Novartis; 
      Janssen; BMS; and Gilead. PJM receives grant/research support from: AbbVie; 
      Amgen; Bristol Myers Squibb; Eli Lilly; Galapagos; Gilead; Janssen; Novartis; 
      Pfizer; Sun Pharma; and UCB. PJM also serves as a consultant at: AbbVie; 
      Acelyrin; Aclaris; Amgen; Boehringer Ingelheim; Bristol Myers Squibb; Eli Lilly; 
      Galapagos; Gilead; GlaxoSmithKline; Inmagene; Janssen; Pfizer; Moonlake Pharma; 
      Novartis; Sun Pharma; and UCB. In addition, PJM receives speakers’ bureau fees 
      from: AbbVie; Amgen; Eli Lilly; Janssen; Novartis; Pfizer; and Union Chimique 
      Belge. SHS is supported by the National Institute on Aging, Intramural Research 
      Program. All other primary authors have no conflicts of interest to declare.
EDAT- 2023/10/30 06:47
MHDA- 2023/10/30 06:48
PMCR- 2023/09/14
CRDT- 2023/10/30 04:34
PHST- 2023/07/10 00:00 [received]
PHST- 2023/08/21 00:00 [accepted]
PHST- 2023/10/30 06:48 [medline]
PHST- 2023/10/30 06:47 [pubmed]
PHST- 2023/10/30 04:34 [entrez]
PHST- 2023/09/14 00:00 [pmc-release]
AID - S2059866123006192 [pii]
AID - 10.1017/cts.2023.619 [doi]
PST - epublish
SO  - J Clin Transl Sci. 2023 Sep 14;7(1):e214. doi: 10.1017/cts.2023.619. eCollection 
      2023.

PMID- 37782499
OWN - NLM
STAT- MEDLINE
DCOM- 20231003
LR  - 20231128
IS  - 2574-3805 (Electronic)
IS  - 2574-3805 (Linking)
VI  - 6
IP  - 10
DP  - 2023 Oct 2
TI  - Accuracy and Reliability of Chatbot Responses to Physician Questions.
PG  - e2336483
LID - 10.1001/jamanetworkopen.2023.36483 [doi]
LID - e2336483
AB  - IMPORTANCE: Natural language processing tools, such as ChatGPT (generative 
      pretrained transformer, hereafter referred to as chatbot), have the potential to 
      radically enhance the accessibility of medical information for health 
      professionals and patients. Assessing the safety and efficacy of these tools in 
      answering physician-generated questions is critical to determining their 
      suitability in clinical settings, facilitating complex decision-making, and 
      optimizing health care efficiency. OBJECTIVE: To assess the accuracy and 
      comprehensiveness of chatbot-generated responses to physician-developed medical 
      queries, highlighting the reliability and limitations of artificial 
      intelligence-generated medical information. DESIGN, SETTING, AND PARTICIPANTS: 
      Thirty-three physicians across 17 specialties generated 284 medical questions 
      that they subjectively classified as easy, medium, or hard with either binary 
      (yes or no) or descriptive answers. The physicians then graded the 
      chatbot-generated answers to these questions for accuracy (6-point Likert scale 
      with 1 being completely incorrect and 6 being completely correct) and 
      completeness (3-point Likert scale, with 1 being incomplete and 3 being complete 
      plus additional context). Scores were summarized with descriptive statistics and 
      compared using the Mann-Whitney U test or the Kruskal-Wallis test. The study 
      (including data analysis) was conducted from January to May 2023. MAIN OUTCOMES 
      AND MEASURES: Accuracy, completeness, and consistency over time and between 2 
      different versions (GPT-3.5 and GPT-4) of chatbot-generated medical responses. 
      RESULTS: Across all questions (n = 284) generated by 33 physicians (31 faculty 
      members and 2 recent graduates from residency or fellowship programs) across 17 
      specialties, the median accuracy score was 5.5 (IQR, 4.0-6.0) (between almost 
      completely and complete correct) with a mean (SD) score of 4.8 (1.6) (between 
      mostly and almost completely correct). The median completeness score was 3.0 
      (IQR, 2.0-3.0) (complete and comprehensive) with a mean (SD) score of 2.5 (0.7). 
      For questions rated easy, medium, and hard, the median accuracy scores were 6.0 
      (IQR, 5.0-6.0), 5.5 (IQR, 5.0-6.0), and 5.0 (IQR, 4.0-6.0), respectively (mean 
      [SD] scores were 5.0 [1.5], 4.7 [1.7], and 4.6 [1.6], respectively; P = .05). 
      Accuracy scores for binary and descriptive questions were similar (median score, 
      6.0 [IQR, 4.0-6.0] vs 5.0 [IQR, 3.4-6.0]; mean [SD] score, 4.9 [1.6] vs 4.7 
      [1.6]; P = .07). Of 36 questions with scores of 1.0 to 2.0, 34 were requeried or 
      regraded 8 to 17 days later with substantial improvement (median score 2.0 [IQR, 
      1.0-3.0] vs 4.0 [IQR, 2.0-5.3]; P &lt; .01). A subset of questions, regardless of 
      initial scores (version 3.5), were regenerated and rescored using version 4 with 
      improvement (mean accuracy [SD] score, 5.2 [1.5] vs 5.7 [0.8]; median score, 6.0 
      [IQR, 5.0-6.0] for original and 6.0 [IQR, 6.0-6.0] for rescored; P = .002). 
      CONCLUSIONS AND RELEVANCE: In this cross-sectional study, chatbot generated 
      largely accurate information to diverse medical queries as judged by academic 
      physician specialists with improvement over time, although it had important 
      limitations. Further research and model development are needed to correct 
      inaccuracies and for validation.
FAU - Goodman, Rachel S
AU  - Goodman RS
AD  - Vanderbilt University School of Medicine, Nashville, Tennessee.
FAU - Patrinely, J Randall
AU  - Patrinely JR
AD  - Department of Dermatology, Vanderbilt University Medical Center, Nashville, 
      Tennessee.
FAU - Stone, Cosby A Jr
AU  - Stone CA Jr
AD  - Department of Allergy, Pulmonology, and Critical Care, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - Zimmerman, Eli
AU  - Zimmerman E
AD  - Department of Neurology, Vanderbilt University Medical Center, Nashville, 
      Tennessee.
FAU - Donald, Rebecca R
AU  - Donald RR
AD  - Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, 
      Tennessee.
FAU - Chang, Sam S
AU  - Chang SS
AD  - Department of Urology, Vanderbilt University Medical Center, Nashville, 
      Tennessee.
FAU - Berkowitz, Sean T
AU  - Berkowitz ST
AD  - Vanderbilt Eye Institute, Department of Ophthalmology, Vanderbilt University 
      Medical, Nashville, Tennessee.
FAU - Finn, Avni P
AU  - Finn AP
AD  - Vanderbilt Eye Institute, Department of Ophthalmology, Vanderbilt University 
      Medical, Nashville, Tennessee.
FAU - Jahangir, Eiman
AU  - Jahangir E
AD  - Department of Cardiovascular Medicine, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Scoville, Elizabeth A
AU  - Scoville EA
AD  - Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - Reese, Tyler S
AU  - Reese TS
AD  - Department of Rheumatology and Immunology, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Friedman, Debra L
AU  - Friedman DL
AD  - Department of Pediatric Hematology/Oncology, Vanderbilt University Medical 
      Center, Nashville, Tennessee.
FAU - Bastarache, Julie A
AU  - Bastarache JA
AD  - Department of Allergy, Pulmonology, and Critical Care, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - van der Heijden, Yuri F
AU  - van der Heijden YF
AD  - Department of Infectious Disease, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Wright, Jordan J
AU  - Wright JJ
AD  - Department of Diabetes, Endocrinology, and Metabolism, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - Ye, Fei
AU  - Ye F
AD  - Department of Biostatistics, Vanderbilt University Medical Center, Nashville, 
      Tennessee.
FAU - Carter, Nicholas
AU  - Carter N
AD  - Division of Trauma and Surgical Critical Care, University of Miami Miller School 
      of Medicine, Miami, Florida.
FAU - Alexander, Matthew R
AU  - Alexander MR
AD  - Department of Cardiovascular Medicine and Clinical Pharmacology, Vanderbilt 
      University Medical Center, Nashville, Tennessee.
FAU - Choe, Jennifer H
AU  - Choe JH
AD  - Department of Hematology/Oncology, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Chastain, Cody A
AU  - Chastain CA
AD  - Department of Infectious Disease, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Zic, John A
AU  - Zic JA
AD  - Department of Dermatology, Vanderbilt University Medical Center, Nashville, 
      Tennessee.
FAU - Horst, Sara N
AU  - Horst SN
AD  - Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - Turker, Isik
AU  - Turker I
AD  - Department of Cardiology, Washington University School of Medicine in St Louis, 
      St Louis, Missouri.
FAU - Agarwal, Rajiv
AU  - Agarwal R
AD  - Department of Hematology/Oncology, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Osmundson, Evan
AU  - Osmundson E
AD  - Department of Radiation Oncology, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Idrees, Kamran
AU  - Idrees K
AD  - Department of Surgical Oncology &amp; Endocrine Surgery, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - Kiernan, Colleen M
AU  - Kiernan CM
AD  - Department of Surgical Oncology &amp; Endocrine Surgery, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - Padmanabhan, Chandrasekhar
AU  - Padmanabhan C
AD  - Department of Surgical Oncology &amp; Endocrine Surgery, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - Bailey, Christina E
AU  - Bailey CE
AD  - Department of Surgical Oncology &amp; Endocrine Surgery, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - Schlegel, Cameron E
AU  - Schlegel CE
AD  - Department of Surgical Oncology &amp; Endocrine Surgery, Vanderbilt University 
      Medical Center, Nashville, Tennessee.
FAU - Chambless, Lola B
AU  - Chambless LB
AD  - Department of Neurological Surgery, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Gibson, Michael K
AU  - Gibson MK
AD  - Department of Hematology/Oncology, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Osterman, Travis J
AU  - Osterman TJ
AD  - Department of Biomedical Informatics, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
FAU - Wheless, Lee E
AU  - Wheless LE
AD  - Department of Dermatology, Vanderbilt University Medical Center, Nashville, 
      Tennessee.
FAU - Johnson, Douglas B
AU  - Johnson DB
AD  - Department of Hematology/Oncology, Vanderbilt University Medical Center, 
      Nashville, Tennessee.
LA  - eng
GR  - T32 CA217834/CA/NCI NIH HHS/United States
GR  - UG3 CA260318/CA/NCI NIH HHS/United States
GR  - R01 CA227481/CA/NCI NIH HHS/United States
GR  - R01 CA240093/CA/NCI NIH HHS/United States
GR  - U54 CA163072/CA/NCI NIH HHS/United States
GR  - P30 CA068485/CA/NCI NIH HHS/United States
GR  - U01 HL156620/HL/NHLBI NIH HHS/United States
GR  - R01 CA225005/CA/NCI NIH HHS/United States
GR  - K12 CA090625/CA/NCI NIH HHS/United States
GR  - UG3 CA265846/CA/NCI NIH HHS/United States
GR  - R01 HL151523/HL/NHLBI NIH HHS/United States
GR  - K08 DK133691/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20231002
PL  - United States
TA  - JAMA Netw Open
JT  - JAMA network open
JID - 101729235
SB  - IM
CIN - doi: 10.1001/jamanetworkopen.2023.35924
MH  - Humans
MH  - *Artificial Intelligence
MH  - Cross-Sectional Studies
MH  - Reproducibility of Results
MH  - *Physicians
MH  - Software
PMC - PMC10546234
COIS- Conflict of Interest Disclosures: Ms Goodman reported receiving research support 
      from the SCRIPS Foundation and the Burroughs Wellcome Fund. Dr Stone reported 
      receiving grants from the American Academy of Allergy, Asthma, and the Immunology 
      Foundation Faculty Development Award during the conduct of the study. Dr Finn 
      reported being on the advisory boards of Eyepoint, Apellis, Allergan, Alimera, 
      and Iveric bio and consulting for and being on the advisory board of Genentech 
      outside the submitted work. Dr Horst reported receiving personal fees from 
      AbbVie, Takeda, BMS, and Janssen outside the submitted work. Dr Agarwal reported 
      receiving personal fees from the American Society of Clinical Oncology (ASCO) 
      (honoraria for faculty speaker at ASCO Advantage Course), the National 
      Comprehensive Cancer Network (NCCN) (honoraria for faculty speaker at NCCN annual 
      conference), the Great Debates and Updates in Gastrointestinal Malignancies 
      (honoraria for faculty speaker), and OncLive (honoraria for faculty speaker) 
      outside the submitted work. Dr Osmundson reported receiving grants from the 
      National Institutes of Health (NIH) unrelated to the present study and grants 
      from Varian Medical Systems unrelated outside the submitted work. Dr Chambless 
      reported receving consulting fees from Integra outside the submitted work. Dr 
      Osterman reported receiving grants from Microsoft, IBM, and GE Healthcare outside 
      the submitted work. Dr Wheless reported receiving grants from the Department of 
      Veterans Affairs during the conduct of the study. Dr Johnson reported receiving 
      grants from BMS and Incyte outside the submitted work and being on the advisory 
      boards of BMS, Catalyst, Merck, Iovance, Novartis, Pfizer. No other disclosures 
      were reported.
EDAT- 2023/10/02 12:42
MHDA- 2023/10/03 06:47
PMCR- 2023/10/02
CRDT- 2023/10/02 11:33
PHST- 2023/10/03 06:47 [medline]
PHST- 2023/10/02 12:42 [pubmed]
PHST- 2023/10/02 11:33 [entrez]
PHST- 2023/10/02 00:00 [pmc-release]
AID - 2809975 [pii]
AID - zoi231053 [pii]
AID - 10.1001/jamanetworkopen.2023.36483 [doi]
PST - epublish
SO  - JAMA Netw Open. 2023 Oct 2;6(10):e2336483. doi: 
      10.1001/jamanetworkopen.2023.36483.

PMID- 38547639
OWN - NLM
STAT- Publisher
LR  - 20240328
IS  - 1873-5134 (Electronic)
IS  - 0738-3991 (Linking)
VI  - 124
DP  - 2024 Mar 6
TI  - Effectiveness of a 5-year health empowerment programme on promoting 
      cardiovascular health for adults from low-income families in Hong Kong.
PG  - 108240
LID - S0738-3991(24)00107-1 [pii]
LID - 10.1016/j.pec.2024.108240 [doi]
AB  - OBJECTIVE: This study aimed to evaluate the effectiveness of a health empowerment 
      programme (HEP) to enhance cardiovascular health for adults from low-income 
      families. METHODS: A prospective cohort study (N&nbsp;=&nbsp;219, Intervention group: 
      n&nbsp;=&nbsp;103, comparison group: n&nbsp;=&nbsp;116) was conducted with participants recruited 
      from January 2013 to November 2015 and followed up until January 2022. Throughout 
      the study duration, intervention group were invited to participate in the HEP. 
      The cardiovascular health status of both groups at baseline and follow-up were 
      assessed using the adapted Ideal Cardiovascular Health Index (ICHI) defined by 
      the American Heart Association. After inverse propensity score weighting, 
      multiple linear regression and Poisson regression were employed to examine the 
      effects of the HEP. RESULTS: The HEP was associated with a greater increase in 
      ICHI total score (B = 0.33, p&nbsp;&lt;&nbsp;0.001), and the increase of proportion of people 
      achieving a normal blood pressure (Incidence rate ratio: 3.39, p&nbsp;&lt;&nbsp;0.05). 
      CONCLUSION: HEP can be an effective and sustainable strategy to reduce social 
      disparities in cardiovascular health of adults from low-income families, as 
      indicated by improvement in the ICHI total score and blood pressure status. 
      PRACTICAL IMPLICATIONS: The sustainable HEP in the community setting has 
      potential for generalizability and scalability to other financially challenged 
      families.
CI  - Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
FAU - Lu, Fangcao
AU  - Lu F
AD  - Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, 
      The University of Hong Kong, Hong Kong Special Administrative Region of China; 
      Department of Applied Social Sciences, Faculty of Health and Social Sciences, The 
      Hong Kong Polytechnic University, Hong Kong Special Administrative Region of 
      China.
FAU - Wong, Carlos King Ho
AU  - Wong CKH
AD  - Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, 
      The University of Hong Kong, Hong Kong Special Administrative Region of China; 
      Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University 
      of Hong Kong, Hong Kong Special Administrative Region of China; Laboratory of 
      Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong 
      Kong Special Administrative Region of China.
FAU - Ng, Amy Pui Pui
AU  - Ng APP
AD  - Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, 
      The University of Hong Kong, Hong Kong Special Administrative Region of China; 
      Department of Family Medicine and Primary Care, The University of Hong 
      Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
FAU - Li, Lanlan
AU  - Li L
AD  - Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University 
      of Hong Kong, Hong Kong Special Administrative Region of China.
FAU - Fong, Daniel Yee Tak
AU  - Fong DYT
AD  - School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 
      Hong Kong Special Administrative Region of China.
FAU - Ip, Patrick
AU  - Ip P
AD  - Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of 
      Medicine, The University of Hong Kong, Hong Kong Special Administrative Region of 
      China; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's 
      Hospital, Hong Kong.
FAU - Tse, Emily Tsui Yee
AU  - Tse ETY
AD  - Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, 
      The University of Hong Kong, Hong Kong Special Administrative Region of China; 
      Department of Family Medicine and Primary Care, The University of Hong 
      Kong-Shenzhen Hospital, Shenzhen, Guangdong, China. Electronic address: 
      emilyht@hku.hk.
FAU - Lam, Cindy Lo Kuen
AU  - Lam CLK
AD  - Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, 
      The University of Hong Kong, Hong Kong Special Administrative Region of China; 
      Department of Family Medicine and Primary Care, The University of Hong 
      Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.
LA  - eng
PT  - Journal Article
DEP - 20240306
PL  - Ireland
TA  - Patient Educ Couns
JT  - Patient education and counseling
JID - 8406280
OTO - NOTNLM
OT  - Cardiovascular health
OT  - Health disparities
OT  - Health empowerment
OT  - Low-income families
COIS- Declaration of Competing Interest During the preparation of this work the 
      author(s) used ChatGPT in order to proofediting. After using this tool, the 
      author(s) reviewed and edited the content as needed and take(s) full 
      responsibility for the content of the publication.
EDAT- 2024/03/29 00:45
MHDA- 2024/03/29 00:45
CRDT- 2024/03/28 19:07
PHST- 2023/10/19 00:00 [received]
PHST- 2024/02/26 00:00 [revised]
PHST- 2024/03/01 00:00 [accepted]
PHST- 2024/03/29 00:45 [medline]
PHST- 2024/03/29 00:45 [pubmed]
PHST- 2024/03/28 19:07 [entrez]
AID - S0738-3991(24)00107-1 [pii]
AID - 10.1016/j.pec.2024.108240 [doi]
PST - aheadofprint
SO  - Patient Educ Couns. 2024 Mar 6;124:108240. doi: 10.1016/j.pec.2024.108240.

PMID- 38379510
OWN - NLM
STAT- MEDLINE
DCOM- 20240222
LR  - 20240224
IS  - 2000-8066 (Electronic)
IS  - 2000-8066 (Linking)
VI  - 15
IP  - 1
DP  - 2024
TI  - The German PCL-5: evaluating structural validity in a large-scale sample of the 
      general German population.
PG  - 2317055
LID - 10.1080/20008066.2024.2317055 [doi]
LID - 2317055
AB  - Background: In attempts to elucidate PTSD, recent factor analytic studies 
      resulted in complex models with a proliferating number of factors that lack 
      psychometrical and clinical utility. Recently, suggestions have been made to 
      optimize factor analytic practices to meet a refined set of statistical and 
      psychometric criteria.Objective: This study aims to assess the factorial 
      structure of the German version of the PCL-5, implementing recent methodological 
      advancements to address the risk of overfitting models. In doing so we diverge 
      from traditional factor analytical research on PTSD.Method: On a large-scale 
      sample of the German general population (n = 1625), exploratory factor analyses 
      were run to investigate the dimensionality found within the data. Subsequently, 
      we validated and compared all model suggestions from our preliminary analyses 
      plus all standard and common alternative PTSD factor models (including the ICD-11 
      model) from previous literature with confirmatory factor analyses. We not only 
      consider model fit indices based on WLSMV estimation but also deploy criteria 
      such as favouring less complex models with a parsimonious number of factors, 
      sufficient items per factor, low inter-factor correlations and number of model 
      misspecifications.Results: All tested models showed adequate to excellent fit in 
      respect to traditional model fit indices; however, models with two or more 
      factors increasingly failed to meet other statistical and psychometric 
      criteria.Conclusion: Based on the results we favour a two-factor bifactor model 
      with a strong general PTSD factor and two less dominant specific factors - one 
      factor with trauma-related symptoms (re-experiencing and avoidance) and one 
      factor with global psychological symptoms (describing the trauma's higher-order 
      impact on mood, cognition, behaviour and arousal).From the perspective of 
      clinical utility, we recommend the cut-off scoring method for the German version 
      of the PCL-5. Basic psychometric properties and scale characteristics are 
      provided.
FAU - Pettrich, Amelie
AU  - Pettrich A
AUID- ORCID: 0009-0007-6368-7486
AD  - Department of Medical Psychology and Medical Sociology, Medical Faculty, Leipzig 
      University, Leipzig, Germany.
FAU - Friedrich, Michael
AU  - Friedrich M
AUID- ORCID: 0000-0002-0528-1564
AD  - Department of Medical Psychology and Medical Sociology, Medical Faculty, Leipzig 
      University, Leipzig, Germany.
FAU - Nesterko, Yuriy
AU  - Nesterko Y
AUID- ORCID: 0000-0002-8296-0958
AD  - Department of Medical Psychology and Medical Sociology, Medical Faculty, Leipzig 
      University, Leipzig, Germany.
FAU - Glaesmer, Heide
AU  - Glaesmer H
AUID- ORCID: 0000-0002-3752-7653
AD  - Department of Medical Psychology and Medical Sociology, Medical Faculty, Leipzig 
      University, Leipzig, Germany.
LA  - eng
PT  - Journal Article
DEP - 20240221
PL  - United States
TA  - Eur J Psychotraumatol
JT  - European journal of psychotraumatology
JID - 101559025
SB  - IM
MH  - Humans
MH  - *Stress Disorders, Post-Traumatic/diagnosis/epidemiology/psychology
MH  - Checklist/methods
MH  - Reproducibility of Results
MH  - Psychometrics
MH  - Factor Analysis, Statistical
PMC - PMC10883083
OAB - We contribute new insights to the debate on the factor structure of the PTSD 
      Checklist (PCL-5) based on a large German general population sample deploying the 
      newest methodological developments in a revised factor-analytical 
      approach.Combining theoretical, statistical and practical considerations, we 
      favour a two-factor bifactor model with a strong general PTSD factor and two less 
      dominant specific factors – one factor with trauma-related symptoms and one 
      factor with global psychological symptoms.For clinical practitioners, we 
      recommend using the cut-off scoring method.
OABL- eng
OTO - NOTNLM
OT  - LEC-5
OT  - PCL-5
OT  - PTSD
OT  - Post-traumatic stress disorder
OT  - TEPT
OT  - Trastorno de estrés postraumático
OT  - estructura factorial
OT  - factorial structure
OT  - propiedades psicométricas
OT  - psychometric properties
COIS- During the revision of this work, the author used ChatGPT-3.5 in order to refine 
      language. After using this tool, the authors reviewed and edited the content as 
      needed and take full responsibility for the content of the publication. The 
      authors reported no potential conflict of interest.
EDAT- 2024/02/21 11:15
MHDA- 2024/02/22 06:43
PMCR- 2024/02/21
CRDT- 2024/02/21 03:43
PHST- 2024/02/22 06:43 [medline]
PHST- 2024/02/21 11:15 [pubmed]
PHST- 2024/02/21 03:43 [entrez]
PHST- 2024/02/21 00:00 [pmc-release]
AID - 2317055 [pii]
AID - 10.1080/20008066.2024.2317055 [doi]
PST - ppublish
SO  - Eur J Psychotraumatol. 2024;15(1):2317055. doi: 10.1080/20008066.2024.2317055. 
      Epub 2024 Feb 21.
</pre>
      
    </div>
  </main>


  
  


  


</body></html>